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CHAPTE R I 
GENERAL INTRODUCTION 
I.l. General approaches 
The first clinical reports of patients suffering from a 
sphingolipid starage disease appeared shortly befare the 
turn of the present century (for instanee Tay,1881; Gaucher, 
1882; Sachs,1887). Most authors noted the familial occurrence, 
the retardation in motor and mental development and the 
rapidly progressive course of these disorders. More specific 
clinical symptoms are hepatosplenomegaly and bony deform.ities 
(Gaucher's disease; GM1-gangliosidosis), a cherry-red spot in 
the macula {most prominent in Tay-Sachs disease but also 
present in some other lipidoses) , blindness and deafness 
(Krabbe's disease; GM2-gangliosidosis; Metachromatic Leuko-
dystrophy) and vascular lesions such as angiokeratomata 
(Fabry's disease; variantsof GM 1 -gangliosidosis). In the 
classical farms of the sphingolipidoses the onset of the 
symptoms usually occurs in the first year(s) of life, and 
most patients die in early childhood. Most of the disorders 
are panethnic, but in some of them the incidence is higher 
among certain popula ti ons. The incidence of Tay-s·achs 
disease, for instance, is as high as 1:3600 newborns among 
Ashkenazy Jews, whereas among Caucasians the incidence is 
less than 1 in 100 000 liveborns. The incidence of most 
sphingolipidoses is low. 
During the last decades an increasing number of variants 
has been described; they aften showed different clinical 
features, the onset of symptoms might be later and the 
course of the disease milder. Delineation on the basis of 
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clinical features alone has therefore been difficult in many 
cases. Studies on the pathological and histological manifes-
tations of these disorders contributed considerably to the 
distinction of the various disorders. For example, Piek 
(1927) provided clear evidence of histological differences 
between what now is called Niemann-Pick disease and Gaucher's 
disease. In 1924, the typical globoid cells in the white 
matter of brain from a patient with Krabbe's disease have 
been described (Collier and Greenfield,1924) and this ab-
normality has for a long time been the main parameter for 
the definitive diagnosis of Krabbe's disease. The same was 
true for the metachromatic staining of the myelin in the 
nervous system of patients with Metachromatic Leukodystrophy 
(Alzheimer,1910). 
Ultrastructural investigations of cells from most patients 
Suffering from a sphingolipidosis revealed concentrically 
laminated, myelin-like figures with a periodicity of soA. In 
both Gaucher's disease and Krabbe's disease tubular arrange-
ments are present, whereas in Metachromatic Leukodys-trophy 
the presence of lamellar leaflets with a herringbone pattern 
has been shown (for reviews on ultrastructural abnormalities 
in sphingolipidoses see in Hers and van Hoof,1973). 
The first disorder in which the chemistry of the accumu-
lated lipid was correctly identified was Gaucher's disease. 
Aghion (1934) and Halliday et al. ( 1940) showed that in the 
organs and tissues of patients with Gaucher's disease the 
sphingolipid glucosylcerêi.mide ac_cumulates. Glucosylceramide 
is composed of sphingosine, a long-chain fatty acid and a 
terminal molecule of glucose. The fatty acid and sphingosine 
form a complex called ceramide. Subsequently, the starage 
products in the other inborn errors of sphingolipid meta-
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Table I.l. The sphingolipidoses 
disease starage product 
Niemann-Pick disease Sphingomyelin 
Gaucher 1 s disease Glucosylceramide 
Krabbe 1 s disease or Galactosylceramide 
Globoid Cell Leuko-
dystrophy 
Metachromatic Leuko- Galactosyl-3-
dystrophy sulfate-eeramide 
Fabry' s di sease 
GM1 -gangliosidosis 
GM2-gangliosidosis 
Farber·disease 
Globotriaosyl-
ceramide 
GMl -ganglioside 
GM2-ganglioside 
eeramide 
enzyme deficiency 
sphingomyelinase 
glucocerebrosidase 
galactosylceramide 
-p-galactosidase 
arylsulfatase A 
a·-galactosidase A 
GM1 -p-galactosidase 
p-N-Acetyl-hexo-
saminidase 
ceramidase 
bolism have been identified (for reviews see in: Hers and 
van Hoof,1973; Svennerholm,1976; in: Stanbury, Wijngaarden and 
Frederickson,1978). eeramide was shown to be common to all 
sphingolipids that accuruulate in the lipid starage diseases,but 
the composition of the terminal residue differed. (Table I.l.). 
The elucidation of the chemical composition of the starage 
products formed the basis for the identification of the 
responsible genetic enzyme deficiencies. 
Gaucher 1 s disease was also the first sphingolipid starage 
disease in which the nature of the underlying metabolic ab-
normality was established. Investigations on the biosynthesis 
of glucosylceramide indicated an essentially normal rate of 
the formation of this substance in spleen tissue obtained 
from patients with Gaucher's disease (Trams and Brady,1960) 
Same five years later, the deficiency of a catabolie enzyme 
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required for the hydralysis of the p-glucosidic bond of gluco-
sylceramide was demonstrated (Brady et al.,1965,1966). Based 
on the nature of the deficient enzyme in Gaucher 1 s disease, 
the roetabolie defect in other sphingolipidoses was postulated 
to be the lack of catabolie enzymes, involved in the degra-
dation of the accuroulating lipids. In the following years, 
deficiencies of catabolie enzymes were shown in all sphingo-
lipid storage diseases (Table I.l.). 
In 1955, de Duve et al. introduced the term "lysosome" to 
indicate membrane-surrounded cytoplasmic vesicles. With the 
use of differential centrifugation and with histochemical 
staining techniques, it was shown that lysosomes contain acid 
hydrolases (de Duve,1955,1965; Novikoff,1961). These enzymes 
can degrade proteins, oligosaccharides, nucleic acids and 
lipid material, exhibit maximal activity at acid pH, and are 
usually specific for one type of linkage (for review see 
de Duve and wattiaux 1 1~66). The concept of lysosomal storage 
diseases was first described by Hers (1965), who postulated 
that the two major criteria for such inborn errors of meta-
bolism are the genetic deficiency of one of the acid hydro-
lases that are normally localized within the lysosome, and 
the accumulation of undigested material within single mem-
brane bound organelles. The d'eficiency of acid a1,4- gluco-
sidase in the glycogen starage disease, glycogenosis II 
(Pompe's disease) was the first example of such a lysosomal 
starage disease (Hers, 1963; Baudhuin et al., 196 4) . In the 
sphingolipidoses, the lysosomal localization of the starage 
products could also be established. The enzymes involved in 
the degradation of the sphingolipids were shown to be local-
ized in the lysosomes as well, and this characterized the 
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sphingolipidoses as lysosomal starage diseases~ 
Since the enzymic defects responsible for the sphingo-
lipidoses are known, the biochemical assay has become an 
important tool in diagnosis~ The enzyme defects are expressed 
in a variety of cells, tissues and body fluids, and the dem-
onstration of an enzyme deficiency allows a diagnosis even 
befare any clinical features are present. Enzyme assays in 
leucocytes or cultured fibroblasts sametimes enable the de-
tection of heterozygotes, and enzyme analysis of cultured 
amniotic fluid cells allows prenatal detection of patients 
and thereby prevention if selective abortion is carried out 
(for review see Galjaard,1979). 
In sorne genetic roetabolie diseases the mutation can be 
demonstrated on the level of the DNA itself. With the use of 
restrietion enzymes and DNA hybridization techniques Wang 
et al. (1978) were able to demonstrate a deletion in the 
globin gene of a patient with a-thallassaemia. Recently, 
Kan and Dozy (1978) performed a prenatal diagnosis of sickle 
cell anaemia by DNA analysis of amniotic fluid cells by taking 
advantage of a polymorphism very near to the p-globin gene. 
The great potential of this approach is that expression of 
the (enzyme)protein that is involved in the genetic defect 
is nat required and any type of DNA-containing cell in prin-
ciple can be used for (prenatal) diagnosis. As far as the 
diagnosis of sphingolipidoses is concerned recombinant DNA 
methods can be used only if specific messenger RNA's can be 
isolated. 
A combination of clinical examiniation, pathological 
studies and biochemical assays of the responsible enzyme 
11 
defect has facilitated the characterization of patients with 
various types of sphingolipidoses. Moreover, one of the con-
sequences of the increasing knowledge is that, what at first 
seemed to be a single clinical entity on closer scrunity ap-
peared to be a heterogeneaus group of conditions with varying 
clinical manifestations and/or biochemical characteristics. 
Clinical heterogeneity, expressed by the occurrence of pro-
gressive infantile farms, later onset juvenile farms and 
milder adult variants, is for example observed in Niemann-
Pick disease, GM 1 -gangliosidosis and Gaucher's disease, 
whereas biochemical heterogeneity has for instanee been found 
in GM2 -gangliosidosis (for review see in: Stanbury et al., 
1978; Galjaard,1979). The occurrence of this heterogeneity 
raises questions about the nature of the underlying gene 
defect, its correlation with the residual enzyme activity and 
the impairment of cellular functions. 
As a first approach, the presence of different gene muta-
tions in clinical or biochemical variants of the ''same'' dis-
order can be established by complementation analysis. This 
analysis is based on the principle that two mononuclear cells, 
each carrying an independent mutation affecting the same 
function, are brought tagether in a bikaryon using cell 
fusion techniques; if restoration of the affected functions 
(complementation) occurs in the heterokaryons this is a 
proof that two different gene mutations are involved in "the 
same" metabolic defect. De Weerd-Kastelein et al. (1972) were 
the first to perfarm complementation studies on cells from 
different clinical variants of the genetic skin disease 
xeroderma pigmentosum. They found restoration of DNA repair 
in binuclear heterokaryons, and similar complementation 
studies have since shown the presence of different gene 
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Table I.2. Diseases for which the presence of multiple complementation groups has been 
demonstra ted. 
Disease 
Xeroderma Pigmentasurn 
Maple Syrup Urine 
Disease 
GM2-gangliosidosis 
Methylmalonic-
acidemia 
GM 1-gangliosidosis 
Propionyl-coA carbo-
xylase deficiency 
Niemann-Pick disease 
Mucolipidoses 
( Sialidoses) 
Deficient enzyme or 
cellular function 
DNA repair 
Authors 
de Weerd-Kastelein 
etal.,1972; 1974 
Bootsmaand Galjaard,1979 
decarboxylase of branched Lyonset al.,1973 
chain keto acids 
~-N-Acetyl-hexosamini­
dase 
methyl malonyl-CoA 
mutase 
~-galactosidase 
propionyl-CoA carbo-
xylase 
sphingomyelinase 
neuraminidase 
Thomas et al.,1974 
Galjaard et al.,1974a 
Gravel et al.,1975 
Willard et al.,1978,1979 
Galjaard et al.,1975 
Gravel et al.,1977 
Wolf et al.,1978 
Besley et al., to be 
published 
Hoogeveen et al.,to be 
published 
d'Azzo et al.,1979 
no. of comple-
mentation groups 
7 
2 
2 
6 
2 
2 
2 
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mutations in a number of variants of other genetic roetabolie 
diseases (for review see Ruddle and Creagan,1975; Ringertz 
and Savage,1976; Bootsma and Galjaard,1979). These studies 
are summarized in table r.2. 
Although the occurrence of genetic cornplernentation indi-
cates that different gene rnutations are involved, the absence 
of restoration of enzyrne activity in heterokaryons does nat 
necessarily mean that different clinical or biochemical 
variants are caused by allelic mutations. No cornplernen-
tation has for instanee been found after fusion of cells 
frorn patients with the infantile and adult farm of Pornpe•s 
disease (Reuser et al.,1978) nor after fusion of cells frorn 
patients with the Hurler and Scheie syndrorne, bath with an 
a-L-iduronidase deficiency, or after hybridization of cells 
with different types of arylsulfatase deficiencies. Although 
the absence of multiple cornplernentation groups rnay be the 
result of the molecular structure of the (iso)enzyrnes in-
volved,it rnay also be due tosome disadvantages inherent to 
the eukaryotic system. Heterokaryens after fusion of human 
fibroblasts have a limited life span and this might be toa 
short for the necessary intracellular and biochemical events 
that are required befare restoration of the particular meta-
bolie function can be demonstrated. Also, the molecules which 
have to interact may be present in separate cell cornpartments. 
The problem of analyzing heterokaryons in the presence of 
homokaryons and unfused parental cells can be avoided by 
using microchemical analysis of single binuclear cells 
(Galjaard et al.,1974b,1975), or by separation of different 
cell populations after labelling with fluorescent beads 
using a FACS II Cell Sarter (Herzenberg et al.,1976). 
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Initially, compleroentation studies were described for 
micro-organisms (for review see Fincharo, 1966). In his clas-
sical studies on bacteriophage genetics, Benzer (1957) devised 
a cis-trans test of genetic function. In this test, two 
haploid genomes, each carrying an independent mutation af-
fecting the same roetabolie function, are brought tagether in 
the saroe cell. If the two mutations are located in two dif-
ferent genes, restoration of the enzyme activity and/or the 
roetabolie function will oecur to the level of the wild type. 
This phenomenon is called intergenie complementation. On the 
other hand, if the two mutations are loealized in the same 
gene, no enzyme at all or a much lower aroount of aetive enzyme 
is produced. If a low amount of aetive enzyme is produced, 
this is the result of intragenie or interallelic complemen-
tation. Two similar polypeptides, which are defective in a 
different way, may assoeiate and correction of the mutation 
by the tertiary structure of the associated subunits may lead 
to partial restoration of enzyme activity. This phenomenon 
will only oceur in enzymes, whieh contain two or more iden-
tical subunits (Crick and Orgel,1964; for reviews see Fincham, 
1966; Ratner and Rodin,1976). 
Intragenie complementation has been described for 
Escherichia coli p-galactosidase. Bath in vivo and in vitro 
experiments, using mutant strains carrying point mutations 
in the z-gene of the Lac-operon, resulted in restoration of 
~-galactosidase activity. Intragenie complementation was 
also achieved by using fragments of the E.coli ~-galactosi­
dase protein (a- and UJ-complementation). In all these ex-
periments it was demonstrated that the complemented enzyme 
was different in structure from the wild type enzyme (Zabin 
and Villarejo,1975). 
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In theory, bath intergenie and intragenie complementation 
mechanisms could occur in eukaryotic systems as well. If inter-
genie complementation occurs, the mutation might be present in: 
- two different structural genes coding for enzymes involved 
in the same roetabolie function, 
- two different structural genes coding for different subunits 
of a particular enzyme, 
- a structural gene coding for the enzyme involved and in a 
gene coding for a cofactor or regulatory process which is 
needed for the enzyme to attain its full enzymatic activity 
and proper intracellular compartmentalization, 
- two different genes coding for factors or processes needed 
for a normal functioning of the enzyme, in which case the 
structural genes coding for (the subunits of) the particu-
lar enzyme are normal. 
Intergenie complementation is involved in the restoration 
of normal roetabolie activity after fusion of fibroblasts from 
different types of methylmalonic acidemia. The six complemen-
tation groups most likely represent two loci involved in the 
production of the methylmalonyl-CoA mutase protein, and four 
loci involved in the production of its coenzyme adenosyl-
cobalamin (Gravel et al.,1975; Willard et al.,1978, 1979). The 
mechanism of complementation of the other disorders listed in 
Table I.2. was still unknown at the moment that the experimen-
tal work described in this thesis, was started. 
Our experiments were aimed at an understanding of the 
nature of the gene mutations involved in different variants 
of GM 1- and GM2-gangliosidosis and of the mechanism of the 
observed complementation after fusion of fibroblasts from 
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patients with differentvariantsof GM1- and GM2-gangliosi-
dosis, respectively. This required knowledge of the molecular 
structure and physico-chemical characteristics of: 
- the normal p-galactosidase and N-acetyl-p-hexosaminidase 
isoenzymes, 
- the mutant j3-galactosidase and 
1
3-hexosaminidase isoenzymes 
present in patients with GM1- and GM 2-gangliosidosis res-
pectively, 
- the restored enzyme activity which is present in hetero-
karyons after fusion of certain combinations of variants 
of GM1- and GM2-gangliosidosis. 
I.2. GM2-gangliosidosis 
GM2-gangliosidoses involve different autosomal recessive 
diseases, characterized by the accumulation of GM2-ganglio-
sides in the lysosomes~ The most common farm of GM2-ganglio-
sidosis is Tay-Sachs disease or type 1 GM2-gangliosidosis. 
Another form is called Sandhoff's disease or type 2 GM2 -
gangliosidosis (Sandhoff,1968; for reviews see O'Brien,1978a 
and Sandhoff and Christomanou,1979). In addition tothese 
most common farms there are a number of variants which differ 
in the onset and properties of the clinical features (for 
review see Galjaard and Reuser,1977; O'Brien,1978a,1978b) 
The clinical manifestations of Tay-Sachs disease and 
Sandhoff's disease are similar. The first symptoms occur a 
few months after birth; the children are apathetic, and un-
able to sit at the usual time. After six months a motor 
weakness develops and unusual limb movements occur. Vision is 
impaired , and due to macular degeneration a cherry-red spot 
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can be detected. After one year motor and mental deterio-
ràtion progresses rapidly. By the age of two years the 
cran~al measurements become larger than normal as a result 
of proliferation of glial cells in the brain and after a 
period of progressive deafness, blindness, spasticity and a 
state of decerebrate rigidity most patients die from broncho-
pneumonia by the age of two to four years. 
The most striking pathological alterations in Tay-Sachs 
disease and Sandhoff's disease occur in the brain. There is 
a loss of ganglion cells and Purkinje cells, which is aceom-
panled by a proliferation of glial cells. The cytoplasm of 
the remaining ganglion cells in the cerebral cortex and 
Purkinje cells are packed with lysosomes in which lipid ma-
terial is accumulated as concentrical membranes. Demyelination 
of the axons is consistently found (Adachi and Volk,1975). 
Distinct from Tay-Sachs disease, accumulation of glycolipid 
material in other tissues than the brain is more common in 
patients with Sandhoff's disease (Sandhoff et al.,1968). 
Klenk (1939) was first to discover that the material 
stared in Tay-Sachs disease was a neuraminic acid containing 
sphingolipid which he called ganglioside. The amount of GM2-
ganglioside in brain of Tay-Sachs patients was found to be 
100 to 300 times higher than normal (Svennerholm,1962,1963) 
Asialo-GM2-ganglioside accumulates to a lesser extent and is 
20-50 times higher than control values. Most of the accumu-
lated GM2-gangliosides are located in the concentrical 
lamellar structures in the lysosomes (O'Brien,1973). In brain 
tissue of patients with Sandhoff's disease the starage of 
asialo-GM2-ganglioside is more pronounced than in Tay-Sachs 
disease. In Sandhoff's disease the visceral organs accuroulate 
globoside in addition to GM2- and asialü-G -ganglioside M2 
(Schr.eck, 1975). 
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Studies on the chemical nature of the starage products 
in GM2 -gangliosidosis led to the prediction that the disease 
would be caused by a defective activity of N-acetyl-P-D-
galactosaminidase (Svennerholm,1957,1966), but no decreased 
hexosaminidase activity could be demonstrated. Robinson and 
Stirling (1968) then showed the presence of two major N-
acetyl-~-D- hexosaminidase isoenzymes, which they called 
hexosaminidase A (hexA) and hexosaminidase B (hexB) . Shortly 
thereafter, Okada and O'Brien (1969) were able to show that 
Tay-Sachs disease is caused by a deficiency of hexA, whereas 
increased activity of hexB is present in these patients. In 
patients with Sandhoff's disease bath hexA and hexB were 
found to be deficient (Sandhoff et al.,1968). HexA catalyzes 
the remaval of the terminal ~-N-acetylgalactosamine from 
(asialo-)GM2-ganglioside and globoside. HexB has activity 
against the asialo-GM2-ganglioside and globoside substrates. 
Assays for hexosaminidase are usually carried out with the 
artificial substrates p-nitrophenyl-~ -D-N-acetylglucosaminide 
(or -galactosaminide) or 4-methylumbelliferyl-2-acetamido-2-
deoxy-~-D-glucopyranoside (or -galactopyranoside) . Based on 
clinical and biochemical studies using bath artificial and 
natural substrates, in the last decade a number of variants 
of GM2-gangliosidosis have been described. These ·will be 
discussed in Chapter III.l. 
Although the clinical expression of Tay-Sachs disease 
and Sandhoff's disease is very similar, bath disorders differ 
in the nature of their residual hexosaminidase activity. To 
investigate the genetic basis of this biochemical hetero-
geneity, complementation studies were carried out (Thomas et 
al., 1974; Galjaard et al., 1974a). In these st.udies, fibro-
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blasts from a patient with Tay-Sachs disease were fused with 
fibroblasts from a patient with Sandhoff's disease. In the 
resulting heterokaryons, restoration of hexA acti.vity could 
be demonstrated, which proved that two different gene muta-
tions are responsible for Tay-Sachs and Sandhoff's disease. 
Co-cultivation of both types of mutant fibroblasts did not 
result in reappearance of hexA activity, nor did mixing of 
cell homogenates from both cell strains. 
For an understanding of the mechanism of this comple-
mentation knowledge is required about the molecular structure 
of the hexosaminidase isoenzymes in normal human cells and 
in cells from patients with Tay-Sachs and Sandhoff's disease. 
Gene localization studies using electrophoretic and immu-
nological methods were carried out to determine the number 
and function of genes involved in the expression of the 
hexosaminidases. The result of these studies will be dis-
cussed in Chapter II.2. 
I.3. G -gangliosidosis Ml 
In 1964, Landing et al. reported on eight patients with 
a lysosomal starage disease, which they called "familial 
neurovisceral lipidosis". This disorder, which has subse-
quently been designated as "generalized gangliosidosis", 
''Landing as disease" and "G -gangliosidosis" shows an auto-MI 
somal recessive inheritance and is characterized by retarded 
psychomator development from birth on. Progressive deterio-
ration of motor and mental functions and deafness and 
blindness occur. Cherry-red spots in the retina, as present 
in Tay-Sachs disease, are present in some patients 1 but not 
in all. Purthermare severe bone deformities and hepatospleno-
megaly are present, and the patients usually expire between 
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one and two years of age, due to bronchopneumonia (for reviews 
0' Brien, 1972, 1978a) . 
The cytoplasm of neurons of all cortices and deep gray 
matter is filled with enlarged lysosomes. Most of these 
consist of concentrically arranged lamellae surrounding an 
inner amorphic core, similar to those seen in Tay-Sachs 
disease. The cerebral and cerebrellar white matter shows 
demyelination, and axonal loss (Adachi and Volk,1975). Foamy 
histiocytes are reported in various visceral organs. Electron 
microscopy of the lysosomal inclusions in the viscera shows 
vacuales containing amorphous or fine-granular materialt 
mixed with mernbranous lamellae (for review see O'Brien, 
l978a). 
In the brain and visceral organs from GM 1-gangliosidosis 
patients there are increased levels of GM 1-ganglioside and 
its asialo-derivative. The amount of GM 1-ganglioside is 
approximately 10 times higher than in controls in the gray 
matter and 20-50 times in liver. The visceral histiocytosis 
is not due to ganglioside storage, but to starage of keratan-
sulfate-like mucopolysaccharides (Suzuki et al.,1971). 
In 1968, Okada and O'Brien showed that GM1-gangliosidosis 
is caused by a defective lysosomal enzyme, acid ~-galacto­
sidase. This ~-galactosidase deficiency can be demonstrated 
in cerebral tissue 1 visceral organs 1 body fluids, leucocytes 
and cultured skin fibroblasts. The enzyme can be assayed 
either withits natural substrate, GM 1-ganglioside, or with 
the artificial substrates p-nitrophenyl-~-D-galactopyranoside 
and 4-methylumbelliferyl- p -D-galactopyranoside. 
Several clinical farms of GM
1
-gangliosidosis have been 
described. In addition to the classical type described by 
Landing et al. (1964) which is referred to as the infantilr 
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type or type 1 GM1-gangliosidosis, Derry et al. (1968) de-
scribeà two siblings with a juvenile farm of the disease or 
type 2 G -gangliosidosis. In these patients the onset of M1 
symptoms is later and the course of the disease is milder. 
Mental and motor development is usually normal during the 
first year of life and early symptoms are loss of speech and 
generalized muscular weakness. Mental and motor deterioration 
progresses during the following years and death usually 
occurs at the age of 3-10 years of life. Bony deformaties 
are mild or absent and the same is true for hepatosplenome-
galy. Histopathology does not enable a distinction between 
the infantile and juvenile farm, nor does the analysis of the 
starage products or the level of the residual ~-galactosidase 
activity, which is less than 1% in both type 1 and type 2 
(O'Brien, 1972,1978a; Galjaard and Reuser,1977). 
During the last years a number of other clinical variants 
with a p-galactosidase deficiency have been described. These 
patients varyin age from 1~ year (Andria et al.,1978) to 41 
years (Stevenson et al.,1978). Mild skeletal abnormalities 
are present in nearly all patients (Suzuki et al.,1977). 
Mental retardation is apparent in some patients (Goldberg et 
al.,1971; Orii et al.,1972; Lowden et al.,1974; Loonen et al., 
1974; Yamamoto et al,1974; Stevensonet al.,1978), but in 
others the intelligence may be (nearly) normal (Pinsky et al., 
1974; Wenger et al.,1974; O'Brien,1976; Andria et al.,1978). 
Other clinical features which may be associated with a ~-galac­
tosidase deficiency are myoclonus, cherry-red spot in the 
macula, ataxia and visceromegaly. In the various patients 
different combinations of clinical manifestations occur. 
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In order to investigate the genetic background of this 
clinical heterogeneity 1 complementation studies have been per-
formed (Galjaard et al.,1975; Bootsmaand Galjaard,1979). 
Fibroblasts from different patients were fused using inac-
tivated Sendai virus~ The ~-galactosidase activity was as-
sayed in individual binuclear cells, using a microchemical 
assay procedure (Galjaard et al.,1974b). An advantage of this 
approach is that quantitative information is obtained about 
the restored ~-galactosidase activity in heterokaryons~ In 
some of the fusion combinations nearly complete restoration 
of ~-galactosidase activity occurred 1 comparable with the ac-
tivity in normal mononuclear fibroblasts~ Another approach 
has been to measure the ~-galactosidase activity in a mixed 
population of heterokaryons 1 homokaryons and non-fused cells 
and to campare the analytical data with those of the two 
parental cell strains measured separately or after co-culti-
vation~ 
Based on these two approaches the patients with different 
farms of ~-galactosidase deficiency could be classified in two 
complementation groups (Table I~3.). In na instanee co-culti-
Table 1.3. Genetic classification of variants with a ~-galactosidase deficiency 
Complementation group A 
Infantile (type 1) GM1-gangliosidosis 
Juvenile (type 2) GM1-gangliosidosis 
Variant described by Lowden et al. (1974) 
Variant described by Norden and O'Brien (1975) 
Adult variants described by Suzuki et al. (1977) 
Variant of Wenger 
Variant of Svennerholm 
Morquio syndrome with ~-GAL deficiency 
(Krins et al.,1979) 
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Complementation group B 
variant described by Pinsky et al. (1974) 
Variant described by Loonen et al. (1974) 
Variant described by Andria et al. (1978) 
Variant described by Kleyer et al. (1979) 
vation of different mutant cell strains or mixture of two 
cell homogenates resulted in a restoration of ~-galactosidase 
activity. These data indicate that at least two different 
gene mutations are involved in the various clinical forms of 
~-galactosidase deficiency. To obtain insight in the mechanism 
of complementation, gel filtratien studies as well as gene 
localization studies using electrophoretic and immunological 
techniques have been performed. These will be discussed in 
Chapter II.3. 
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CHAPTER II. 
INTRODUCTION AND DISCUSSION OF THE EXPERTMENTAL WORK 
II.l. Introduetion 
For a correct interpretation of bath the absence and occur-
rence of complementation the following three aspects are im-
portant: 
a. the molecular structure and the processing of the 
normal enzymes 
b. the properties of the mutated enzymes 
c. the characteristics of the restored enzyme activity 
after fusion of two variants with "the same" disorder. 
Paigen (1971) used the term "enzyme realization" to indi-
cate all the processes required for the production of a 
catalytically active enzyme. According to de Duve and 
Wattiaux (1966) for lysosomal enzymes thèse processes in-
clude transcription of the structural genes involved, pro-
duction of the protein parts of the enzyme at the rough 
endoplasmatic reticulum, their transfer to the Golgi system 
and finally their release within vesicles detached from this 
system, called primary lysosomes (De Duve and Wattiaux,1966). 
In some cell types there exists near the Golgi apparatus a 
relatively direct transport of acid hydrolases from rough 
endoplasmatic reticulum to lysosomes. This complex system is 
indicated as the GERL system (Golgi Endoplasmatic Reticulum 
Lysosomes) (Novikoff, 1973). The sugar parts of the acid hy-
drolases, which are glycoproteins, are added by glycosyltrans-
ferases of the Golgi apparatus. There is some evidence that 
this process already starts in the endoplasmatic reticulum 
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(for review see Holzman, 1976). In the secretion-recapture 
model postulated by Riekman and Neufeld (1972) the lysosomal 
enzymes are first secreted, followed by a receptor-mediated 
uptake by the same or-by adjacent cells toperfarm their 
enzymatic functions (for review see Neufeld et al.,1977). In 
human fibroblasts the phosphorylation of the carbohydrate 
moiety of precursors of the lysosomal enzymes is critically 
involved intheir recognition (Hasilik et al.,1979). Sly et 
al. (1979) postulated that the recognition marker functions 
mainly as an 11 intra cellular traffic signal" to prevent 
enzyme secretion and to deliver receptor-bound acid hydrolases 
to lysosomes, where the marker is removed and the enzyme can 
exhibit its full enzymatic activity. 
In some cases, the naturally occurring substrates for the 
lysosomal enzymes have to be activated. In vivo, lipids are 
incorporated into membranes, where they are hardly accessible. 
Activation of (sphingo)lipids in the membranes might be ac-
complished by non enzymic proteins, which have recently been 
demonstrated for a number of acid hydrolases (Li and Li, 1976; 
Mraz et al.,1976; Hechtman and leBlanc,1977; Fischer and 
Jatzkewitz,1978; Sandhoff and Conzelmann,1979). The activator 
proteins are thought to bind to the lipid substrates, thus 
solubilizing it, the resulting· complex being the true sub-
s_trate for the degrading enzyrne. 
realization of an enzyme. If structural or regulatory genes, 
which control the rate of transcription of a structural gene, 
are involved, only deficiency of one enzyme is expected. If 
more general fUnctions are mutated, deficiency of a number of 
enzymes may occur. This is the case in I-cell disease, where 
due to an altered structure of the common recognition marker 
of lysosomal enzymes, a severe intracellular deficiency of 
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these enzymes occur (Me Kusick et al.,1978). 
Several techniques are available for the characterization 
of the genes and geneproducts. A first approach is the deter-
mination of the physico-chemical, kinetic and biochemical 
properties of the enzyme, such as pH optimum, heat inac-
tivation pattern, K and V , electrophoretic mobility and 
m max 
molecular weight. The probability that a mutation in a struc-
tural gene would be reflected in one of these parameters 
can be estimated. Empirically 65% of the aminoacid substi-
tutions were found to alter the heat lability of E.coli 
~galactosidase (Langridge,1968) and 67% of the variantsof 
glucose- 6--phosphate dehydrogenase showed an altered K for 
m 
substrate (Yoshida,1973). Approximately 30% of the aminoacid 
substitutions will produce a protein with altered electra-
pharetic mobility (Felton et al.,1974; Neel.1978). 
The use of immunological techniques is a second way of 
studying normal and mutant isoenzymes (for review see 
Nagradova and Grozdova,1977). Specific antibocties can be 
raised to purified human enzymes and the amount of cross 
reacting material in cells and tissues from normal individ-
uals and patients can be established. If an altered amount 
of antigen per unit enzyme activity is demonstrated, this is 
an indication for the preserree of a structurally altered 
enzyme in the cells of the tissue tested. The absence of 
cross reactive material or the preserree of reduced amounts of 
enzyme molecules with a normal activity per unit antigen may 
be the result of decreased synthesis of the protein, an in-
creased rate of degradation, or a mutation interfering with 
the binding of the antibody. 
A third approach to the characterization of gene(s) and 
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geneproducts is the analysis of the number of genes that is 
involved in the expression of a particular protein by studying 
the (iso)enzyme pattern in interspecies hybrids. For such gene 
localization studies human fibroblasts or white blood cells 
are fused with rodent cells. In the resulting heterokaryons 
nuclear fusion may occur and with the use of selective media 
(Littlefield,1964) proliferating hybrid cell lines can be 
isolated. In these hybrids a preferential loss of human 
chromosarnes occurs. The recognition of individual chromosarnes 
or parts of these is essential and this has become possible 
since the work of Casperssen et al. (1970) who have shown 
that each human chromosome possesses an unique banding pattern 
after staining with the fluorochrome quinacrine. During the 
last years, many other differential staining techniques have 
been developed (for reviews see Schwarzacher and Wolf,1974; 
Dutrillaux and Lejeune,1975). 
By relating the presence or absence of certain (enzyme) 
proteins to the presence or absence of specific human chromo-
sames or parts of these, it has been possible to assign more 
than 200 gene loci to the various human chromosarnes (see Pro-
ceedings of the Human Gene Mapping Conferences 1 to 5, 1973-
1979). 
Electrophoretic studies have been used most often to 
characterize the presence or absence of human gene products in 
hybrid clones (Ruddle and Creagan,1975). Insome instances 
however, the use of specific antisera may be required to 
distinguish the human and rodent gene products; this is 
especially important if heteropolymerie man-rodent molecules 
are formed, which may have an electrophoretic mobility that 
is similar to one of the isoenzymes of both species. Electra-
pharetic and immunological studies after fusion of normal 
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radent cells with fibroblasts or lymphocytes from a patient 
with a genetic protein defect may contribute to the localiz-
ation of the gene that carries the mutation. 
In our studies, cultured human fibroblasts are used as a 
model system for the ganglioside starage diseases. A prerequi-
site for this is the expression of the (deficient) isoenzymes 
in these cells, which is the case for quite a number of 
lysosomal enzymes. Fibroblasts are a homogeneaus population 
of cells, and their use is nat limited to the patients life. 
The disadventages only relying on cultured fibroblasts con-
cern the limited amounts of material 1 which hamper extensive 
purification of enzymes. Furthermore, in the gangliosidosis 
most starage products are found in the nervous tissue 1 whereas 
connective tissue is not affected. In fact, cultured fibro-
blasts from patients with GM2-gangliosidosis do not accuroulate 
gangliosides (Kolodny et al., 1973; Hoffman et al.,1976). Al-
though Svennerholm (personal communication) could not detect 
any starage of gangliosides in fibroblasts from a GM 1-ganglio-
sidosis patient, Suzuki et al., (1978) reported an increase 
of GM 1-ganglioside in cells from similar patients. 
All three approaches mentioned in this introduetion have 
been used in our experimental work on the elucidation of the 
nature of the genetic defect in GM2- and GM 1-gangliosidosis, 
as will be apparent from the next two sections. 
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II.2. GM2-gangliosidosis 
II.2.1. The molecular structure of the p-hexosaminidase 
isoenzymes 
The major acidic P-D-N-acetylhexosaminidase (E.C.3.2.1.30) 
isoenzymes designated hexA and hexB {Robinson and Stirling, 
1968) have been demonstrated in a number of human tissues. 
They can be separated by electrophoresis, iso-electric 
focusing and ion-exchange column chromatography (Srivastava 
et al.,1974a). HexA has a faster electrophoretic mobility 
(anodal) , which is thought to be due to significant amounts 
of neuraminic acid residues (Freeze et al.,1979). Also diffe-
rences in heat stability are used for the separate measurement 
0 
of the activities of bath enzymes: 5-10 minutes at 50 C de-
stroys hexA activity whereas hexB is stable {for review see 
Barrett and Heath,1977). HexA and hexB have a similar molecu-
lar weight, 100 000-140 000, depending on the methods used, 
and similar pH optima 
Beutler et al.,1976). 
and K values (Srivastava et al.,1974b; 
m 
Bath isoenzymes are glycoproteins 
(Freeze et al.,1979) and are composed of multiple subunits. 
The molecular weight of the subunits varies from 17 000-35 000, 
depending on the methods used (Robinson et al.,1973; Srivas-
tava et al.,1974b; Tallman et al.,1974a; Beutler et al.,1976) 
Antibodies raised to purified' hexA or hexB are reactive to 
both isoenzymes (Srivastava and Beutler,1973). 
These data suggest a structural relationship between hexA 
and hexB, and several models have been proposed. Robinson and 
Stirling (1968) originally suggested that hexA and hexB share 
the same protein part, only differing in neuraminic acid 
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content. Later Robinson and Caroll (1972) and Desnick et 
al. (1972) suggested that both hexA and hexB are composed of 
multiple subunits, one of which is cornmon to bath- forms. The 
deficient activity of hexA and hexB in patients with GM2-
gangliodosis type 2 (Sandhoff's disease) and the deficiency 
of hexA in patients with Tay-Sachs disease (GM2-gangliosidosis 
type 1) also suggests the presence of a common subunit in 
hexA and hexB (Rapers and Schwantes,1973). A third hypothesis 
about the molecular structure of the normal hexosaminidases 
was proposed by Tallman et al.(1974a) who suggested that the 
two acidic hexosaminidases represent different conformational 
changes of the same enzyme. 
Gene localization studies on the segregation of the 
hexosaminidase isoenzymes in man-radent somatic cell hybrids 
should in principle enable discrimination between some of the 
models proposed. The data of the first gene localization 
studies were however contradictory. Gilbert et al. (1975) and 
van Someren and Beyersbergen van Henegouwen (1973) reported an 
independent segregation of hexA and hexB whereas Tedesco et 
al. (1973) and Lalley et. al. (1974) found that hexA activity 
was only expressed in hybrid clones if hexB activity was 
present as well. The purpose of the experimental work de-
scibed in Appendix paper I was to investigate the reasons 
for this discrepancy and to characterize the hexosaminidase 
isoenzymes in man-Chinese hamster hybrids by means of electro-
phoretic and immunological methods. With specific antisera 
against hexA, hexB and an anti-Chinese hamster hexosaminidase 
antiserum it could be demonstrated that the discrepancies 
mentioned above were due to misinterpretation of one of the 
bands of activity on electrophoresis. This band, with an 
~ 1 
electrophoretic mobility nearly identical to human hexA was 
shown to contain a heteropolymerie molecule, with Chinese 
hamster subunits and subunits specific for human hexA. The 
expression of normal hexA in hybrid clones turned out to be 
dependent of the expression of hexB, which fits the two locus 
subunit model in which hexA= (a (3) n and hexB= ( (3 (3 ) n. 
Similar conclusions, based on the application of a nurnber 
of different techniques, had been drawn by others (Van Cong, 
1975; Lalley and Shows,1976; Chern et al.,1976; Swallow et al. 
1977). The gene coding for hexB ((J-subunit) has been assigned 
to chromosome 5 (Gilbert et al.,1975; Boedecker et al.,1975), 
whereas the gene coding for the a-subunit of hexA has been 
assigned to chromosome 15 (van Heyningen et al.,1975; Wester-
veld et al.,1975; see also Appendix paper I). 
In addition to hexA and hexB a third isoenzyme of P-hexosa-
minidase (hexC) with an electrophoretic mobility anodal to 
hexA and hexB was descibed by Hooghwinkel et al. (1972). HexC 
has a neutral pH optimum, a cytoplasmic localization and it 
is immunologically distinct from hexA and hexB. The loss of 
this isoenzyme after freezing of cells and tissues is prob-
ably responsible for the fact that it has remained undetected 
for a considerable period of time. Several investigators have 
suggested that the genetic origin of hexC is different from 
that of hexA and hexB (Braidman et al.,1974; Penton et al., 
1975; Swallow et al.,1976), but the molecular structure of 
hexC is still unknown. 
Another minor isoenzyme with an electrophoretic mobility 
similar to that of hexC is the acidic farm hexS, which was 
first detected by Ikonne and Desnick (1974), and more fully 
described by Ikonne et al. (1975) and Beutler et al. (1975). 
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The sirnilar electrophoretic rnobility of hexS and hexC has led 
to confusion about the characteristics of both isoenzymes and 
about their presence or absence in interspecies cell hybrids 
(Van Cong et al.,1975) and in cells from patients with Tay-
Sachs disease and Sandhoff 1 S disease (Ropers and Schwantes, 
1973). Methods have been developed to investigate hexS and 
hexC separately (Swallow et al.,1976; Reuser and Galjaard, 
1976), and this has enabled the conclusion that hexC is 
present in patients with Tay Sachs disease, whereas hexS and 
hexC are present in patients with Sandhoff 1 s disease. No major 
differences were found between hexS and hexA regarding thermo-
stability, pH optimum and kinetic properties (Ikonne et al., 
1975). HexS reacted with an anti hexA antiserum, but not with 
anti hexB antibodies (Beutler et al.,1975). This suggests a 
common subunit in hexA and hexS. 
Definite evidence for the subunit structure of the acid 
hexosaminidases came from a series of in vitro experiments 
by Beutler and Kuhl (1975). By freezing and thawing they 
were able to dissociate purified hexA and to reassociate the 
subunits to farm hexB and hexS. In a similar way, dissociation 
and reassociation of hexB and hexS led to the formation of 
hexA. These results are compatible with the following model 
of the acidic hexosaminidase isoenzymes (Beutler et al.,1976; 
Geiger and Arnon, 1976) : hexB = ( [3 [3) 2 ; hexA = (Ct f3) 2 and 
hex s = (a Ct) 2 . 
In actdition to these three acidic hexosaminidase isoenzymes, 
intermediate forms r 1 and r 2 have been identified with an 
electrophoretic mobility in between hexA and hexB (Price and 
Dance,1972). The intermediate r 2 form is identical to the 
P-form, which is the main isoenzyme of hexosaminidase in serum 
during pregnancy (Stirling,1972). Biochemicaland immuno-
logical data suggest that hexP or hexr 2 is a hexB-like enzyme 
with a higher degree of glycosylation, or that it is a hexamer 
of ~-chains ( ~ 6) (Geiger et al., 1978). Heterogeneity of the 
carbohydrate part of the ~-chains may also account for the 
formation of hexr 1 (Beutler and Kuhl,1975). 
The relationship between the various hexosaminidase iso-
enzymes as determined with artificial methylumbelliferyl 
substrate and those acting on natural GM2-ganglioside is not 
yet clear. Loss of activity towards GM2-ganglioside substrate 
occurs upon purification of hexA. Li et al. (1973), Srivastava 
et al. (1974a), and Hechtman (1977) indicated that this loss 
of activity is due to the remaval of an activating factor 
(see page 26). Sandhoff and Conzelmann (1979) showed that 
certain variants of GM2-gangliosidosis are due to the genetic 
deficiency of an activating protein. These will be discussed 
in chapter III. 1. 
The hydralysis of GM2-ganglioside by hexA can also be 
stimulated by sodium taurocholate. Neither the activating 
protein nor sodium taurocholate can increase the barely 
significant hydralysis of GM2-ganglioside by hexB. The ac-
tivating factor has been purified and characterized as a 
heat-stable, non-enzymatic protein, with a molecular weight 
of 36 000 (Hechtman and leBlanc,1977; Sandhoff and Conzelmann, 
1979; for review see Sandhoff and Christomanou,1979). 
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II.2.2. The nature of the mutation in Tay-Sachs disease and 
in Sandhoff's disease 
Tay-Sachs disease is characterized by a deficiency of 
both hexA and hexS and increased activity of hexB (Okada and 
0 1 Brien,1968; Reuser and Galjaard,1976; O'Brien, 1978a). In 
Sandhoff's disease hexA and hexB are deficient and the hexS 
activity increased (Sandhoff et al.,1968; Beutler et al.,l975). 
Initially in Tay-Sachs disease no cross reacting material 
could be shown with anti-hexA antiserum (Srivastava and 
Beutler,1973) but recently Srivastava and Ansari (1978) found 
cross reacting material in livers from eight unrelated Tay-
Sachs patients, using a monospecific anti-cross linked hex-a 
antiserum. These data indicate that Tay-Sachs disease is caused 
by a mutation in the a-subunit of hexosaminidase, as had been 
suggested earlier by Ropers and Schwantes (1973) 
and Beutler (1974) and Galjaard et al. (1974a). 
Srivastava 
Sandhoff's disease is thought to be due toa mutation in 
the ~-subunit (Rapers and Schwantes,l973; Galjaard et al.1974a; 
Beutler et al.,l975). Studies on the presence of enzymatically 
inactive but antigenically reactive enzyme in Sandhoff 
patients have been inconclusive (Srivastava and Beutler,1973; 
Braidman,1974 (personal communication). 
A further investigation on the nature of the mutation and 
on the properties of the residual activity in Sandhoff's 
disease was performed by analyzing proliferating hybrids 
between Sandhoff fibroblasts and Chinese hamster cells, as 
described in Appendix paper II.In the hybrid clones, the 
formation of heteropolymerie hexosaminidase molecules con-
sisting of Chinese hamster subunits and human hex-a subunits 
could be demonstrated. Electrophoretic and immunological 
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studies showed that the properties of the human hex-a sub-
unit were similar to those in hybrids between normal human 
fibroblasts and Chinese hamster cells. The heteropolymerie 
isoenzyme is not present in hybrids between fibroblasts from 
a patient with Tay Sachs disease and Chinese hamster cells 
(Van Cong et al.,1977). From these data it can be concluded 
that Sandhoff cells contain an a-subunit of hexosaminidase 
with normal characteristics, and Sandhoff's disease is there-
fore likely to be caused by a mutation in the ~-subunit of 
hexosaminidase. 
II.2.3. On the mechanism of complementation 
After fusion of Tay-Sachs and Sandhoff fibroblasts, hetero-
karyons show a restoration of hexA activity as revealed by 
heat inactivation studies and electrophoresis (Thomas et al., 
1974; Galjaard et al.,1974a). In view of the data available 
on the molecular structure of the acid ~-hexosaminidases and 
on the nature of the different gene mutations it is most likely 
that complementation is the result of combination of normal 
hex-~ chains coded for by the Tay-Sachs genome, and normal 
a-chains coded for by the Sandhoff genome. 
When the protein synthesis is inhibited by cycloheximide 
no restoration of hexA activity occurs in the heterokaryons 
which suggests the necessity of de novo protein synthesis. 
This could explain why co-cultivation of Tay-Sachs and 
Sandhoff fibroblasts or mixtures of cell homogenates of these 
two mutant cell types does not lead to reap_pearance of hexA 
activity. 
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II.3. GM 1-gangliosidosis 
II.3.1.The isoenzymes of normal p-galactosidase 
Different farms of ~-galactosidase (E.C.3.2.1.23) exist 
in various human tissues. Acid p-galactosidase is a sialo-
glycoprotein and can be separated into two isoenzymes A and 
B on the basis of electrophoretic mobility and molecular 
weight (Ho et al.,\973; Norden and O'Brien,\973). Bath iso-
enzymes are heat labile, stimulated and stabilized by chloride 
ions (Ho and O'Brien, 1971) and antiboclies to purified 
fJgalA and {JgalB are reactive to bath isoenz-ymes (Norden et 
al, 1974). Acid ~-galactosidase is able to hydrolyse the 
terminal galactose from GM 1-ganglioside, asialo-GM 1-ganglio-
side, asi.alofetuin, keratan sulphate and from artificial 
{3-galactopyranosides (for review see O'Brien,1975; Sandhoff 
and Christomanou,\979). 
Neutral ~-galactosidase (M.W.45 000) has a higher pH 
~ptimum than acid {3-galactosidase. It does not absorb to 
ConA sepharose and is presumably not a glycoprotein. Mono-
specific antibodies to acid ~galA do not precipitate neutral 
~-galactosidase (Narden et al.,1974) ~ Two neutral isoenzymes 
are present which are heat stabile and one of the isoenzymes 
is inhibited by chloride ions (Cheetam and Dance,\976). Neutral 
~-galactosidase cleaves aryl-~-D-galactoside and aryl- ~ -D-
glucoside linkages, but does not cleave galactose frorn 
ganglioside GM\ (Ho et al.,\973). These data indicate that 
the acid and neutral ~-galactosidases are genetically inde-
pendent. 
In hurnan tissues there is yet another acidic ~-galacto­
sidase, which specifically cleaves galactosylcerarnide. This 
enzymeis deficient in Krabbe's disease (Suzuki and Suzuki, 
1970; Tanaka and Suzuki,1977; for review see Suzuki and Suzuki 
1978). After initial controversy, bath galactosylceramide-P-
galactosidase and GM 1-p-galactosidase were shown to hydrolyse 
galactose from lactosylceramide (Wenger et al,1974; Suzuki 
and Suzuki,1974; Tanaka and Suzuki,1975). GM 1 -~-galactosidase 
does not cleave galactosylceramide nor does galactosyl-
ceramide-P- galactosidase hydrolyse GM1-ganglioside. 
The major acidic GM1-p- galactosidase isoenzyme, pgalA, 
has been purified from human liver and was found to be a mono-
mer of molecular weight 72 000 (Narden et al., 1974) The 
minor acidic p-galactosidase, ~galB, has a molecular weight 
of about ten times than that of ~galA (700 000). Because of 
the innnunological relationship between pgalA and ~galB i t was 
suggested· thatpgalB is a multimeric aggregate of monomeric 
~galA (O'Brien,1975). 
To charactérize the p-galactosidase isoenzymes of human 
fibroblasts gel filtration experiments were performed. In 
Appendix paper III it is shown that fibroblasts, under con-
ditions of low ionic strength and neutral pH, show an ident-
ical gel filtration pattern as is present in human liver: 
a major monomeric farm of about 70 000 M.W. and a minor 
multimeric ~-galactosidase of 700 000 M.W. If, however, gel 
filtration was performed in the buffer that is used for the 
enzyme assay (high ionic strenght acid pH) mainly dimeric 
p-galactosidase was found. The transitions between monomeric 
and dirneric p-galactosidase were shown to be reversible. Ap-
parently, dimeric ~-galactosidase is the enzYmatically active 
isoenzyme. Hence it follows that kinetic and biochernical 
parameters cannot be determined separately for ~galA and 
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~galB. Dimeric ~-galactosidase has also been demonstrated in 
human liver (Hultberg and Ockermannr1972; Cheetham and Dance, 
1976) and in human small intestine (Asp,1971). 
Gene localization studies were performed to determine the 
number of genes which are involved in the expression of the 
acid fi-galactosidase isoenzymes. As is described in Appendix 
paper IV,human white blood cells from a patient with an X/22 
translocation were fused with Chinese hamster cells. The iso-
lated hybrid clones were analysed for chromosome content and 
enzyme markers for each of the human chromosomes. In none of 
the hybrid clones, even if these contained the complete human 
genome was ~-galactosidase activity found with an electra-
pharetic mobility similar to the human parental cell strain. 
To identify the slower migrating band of ~-galactosidase 
activity in between normal human and Chinese hamster bands, 
immunological characterization was performed with an anti-
human acid ~-galactosidase antiserum. Human determinants were 
shown to be present in this "marker bal).d", which could thus 
be used for the localization of structural genes coding for 
~-galactosidase. 
A structural gene for acid ~-~alactosidase could be located 
on chromosome 22 distal to the breakpoint in q.l .. 3. These 
data were contradictory to observations by other investigators. 
Bruns et al. (1977,1979) and Shows et al. (1977,1979) local-
ized a gene for 0-galactosidase on chromosome 3, whereas 
Rushton and Dawson (1977a) located a ~-galactosidase gene on 
chromosome 12. We have therefore reinvestigated our previous 
hybrid panel, and isolated a new series of hybrids using nor-
mal human white blood cells and Chinese hamster cells. As is 
described in Appendix paper V, in these hybrids the presence 
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of two structural genes for ~-galactosidase on the human 
chromosarnes 3 and 22 could be demonstrated. The products of 
the two genes differ in stability and in sensitivity to neur-
aminidase treatment. Chromosame 3 has to be present in more 
than 20% of the metaphases in a hybrid clone before the ~­
galactosidase activity can be demonstrated on electrophoresis. 
This is probably the reason that we missed the p-galactosidase 
gene on chromosome 3 in studies on the first hybrid panel, 
reported in Appendix paper IV. In these hybrids all clones 
containing chromosome 3 and no chromosome 22 the proportion 
of metaphases with chromosome 3 varied from 10 to 20%. 
Hybrids containing both chromosarnes 3 and 22 show on elec-
trophoresis an additional band of activity, which migrates 
to a position similar· to ~galB in the normal human cells. 
This band is most pronounced after neuraminidase treatment. 
These studies suggest that there are two genes that code for 
closely related ~-galactosidase subunits. As is shown in 
Appendix paper VI, which will be discussed later, the P-
galactosidase involved is GM 1 -~-galactosidase. 
In view of the available data on the molecular structure 
of p-galactosidase that is thought to consist of one type of 
polypeptide, there is no obvious role for two structural 
GM1-p-galactosidase genes. As discussed earlier dimeric and 
multimeric aggregationforms of the monomeric p-galactosidase 
protein are present. One possibility is that the monomeric 
protein in fact is a dimer, consisting of two polypeptides, 
which has been suggested by C.Wynn (personal communication). 
Another possibility is that one gene codes for the monomeric 
protein whereas a second gene codes for a protein that is 
part of the mul timer. Recently, additional subunits of p-
galactosidase have been demonstrated in human urine (Kress 
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and Miller, 1978), in human liver (Frost et al., 1978) and 
in human placenta (Loet al., 1979). 
II.3.2. Properties of the residual '~-galactosidase activity; 
nature of the mutation in GM
1
-gangliosidosis 
Tissues and cells from patients with the infantile and 
juvenile types of GM 1-gangliosidosis show a profound ~-galac­
tosidase deficiency. Measured with bath artificial substrate 
and with natural GM 1-ganglioside substrate the residual ~­
galactosidase activity is less than 1% of control values. For 
all patients with the infantile or juvenile farm of GM 1-
gangliosidosis tested, the presence of cross-reacting material 
to an anti-human p-galactosidase antiserum has been demon-
strated (Meisler and Rattazzi,1974; O'Brien,1975;1978a; Ben 
Yoseph et al.,1977). Our studies described in Appendix paper 
III showed that the aggregation farms of ~-galactosiàase in 
fibroblasts from patients with the infantile or juvenile 
farm àiffer from normal. In cells from the infantile farm 
only multimeric ~-galactosidase was found whereas cells 
from a patient with the juvenile farm only showed the mono-
meric ~-galactosidase. Fusion of both cell types did not 
result in complementation (Galjaard et al.,1974a) and it 
has been suggested that the infantile and juvenile types of 
GM 1-gangliosidosis arebasedon allelic mutations. 
To study the nature of the gene mutation, gene localization 
studies were performed using fibroblasts from a patient with 
infantile GM 1-gangliosidosis (type 1) and Chinese hamster 
cells (Appendix paper VI). The hybrid cell lines isolated 
were analysed with electrophoretic and immunological methods. 
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The presence of two structural ~-galactosidase genes on 
chromosome 3 and 22 could be confirmed. In type 1 X Chinese 
hamster hybrids a band of activity was shown on electra-
phoresis which contained human determinants similar as has 
been described for hybrids between normal human cells and 
Chinese hamster cells ("control hybrids"). Since the residual 
P-galactosidase activity in the patient's fibroblasts is 
below the detectionlevel on electrophoresis, it is likely 
that the human determinants occur in man-Chinese hamster 
heteropolymerie molecules. The additional band of activity 
which is present in "control hybrids" containing bath chromo-
sames 3 and 22, is absent in type 1 X Chinese hamster hybrids. 
The heteropolymerie isoenzyme present in hybrids containing 
chromosome 3 but no chromosome 22 was shown to be very labile 
and sensitive to neuraminidase treatment, which was not the 
case in "control hybrids". From these observations it is 
concluded that the infantile type 1 GM 1-gangliosidosis is 
caused by a mutation in the structural GM 1 -~-galactosidase 
gene on chromosome 3. 
During the last five years a number of patients have been 
described who are characterized by a later onset of symptoms, 
milder physical and mental handicaps and. survival into adult 
age. Other variants are still in their youth but have milder 
clinical features than is the case in the juvenile form of 
GM 1-gangliosidosis. The fibroblastsof all these patients 
have a higher residual ~-galactosidase activity than is pre-
sent in infantile and juvenile GM 1-gangliosidosis. Bath with 
artificial and natural substrates, the p-galactosidase activ-
ity in the variantsis 10-20% of normal (Pinsky et al.,1974; 
Galjaard et al.,l974a; Koster et al.1976; Suzuki et al. ,1977; 
42 
Andria et al. ,1978). The residual Jl-galactosidase activity 
from three of these clinical variants (Loonen et al.,1974; 
Pinsky et al. ,1974; Andria et al. ,1978), belonging to the same 
complementation group (see Table I.3, page 23) have been in-
vestigated in more detail. The kinetic properties, pH optima 
and heat stahilities of the residual p-galactosidase activities 
in the variants were found to be the same as the ~-galacto­
sidase from normal cultured fibroblasts (Galjaard and Reuser, 
1977; Reuser et al.,1979). As described in Appendix paper III, 
the p-galactosidase in the variants is present in only the 
monomeric form (M.W. 70 000) under conditions of low ionic 
strengthand pH 7.0. Under the same circumstances p-galac-
tosidase from normal human fibroblasts is present bath in 
monomeric and multimeric farms. Immunological studies revealed 
the presence of normal amounts of cross reacting material to 
anti-human p-galactosidase antiserum (O'Brien and Norden,1977; 
O'Brien,1978a; Reuser et al.,1979). These data indicate the 
presence of structurally altered p-galactosidase in these 
clinical variants, with a disturbance in the formation of 
multimeric aggregates. 
Hybrid cell lines were isolated following fusion of fibro-
blasts from the adult variant of p-galactosidase deficiency 
(type 4) (Loonen et al. ,1974; Galjaard et al. ,1975) and 
Chinese hamster cells. As described in Appendix paper VI 
these hybrids were analysed with electrophoretic and immun-
ological methods. No differences were observed between these 
hybrids and "control hybrids", thus no indication fora struc-
tural ~ -galactosidase mutation in thi s adult type of ~-galac­
tosidase deficiency was obtained. 
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II.3.3. On the mechanism of complementation 
The restored )3-galactosidase. activity after fusion of 
fibroblasts from patients with the infantile form of GM 1-
gangliosidosis and patients with a(n) (adult) variant of p-
galactosidase deficiency has been further investigated. The 
kinetic properties, pH optimum and heat stability of this 
~-galactosidase activity are very similar to the )3-galacto-
sidase of normal human fibroblasts. Appendix paper III shows 
that the restoration of enzyme activity is mainly due to an 
increase in the fractions corresponding to the monomeric ~­
galactosidase. In addition, the aggregation to the high 
molecular weight multimers is restored. Mixing experiments 
with cell-free extracts ruled out the possibility that the 
formation of dimeric ~-galactosidase would be required for 
complementation. 
Based on these observations a model was suggested 
invalving two different genes: A structural gene responsible 
for the synthesis of the protein subunit, and a second gene 
which is involved in a post-translational modification process. 
The mutation in the infantile type GM1-gangliosidosis is in 
the structural ~-galactosidase gene on chromosome 3. In the 
(adult) variant forms of ~-galactosidase deficiency, the ~­
galactosidase genes are not mutated, but instead a mutation 
would be preSent in a gene, affecting the post-translational 
modification of )3-galactosidase. 
In 1978, Wenger et al. found a profound deficiency of 
N-acetyl-neuraminidase in cells from a 12-year old patient 
with cherry red spots, intellectual impairment and myoclonus, 
symptoms which are very similar to those in the variants de-
cribed above. In the patient described by Wenger et al., (1978) 
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the ~-galactosidase was deficient in leucocytes and in cul-
tured skin fibroblasts. Based on normal p-galactosidase 
values in the leucocytes of the patient's parents, Wenger et 
al. (1978) concluded that the p-galactosidase deficiency was 
secondary to a primary defect of neuraminidase. In our lab-
oratory a neuraminidase deficiency was also shown in fibro-
blasts from the adult variant of ~-galactosidase deficiency 
(Loonen et al.,1974) and from patients described by Pinsky et 
al. ( 1974) and by Andria et al. ( 1978). 
The complementation observed for p-galactosidase after 
fusion of fibroblasts from patients with different types of 
p-galactosidase deficiency may be explained by the fact that 
normal neuraminidase is supplied by cells from the infantile 
type GM1-gangliosidosis, which somehow corrects the low p-
galactosidase activity present in cells from the p-galacto-
sidase deficient variant. Fusion experiments after enucleatj_on 
(de Wit-Verbeek et al.,1978) showed that the cytoplasts of 
fibroblasts from the infantile type G -gangliosidosis could M1 
complement cells from the adult variant. This indicates that 
the turnover time of neuraminidase must be sufficient to 
allow cytoplasts to complement the cells from the adult va-
riant. 
It still remains to be explained how a neuraminidase de-
ficiency may lead to a deficiency of p-galactosidase, whilst 
the activities of the other lysosomal enzymes are normal. The 
relation between neuraminidase deficiency and ~-galactosidase 
deficiency will be discussed further in chapter III.2. 
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CHAPTER III. 
GENERAL DISCUSSION 
III.l. Variantsof GM2-gangliosidosis 
Increasing knowledge about the genetic defect in GM2-
gangliosidosis and about the molecular structure of the hexo-
saminidases has led to the identification of a number of 
clinical and biochemical variants, in addition to the clas-
sical types Tay-Sachs disease and Sandhoff 1 s disease. 
Different types of GM2-gangliosidosis with a varying degree 
of hexA deficiency and with normal or elevated hexB activity 
are listed in table III.l. Clinically, lateronset and/or 
less progressive juvenile and adult variants of Tay-Sachs 
disease have been reported. Arnong these patients a profound 
deficiency of hexA as well as a relatively hiqh residual 
hexA activity was found. Part of this variation is probably 
due to the fact that in various studies different cells and 
tissues have been used for hexosaminidase assays. So far, no 
correlation could be demonstrated between the time of onset 
of the symptoms, the severity of the clinical features and 
the degree of hexosaminidase deficiency as assayed with arti-
ficial substrates. Assays with natural substrate might give 
a better insight in a possible correlation between residual 
enzyme activity and clinical features, but the hexA activity 
towards presently available G -gangliosides is very low M2 
compared with that towards artificial substrate and reliable 
assays are therefore still very difficult. 
Several normal healthy adults have been described who 
showed a partial deficiency of hexA both with artificial and 
natural substrates (see tabel III.l). O'Brien et al. (1978) 
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TABLE III.l. VARIANTS OF GM2 -GANGLIOSIDOSIS type 1 
Variants I origin age at onset age at 9.s hexA hexB souree references 
ar of symptoms death activity activity 
race (years) (years) 4MU GM2 
Infantile type of Ashk. 0-6 months 2-4 0-5 0-5 normal or liver,serum Okada & O'Brien, 1968 
Tay-Sachs disease Jewish elevated fibroblasts 
Tay-Sachs variant English 4 months 3 25 6 normal fibroblasts O'Brien et al.,1978b 
Juvenile type of Non- 2 4 Bernheimer & 
Tay-Sachs disease Jewish 2 9 Seitelberger,1968 
Puerto- 5 14", 40 10 normal liver Suzuki et al.,1970 
Rican Suzuki & Suzuki,1970 
Zerfowski & Sandhoff 
1974 
I 
European 
'" 
25 normal fibroblasts Okada et al.,1970 
"' --J 
Greek 1-9'1 4-15 5-31 normal leucocytes Brett et al.,1973 
Adult type of I Ashk. 4 32 x 2,5 serum Tay-Sachs disease Jewish 48 normal leucocytes Rapin et al.,1976 
4 29 x 8,5 serum 
40 normal leucocytes 
Normal individualsl Ashk. 6 79 normal leucocytes Navonet al.,1973,1976 
with (profound) Jewish Tallman et al.,1974b 
deficiency of hexA 
Non- 0 serum Vidgoff et al.,1973, 
Jewish 15 normal leucocytes 1974 
50 fibroblasts 
Non- 20 50-60 normal fibroblasts Kelly et al.,1976 
Jewish 
Ashk. 8 41 normal fibroblasts O'Brien et al.,1978 
Jewish 
reported on a child with Tay-Sachs disease whose fibroblasts 
showed a profound deficiency of hexA with natural substrate 
and 25% residual activity with methylumbelliferyl substrate. 
It is possible that different gene mutations affect the 
affinity of hexosaminidase A for natural and artificial sub-
strates in a different way. So far, we have never found any 
restoration of hexA activity after fusion of celJs from dif-
ferent variants of GM2-gangliosidosis type 1, which might indi-
cate that these are allelic mutations (Galjaard, personal 
communication). 
Variants in which the total hexosaminidase activity is 
decreased are listed in table III.2. In addition to the clas-
sical type of Sandhoff's disease there is a juvenile form of 
the disease, and cells from these patients were found to have 
at least twice the activity of the clinical infantile ferm 
of Sandhoff's disease. Furthermore a normal individual has 
been reported whose leucocytes show a total hexosaminidase 
activity of about 10% of control values. When assayed with 
the natural GM2-ganglioside substrate the hexosaminidase ac-
tivity was found to be about 50%, indicating that also this 
mutation affects the activities towards natural and arti-
ficial substrates in a different way. The same is t!ue for 
two patients with the clinical features of classical GM2 -
gangliosidosis but with normal or elevated activities of 
hexosaminidase, as assayed with artificial substrates. With 
GM 2-ganglioside as a substrate activities of 10% of normal 
were found (table III.2). Finally there is one patient with 
an elevated hexosaminidase activity, in whom clinical symp-
toms became apparent at the age of 18 years (table III.2.). 
Studies on the molecular structure of hexosaminidase have 
indicated that two structural genes are involved in the ex-
TABLE III .2. VARIANTS OF GM2-GANGLIOSIDOSIS type 2 
Variants I origin age at age at total hex % of the total souree references 
or onset of death acti vi ty hex activity 
race symptoms (years) (% of controls) 
(years) 4-MU GM2 4-MU 4-MU 
hexA+S hexB 
Sandhoff's disease I non·- 0-6 2-4 0-5 50 50 liver Sandhoff et al.,1971 
Jewish mantbs serum Okada et al.,1972 
fibroblasts 
Juvenile type of I Ukranian- 5 lOK 5 86 14 
fibroblas ts McLeod et al.,1977 
Sandhoff's disease Welsh 15 leucocytes Wood and McDougall,1976 
"'" I Irish 3 4~ * 13 90 10 fibroblasts Johnson et al.,1977 co 2,5 85 15 leucocytes 
Normal with I French 10 50 leucocytes Dreyfus et al.,1975 deficiency of Dreyfus et al.,1977 
hexA and hexB 
Variant AB+of 0-6 2-4 120 10 42 58 liver Sandhoff et al.,1971 
G~t-gangliosidosis mantbs Conzelmann et al.,1978 
Wl h normal hexA 
and hexB Negro 6 14 * 140 52 48 leucocytes de Baeque et al.,l975 
months mantbs 
Adult type of I non- 18 22 185 60 40 brain O'Neill et al.,1978 GM2-gangliosidosis Jewish 
* still ali ve 
pression of the acid hexosaminidase isoenzymes. Thea-subunit 
is coded for by a locus on chromosome 15, whereas the gene for 
the p-subunit is located on chromosome 5 (hexA=(ap) 2 ; 
hexB= ( p p) 2 ; see chapter II. 2 .1.) . An activator pro te in is 
thought to be involved in the stimulation of hexA t.o cleave 
GM2-ganglioside, by solubilization this lipid substrnte 
(Liet al.,\973; Hechtman and leBlanc,1977; Sandhoff and 
Conzelmann,1979). A genetic defect of the locus coding for 
+ . 
this protein is likely to be responsible for the AB -varlant 
(see table III.2). 
The clinical and biochemical variants described in table 
III.l most likely are all variants due to a mutation in the 
Cl'-subunit, whereas those listed in table III.2 are thought 
to be mutated in the p-subunit or in the activator protein. 
The number of different alleles involved, and the possible 
genotypes of the variants described so far are listed in 
table III.3. 
o•Brien (1978b) considered one of the mutations in the 
normal individual described by Navonet al. (1973,1976) as 
a distinct mutation (allele a 6 ) , which would lead to a 
reduction in hexA synthesis. Tallman et al. (1974b), however, 
found that in contrast to the 6% residual hexA activity and 
5-7% cross-reacting material, 79% GM2 -ganglioside hexosamini-
dase activity is present. It is therefore possible that this 
normal individual has bath an allele as involved in the in-
fantile type of Tay-Sachs disease ( a 2) and an allele coding 
for hexosaminidase with activity against natural but not 
against synthetic substrates (a 5 ). The a 2 a 5 genotype is 
also thought to be present in the individuals described by 
Vidgoff et al. (1973), Kelly et al. (1976) and O'Brien et al. 
(1978). The same phenomenon has been suggested fora mutation 
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Cl' 
~ 
TABLE I I I. 3. 
ALLELES 
----
Hex-a locus 
hexa
1 
hexa2 
hexa 
3 
hexa
7 
hexa4 
hexa5 
---
Hex-{3 locus 
hexf\ 
hex/)2 
hex/)4 
hex/)3 
THE POSSIBLE GENETIC AND MOLECULAR BACKGROUND OF DIFFERENT VARIAN1'S OF GM 2-GANGLIOSIDOSIS (according to O'Brien, 1978b) 
GENOTYPE 
hexa
1 
hexa1 
hexa_2 hexa2 
hex"J hexa f hex/)1 hex/) 1 
hexa7 hexa~ activator protein 
hex~ hexa4 xlxl 
hexa2 hexa5 
hexa1 hexa1 [ """'' """ ,, activator hex/)2 hex/)2 
pro te in hex/)4 hex/)4 
xlxl hex/)2 hex/)3 
TYPE OF INDIVIDUAL 
normal 
Tay-Sachs disease 
juvenile Tay-Sachs disease 
adult Tay-Sachs disease 
a4: allele which codes for hexA with activity 
towards synthetic substrates but nat 
towards natural substrates 
Q'S: allele which codes for hexA with activity 
towards natura! substrates, but nat 
towards synthetic substrates 
normal 
Sandhoff's disease 
juvenile Sandhoff's disease 
{33: mutation resulting in hexosaminidase 
with activity for natura! substrate but 
not for synthetic substrates 
Activator protein 
locus 
x1 
x 
2 
hexa1 hexa1 
x 
3 
hex/)1 hex/)1 
xlxl 
x 2x2 
xl3 
normal 
AB+ variant: Tay-Sachs disease with normal 
hexA and hexB 
adult onset GM2-gangliosidosis 
at the p-locus in a healthy individual described by Dreyfus 
et al., (1975,1977). Here, 10% residual hexosaminidase activ-
ity was present when measured with artificial substrates, 
a.nd 10-20% cross-reacting material was found. With the GM2 -
ganglioside substrate however, 50% residual hexosaminidase 
activity was measured. This individual was thought to be a 
compound heterozygote of the Sandhoff allele ( p 2 ) and an 
anomalous hex-(3 allele ( j3 3 ) wi th acti vi ty towards the 
natural substrate but nat towards synthetic substrates 
(O'Brien,1978b). Most of these compound heterozygotes are 
detected because, when married to a carrier of the infantile 
farm of Tay-Sachs disease, they have affected children in 
their offspring. 
Same patients have been reported where the biochemical 
and clinical features are difficult to classify. Examples 
are the patients described by Spenee et al. (1974) and Lane 
and Jenkins (1978). In theory many types of compound hetero-
zygotes will occur, and studies of the hexosaminidase activ-
ity of the parents and other relatives bath with artificial 
and natural substrates are necessary befare a proper classi-
fication can be attempted. More data on the molecular struc-
ture of the hexosaminidases and on the various steps involved 
in the intracellular processing of these (iso)enzymes are 
required befare conclusions abou·t the relation between the 
residual hexosaminidase activity and severity of the clini-
cal features can be made. For an understanding of the patho-
genesis of the various types of G 2 -gangliosidosis more M 
should be known about the function and the tissue distribution 
of the hexosaminidases and their natural substrate(s). 
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III.2. GM1-gangliosidosis 
III.2.1. Mouse ~-galactosidase 
For the study of gene regulation in man much can be 
learned from experiments on lower organisms where normal gene 
expression can be perturbed and where crosses between diffe-
rent strains can be carried out to establish the genetic 
nature of the perturbations. One example of this are the ex-
tensive studies on inbred strains of mice where genetic vari-
ation exists with regard to their tissue levels of ~-galac­
tosidase. The number and nature of the genes involved in the 
expression of ~-galactosidase in these animals may help to 
understand the variability in the clinical features among 
patients with different clinical types of GM 1-gangliosidosis. 
The molecular weight of purified and reduced ~-galactosi­
dase in mice is 63 000. The native farm of the enzyme ap-
pears to be a tetramer of MW 240 000 at pH 5.0. This is re-
versibly dissociated at alkaline pH to a dimer with an ap-
parent molecular weight of 113 000 (Tomino and Meisler, 1975; 
Seyedyazdani et al.,1975). Polyacrylamide electrophoresis 
reveals multiple charge isomers of mouse liver ~-galactosi­
dase. It could be demonstrated that these isomers have the 
same molecular size but they differ in net charge. Treatment 
of the enzyme with neuraminidase resulted in a reduced elec-
trophoretic mobility of all bands. Sialylation of ~-galacto­
sidase is most extensive in liver, less so in brain, spleen 
and lung, and it does not occur at all in kidney. It is 
thought that the multiple charge isomers differ in carbo-
hydrate and/or amide content (Tomino and Meisler,1975). 
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~-galactosidase exhibits a dual subcellular distribution 
which is tissue-specific. The liver enzyrne is almast entirely 
localized in the lysosomes, whereas in kidney 30-40% of the 
enzymeis in the mierasomal fraction (Lusis et al.,1977). 
A number of gene loci determines the level of ~-galacto­
sidase activity and the characteristics of ~-galactosidase 
in the different tissues of the mouse. So far, the Bgs, Bgt 
and Bge loci have been identified and a number of genes in-
volved in the secretion of the enzyme. 
The Bgs locus 
The Bgs locus determines tissue levels of ~-galactosidase 
in the mouse; enzyme levels in mice carrying the Bgsh allele 
d 
are twice as high as in mice carrying the Bgs allele. 
Linkage studies have shown that the Bgs locus is located on 
chromosome 9 (Lundin and Seyedyazdani,1973; Felton et al., 
1974). Immunological studies with antiserum to purified ~­
galactosidase have indicated that the Bgs locus influences 
the amount of enzyme protein present in the tissues (Meisler, 
1976). After the development of an assay for the in vivo 
ra te of jl-galactosidase synthesis, i t could be demonstrated 
tha t the Bgs locus regulates .the /)-galactosidase acti vi ty by 
cantrolling the rate of synthesis of the j)-galactosidase 
molecule (Berger et al.,l978). 
The Egt locus 
Closely linked with the Bgs locus on chromosome 9 is the 
Bgt site, belonging to the temporal class of genes that have 
been defined as the set of DNA sequences containing the gen-
54 
etic information for the developmental program (Paigen et al., 
1976). The Bgt locus determines the developmental expression 
of p-galactosidase in liver. Adult Bgsh mice carrying the 
b Bgt allele have approximately a 
h dase activity in liver than Bgs 
two times higher p-galactosi-
d 
mice carrying the Bgt 
allele. It was found that this increase in activity is due to 
an increase in the number of j3-galact.osidase molecules (Paigen 
et al.,l976). Berger et al. (1978) showed that the Bgt locus 
controls the rate of synthesis of ~-galactosidase in liver. 
The Bge locus 
An electrophoretic polymorphism for ~~galactosidase has 
been identified in all tissues of common inbred strains of 
mice. It is inherited as a single Mendelian trait and is 
called the Bge locus. This structural ~-galactosidase gene is 
closely linked with the Bgs site on chromosome 9. Two alleles 
are present, Bgeb with a slow electrophoretic mobility and 
Bgea with a fast electrophoretic mobility of ~-galactosidase 
(Breen et al.,1977). Another.polymorphism which is expressed 
in all tissues affects the thermal stability of p-galactosi-
dase. Electrophoretic mobility and thermal stability show 
concordant strain distributions and cosegregate in genetic 
crosses (Berger and Lusis,1978). This indicates that a single 
~-galactosidase structural locus is expressed in all tissues. 
Genes involved in secretion 
A set of genes has been identified in mice that affects 
lysosomal enzymes by determining the rate of lysosome excre-
tion. All genes of this type discovered so far also affect 
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the pigmentation. This is presumably due to abnormal trans-
port of melanosomes, that are structurally related to lyso-
somes. The beige mutation, located on chromosome 13 results 
in enlarged lysosomes, diluted pigmentation and abnormal ex-
cretion of lysosomal enzymes (Brandt and Schwank, 1976). 
Animals with the light ear and pale ear mutations, located 
on the mouse chromosarnes 5 and 19 respectivel~ have a four-
fold elevated concentration of kidney ~-galactosidase, due 
to defective urinary excretion of lysosomal enzymes (Meisler, 
1978) . 
Three aspects of ~-galactosidase realization, its struc-
ture, the regulation of its synthesis and its developmental 
program are now known to be coded for by genes in close prox-
imity on chromosome 9. This is in agreement with the concept 
that much of the regulatory information relevant to a par-
ticular structural gene is in close association with that gene. 
Whether this is also the case for the human genome is still 
unknown, and so far there is no experimental proof of mutations 
invalving a regulatory process in man. Gene localization stu-
dies are not a suitable tool to map regulator genes. In man-
radent somatic cell hybrids the regulators of radent origin 
may take over the function of a deficient regulator of human 
origin, that thus will not come to expression. As far as struc-
tural genes in man are concerned, it has been found for dif-
ferent enzymes that genes coding for isoenzymes: hydrolysing 
the same substrate are located on different chromosomes. Even 
human genes, coding for different subunits of the same iso-
enzyme can be located on different chromosarnes as has been 
described in this thesis for the a- and ~-subunit of hexosa-
minidase A. It is evident that much experimental work has to 
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be done befare the organization of the human genome is es-
tablished. 
III.2.2. ~-Galactosidase and neuraminidase deficiency 
After the observation by Wenger et al. (1978) that cells 
from one of his patients with an adult type of ~-galactosi­
dase deficiency showed a deficiency- of N-acetyl-neuraminidase 
as well, in our laboratory a neuraminidase deficiency was 
also found in some patients who had previously been described 
as variantsof GM1-gangliosidosis (Loonen et al.,1974; 
Pinsky et al.,1974; Andria et al.,1978). The neuraminidase 
activities in the parents of one of these patients fall in 
the heterozygote range, whereas the ~-galactosidase activ-
ities of these parents showed low control values. This would 
suggest that the ~-galactosidase deficiency is secondary, 
due to a primary genetic defect in neuraminidase. 
In some patients a ~-galactosidase deficiency has been 
found in tissues, whereas the serum activity was normal 
(Suzuki et al.,1977). Basedon this observation it has been 
suggested that ~-galactosidase could be inactivated by neur-
aminic acid containing starage products. A similar phenom-
enon has been well documented for some tissues f+om patients 
with mucopolysaccharidoses, where certain _glycosaminoglycans 
were found to inhibit the ~-galactosidase activity (Ho and 
O'Brien,1969; Matalon and Dorfman,1972; Kint et al.,l973). 
Complete inhibition of ~-galactosidase activity by heparan-
sulfate and dermatansulfate has also been demonstrated in 
vitro (Rushton and Dawson,1977b). HOwever, similar experi-
ments with sialyloligosacharides .in vitro did not give the 
same results _(Lowden and 0 1 Brien, 1979). 
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Another possibili ty is that a mutation affects an as yet 
unknown roetabolie process that is required to give bath neur-
aminidase and ~-galactosidase their full activity. More 
basic research is required to elucidate the relationship 
between ~-galactosidase and neuraminidase deficiencies. 
In addition to these variants with a combined neura-
minidase and ~-galactosidase deficiency there are also adult 
GM1-gangliosidosis patients with a severe ~-galactosidase 
d~ficiency and normal neuraminidase (Suzuki et al.,1977). 
Wolfe et al. (1970) defined three biochemical abnormalities 
which must be present to enable an "unambigous and specific" 
diagnosis of GM1-gangliosidosis: 
- excessive accumulation in the nervous system of (asialo-) 
GM1-ganglioside 
- a profound deficiency of acid ~-galactosidase 
- accumulation in liver, spleen and kidney of a keratansul-
fate-like mucopolysaccharide. 
Because biopsies of brain and liver are nat readily available, 
the biochemical diagnosis must aften be based on the analysis 
of blood(cells), urine and cultured skin fibroblasts. In 
these instances accumulation of G -gangliosides is usually 
· Ml 
not possible and hence a certain diagnosis of GM1-gangliosi-
dosis cannot easily be made. It has now become evident that 
the finding of a p-galactosidase deficiency alone does not 
allow the extrapolation to the diagnosis GM 1-gangliosidosis, 
but that also the heriditary nature, of the p-galactosidase 
deficiency has to be considered. A practical problem in the 
establishment of heterozygosity in the patients 1 parents 
is the fact that for most lysosomal enzyme activities over-
lapping values are found between controls and heterozygotes. 
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There are a nurnber of other diseases in which a neuramini-
dase deficiency is present (for review see Lowden and O'Brien, 
1979). The neuraminidase deficiency in mucolipidosis II 
(''I-cell" disease) and III, associated with multiple hydrolase 
deficiencies (Me Kusick et al.,1978), is not thought to be 
the primary defect (Spritz et al.,1979). Recently, the group 
of Neufeld provided evidence that the processing of the lyso-
somal hydrolases in I-cell disease is affected which leads 
to a loss of precursor enzymes out of the cell. This should 
explain the severe intracellular deficiency of a number of 
lysosomal enzymes, including neuraminidase (Hasilik et al., 
19 79) . 
Mucolipidosis I is a neurodegenerative disorder in which 
neuraminidase deficiency is the only defect sa far demon-
strated. The activity of ~-galactosidase in patients suffer-
ing from this disorder is normal (Spranger et al.,1977). 
During the last years several patients have been described 
with a "cher:ry-red spot-myoclonus syndrome" (O'Brien,1977; 
Rapin et al.,l978; Thomas et al.,1978;- Lowden and O'Brien, 
1979). In these young adults an isolated neuraminidase 
deficiency hq_s-~.been found. Similar clinical features are, 
however, also.:J9und in the patients described by Loonen et 
al. ( 1974) and~by Wenger et al. (1978) and these· patients 
., 
have bath a neuraminidase and a ~-galactosidase deficiency. 
Complementation. analysis showed that the neuraminidase 
deficiencies in mucolipidosis I, I-cell disease and the 
"cherry-red spot-myoclonus syndrome" wi th cornbined ~-galac­
tosidase and nèuraminidase deficiency are caused by different 
gene mutations (Hoogeveen et al., to be published). Further 
studies are required to establish whether the "cherry-red 
spot-myoclonus syndrome" with isolated neuraminidase defi-
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TABLE III.4. DISORDERS WITH A (PRIMARY?) NEURAMINIDASE DEFICIENCY 
Disorder 
Classica! 
mucolipidosis I 
Adult variant of 
mucolipidosis I 
Variants of ~GAL 
deficiency previously 
described as GM1-gangliosidosis 
Cherry-red spot-
myoclonus syndrome 
authors 
Spranger et al.,1977 
Durand et al.,1977 
Goldberg et al.,1971 
Pinsky et al., 1974 
Loon en et al., 1974 
Suzuki et al., 1977 
Andria et al., 1978 
Wenger et aL, 1978 
Rapin et al.,1978 
Thomas et al., 1978 
neuraminidase 
activity 
not detectable 
nat detectable 
nat detectable 
~-galactosidase 
activity 
(% of control) 
normal 
normal 
10-20 
10 
normal 
normal 
ciency is a separate clinical entity or that it must be con-
sidered as a clinical variant of mucolipidosis I (see also 
Durand et al.,1977). Table III.4 summarizes the clinical syn-
drames where a neuraminidase deficiency might be the primary 
defect. 
It is possible that different types of neuraminidases 
are involved in the various genetic defects. In normal 
tissues at least two neuraminidase isoenzymes are known 
(Wenger et al.,1978; for review see Lowden and O'Brien,1979) 
one active towards sialyloligosaccharides, another towards 
gangliosides. No human mutants have been reported with a 
ganglioside (G and G 1 ) neuraminidase deficiency. The M3 D a 
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neuraminidase(s) which act on sialyloligosaccharides hydro-
lyse both a2---3 and a2---6 linkages. Thus far no multiple 
isoenzymes of this neuraminidase have been described, which 
can partly be due to methodological problems. The recent 
availability of fluorescent methylumbelliferyl substrate 
for neuraminidase will be of help in distinguishing various 
isoenzymes (Potier et al.,1979; Warner and 0 1 Brien,1979). 
The heterogeneity of the clinical features among patients 
with p-galactosidase deficiency is certainly in part deter-
mined by different mutations affecting neuraminidase(s) and/ 
or p-galactosidase in various ways. Bath of these enzymes 
seem to follow a "one enzyme - many substrates" model, and 
a particular gene mutation may only affect the capacity of 
hydrolysing some of these substrates. As a consequence dif-
ferent starage products may be present in the various organs 
of patients with different gene mutations thus causing a 
braad spectrum of clinical symptoms. The molecular structure 
of the enzymes involved, their intracellular processing and 
their interaction with the various substrates in vivo have 
to be understood befare complete insight can be obtained in 
the relation between the nature of the genetic defect and 
the clinical features in the different variants of a genetic 
roetabolie disease. 
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SUMMARY 
The observed clinical and biochemical heterogeneity in 
GM 1- and GM2-gangliosidosis was shown to have a genetic origin 
by complementation analysis. The existence of two complemen-
tation groups demonstrates that in bath lysosomal starage dis-
eases at least two different gene. mutations may be involved. 
The aim of the study described in this thesis was to investi-
gate the nature of the gene mutations involved. For this pur-
pose, the molecular structure of the enzymes p-galactosidase 
and hexosaminidase, which are deficient in GM 1- and GM2-gan-
gliosidosis respectively, has been analysed in fibroblasts 
from control individuals and patients. In addition, the prop-
erties of the restored enzyme activity in heterokaryons after 
fusion of cells from different variants of GM 1-gangliosidosis 
has been investigated. 
GM2- gangliosidosis 
Bath the classical types cf Tay-Sachs disease and Sand-
hoff's disease are characterized by progressive mental and 
motor deterioration, a cherry-red spot in the macula and the 
early death of the patientse Although the clinical features 
in both diseases are very similar, the nature of the hexosa-
minidase deficiency is different. The two major hexosaminidase 
isoenzymes, hexA and hexB, are both deficient in sandhoff 1 s 
disease, whereas only hexA is deficient in Tay-Sachs disease. 
The relation between these hexosaminidase isoenzymes is in-
vestigated in Appendix paper I. Gene localization studies, 
using man-Chinese hamster somatic cell hybrids, indicated that 
the expression of hexA is dependent on the presence of hexB 
in the hybrids. This is in agreement with a model in which 
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hexA and hexB are composed of multiple subunits, one of which 
is camman ta bath farms (hexA= (ap) n; hexB= (p {Jl n). The a-
subunit was shown to be located on the hwnan chromosome 15, 
whereas the ~-subunit was assigned to chromosome 5. In hybrid 
clones where hexB is absent, a heteropolymerie isoenzyme is 
formed, consisting of human hex-a and Chinese hamster subunits 
( (aCH) ) . 
n 
The characterization of the residual hexosaminidase activ-
ity in Sandhoff's disease is described in Appendix paper II. 
Hybrid cell lines were isolated after fusion of fibroblasts 
from a patient with Sandhoff 1 S disease and Chinese hamster 
cells. Allthough both hexA and hexB were absent in the parental 
Sandhoff fibroblasts, the isolated hybrids expressed the het-
eropolymerie isoenzyme ( (Ct CH) ) . The electrophoretic and im-
n 
munological properties of this heteropolymer were identical 
to those of the heteropolymer occurring in "control hybrids 11 • 
It was concluded that in patients with Sandhoff's disease a 
normal Ct-subunit is present, which indicates that the ~-sub­
unit carries the mutation. 
According to the model proposed, Tay-Sachs disease is 
caused by a mutation i~ the et-subunit. The cumplementation 
occurring after fusion of Sandhoff and Tay-Sachs fibroblasts, 
can be explained by a combination of normal a·-subunits from 
Sandhoff cells with normal ~-subunits present in the Tay-
Sachs cells, leading to a restoration of hexA activity. 
GM 1-gangliasidasis 
In addition to the infantile and juvenile forms of GM 1-
gangliosidosis a number of clinical variants have been de-
scribed which differ in time of onset of the symptoms, the 
6J 
involvement of visceral organs, the severity of mental retar-
dation and the level of the residual p-galactosidase activity. 
Restoration of ~-galactosidase activity occurs after fusion 
of fibroblasts from infantile or juvenile patients with fibro-
blasts from some of these clinical variants. 
As described in Appendix paper III, in control human 
fibroblasts p-galactosidase exists in dimeric and rnultimeric 
aggregation farms probably consisting of one type of polypep-
tide (Mol. weight 70 000) . As the transitions between monomer 
and dimer are reversible, the dirneric farm, which is the pre-
dominant farm under the conditions of enzyme assay, is thought 
to be the enzymatically active ~-galactosidase isoenzyme. 
Gene localization studies were performed to establish the 
number of genes involved in the expression of p-galactosidase. 
As described in the Appendix papers IV, V and VI, two struc-
tural loci, coding for GM 1- p-galactosidase could be assigned 
to the human chromosarnes 3 and 22. The relation between these 
two gene loci and the monomeric, dimeric and multimeric P-
galactosidase still has not yet been established. 
All mutant cell strains tested showed abnormal aggregation 
patterns for p-galactosidase, indicating that structurally 
altered p-galactosidase is present (Appendix paper III). 
Furthermore it is shown in Appèndix paper VI that the infantile 
farm of GM 1-gangliosidosis is caused by a mutation in the 
structural p-galactosidase gene on chromosome 3. There was no 
evidence for the presence of a mutation in a structural locus 
for p-galactosidase in an adult patient with a p-galactosidase 
deficiency. Since the cells from this patient also showed a 
neuraminidase deficiency, it is thought that the p-galactosi-
dase deficiency is secondary, due to a primary defect in neu-
raminidase. As yet, the mechanism of inactivation of p-galac-
tosidase is unknown. 
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The restoration of p-galactosidase activity after fusion 
of fibroblasts from patients with the infantile and adult 
types of p-galactosidase deficiency is mainly due to an in-
crease in monomeric p-galactosidase (M. W. 70 000) (Appendix 
paper VI). It may very well be that in the heterokaryons the 
neuraminidase activity of the cells from the infantile type, 
tagether with ~-galactosidase polypeptides present in the 
cells of the adult patient, result in restoration of ,8-galac-
tosidase activity. 
GS 
SAMENVATTING 
In patienten met de ziekte GM2-gangliosidosis is het enzym 
hexosaminidase geheel of·gedeeltelijk afwezig. Er bstaan twee 
vormen van deze ziekte, de ziekte van Tay-Sachs en de ziekte 
van Sandhoff, genoemd naar de ontdekkers ervan. Er bestaan ook 
tenminste twee vormen (iso-enzymen) van het hexosaminidase, 
die hexA en hexB worden genoemd. Bij de ziekte van Tay-Sachs 
is alleen hexA afwezig, terwijl bij de ziekte van Sandhoff 
zowel hexA als hexB afwezig zijn. Dit roept vragen op omtrent 
de opbouw en relatie van deze iso-enzymen. 
In Appendix paper I kon met genlocalisatie technieken aan-
nemelijk worden gemaakt dat hexA en hexB één eiwitketen ge-
meenschappelijk hebben, de ~-subeenheid. Daarnaast bezi.t hexA 
nog een eigen, specifieke subeenheid (a-subeenheid). In een 
model: hexA =a (3; hexB = {3 (!>. Eveneens met genlocalisatie tech-
nieken kon worden aangetoond, dat patienten met de ziekte van 
Sandhoff wel in staat zijn een normale a-subeenheid te maken 
(Appendix paper II). Een defecte {)-subeenheid belemmert in 
deze patienten de vorming van hexA en hexB. De ziekte van 
Tay-Sachs wordt volgens het model veroorzaakt door een defecte 
a -subeenheid. 
Bij patienten waar het enzym p-galactosidase defect is 
(GM
1
-gangliosidosis) kan de ernst en de aard van de ziekte 
erg verschillen. Sommige patienten overlijden al in hun eer-
ste levensjaar (infantile vorm van de ziekte) terwijl andere 
de volwassen leeftijd bereiken (volwassen vorm) • De oorzaken 
van deze "klinische heterogeniteit 11 zijn bestudeerd. 
In Appendix paper III zijn de eigenschappen van het nor-
male {J-galactosidase onderzocht. De werkzame vorm van het en-
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zym bleek een molekule te zijn bestaande uit twee identieke 
eiwitketens. Onder sommige omstandigheden waren ook grotere 
molekulen, met meer dan twee identieke eiwitketens mogelijk, 
terwijl de eiwitketen ook apart kon voorkomen. In patienten 
waar slechts een geringe hoeveelheid actief p-galactosidase 
aanwezig was, bleek tevens dat de nog aanwezige eiwitketens 
van structuur veranderd waren. 
Genlocalisatie technieken leerden (Appendix papers IV, 
V en VI) dat twee genen, gelegen op de menselijke chromosomen 
3 en 22, informatie bevatten voor structurele onderdelen van 
het p-galactosidase. Hoe dit gegeven in overeenstemming ge-
bracht moet worden met de thans bestaande opvattingen over 
de molekulaire bouw van P-galactosidase is nog onduidelijk. 
Tevens kon worden aangetoond (Appendix paper VI) dat de 
infantile vorm van de ziekte veroorzaakt wordt door een er-
felijke verandering in het gen op chromosoom 3. Voor de 
volwassen vorm konden geen erfelijke veranderingen in beide 
p-galactosidase genen worden vastgesteld. In dergelijke pa-
tienten is echter ook een defect aangetoond van een ander en-
zym, neuraminidase. Verondersteld wordt nu dat in sommige 
volwassen varianten het neuraminidase defect verantwoordelijk 
is voor het onwerkzaam worden van p-galactosidase. Verder on-
derzoek is nodig om op te helderen hoe de gecombineerde neur-
aminidase en p-galactosidase deficiënties onderling samen-
hangen. Wel is nu duidelijk geworden dat de verschillende 
klinische varianten van GM1-gangliosidosis eigenlijk een an-
der ziektebeeld betreffen dan de afwijkingen die gepaard gaan 
met zowel een neuraminidase als een p-galactosidase defect. 
Voor belangstellenden is een nadere uitleg van de gebruik-
te methoden, technieken en verkregen resultaten verkrijgbaar. 
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PAPER I 
Characterization of ,6-D-N -Acetylhexosaminidase Isoenzymes in 
Man-Chinese Hamster Somatic Cel! Hybrids 
H.L. HOEKSEMA, 1 A. J. J. REUSER, 1 A. HooGEVEEN, 1 A. WESTERVELD, 1 
I. BRAIDMAN, 2 AND D. ROBINSON 2 
INTRODUCTION 
Several farms of j3-o-N-acetylhexosaminidase (E.C.3.2.1.30) have been demonstraled 
in different hu man tissues [1-3]. Four isoenzymes, characterized by immunological and 
biochemica! techniques [4-8], have been designated j3-o-N-acetylhexosaminidase A, 
B, C and S, further to be referred to as he x A, hex B, hex C, and hex S. 
Deikient hex A activity and an increased activity of hex B is found in GM 2 
gangliosidosis type l or Tay-Sachs disease, whereas GM 2 gangliosidosis type 2 or 
Sandhoff discase is associated with a deficiency of both hex A and hex B [9-12]. 
Biochemical, imrnunological, and genetkal studies suggest a structural relationship 
between he x A and he x B [I, 5, 10, 13-19]. Robinson and Carroll [19] and Desnick et 
al. [10] suggested that bath isoenzymes are composed of multiple subunits, one of which 
is camman to bath forrns. Two subunit rnadeis have been suggested: (I) the three locus 
model [10]: hex A= (aj3)., hex B = (j3y)n; and (2) the two locus model: hex A= (a{3)., 
hex B = (j3j3) .. Tay-Sachs discase can be explained by a defective a subunit specific for 
hex A and Sandhoff disease, by a defective common j3 subunit. Recently, strong 
evidence in favor of the two locus model has been presented by Beutierand Kuhl [20] in 
in vitro enzyme hybridization studies. 
Studies of the segregation of the hexosaminidase markers in man-rodent somatic cell 
hybrids can discriminate between the different subunit theories. The results however are 
contradictory. Lalley et al. [21] found that hex A was never expressedinthese hybrids in 
the absence ofhex B, which fits the two locus model. Gilbert et al. [IS]and van Someren 
and Beyersbergen van Henegouwen [14], however, reported an independent loss ofhex 
A and hex B in cell hybrids, which fa vors the three locus model. 
These confticting results m~.y be due to a misinterpretation of the electrophoretic 
patterns obtained from hybrid lines, if one re lies solely on electrophoretic mobility. The 
formation of heteropolymerie molecules, especially farms with nearly the same 
electrophoretic mobility as hex A, might confuse the interpretation of the segregation 
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results. Therefore, a forther characterization of the hexosaminidase isoenzymes in 
hybrid lines is needed. lt is possible to obtain inforrnation about the presence ofpossible 
heteropolymerie molecules in hybrid cell lines by using specific antisera against human 
and Chinese hamster hexosaminidase. 
In the present study, a series of man~Chinese hamster hybrids were investigated using 
an anti-Chinesehamster hexosaminidase serum, a specific anti-human he x A serum, and 
an anti-human hex B serum. It was found that a hex A-like enzyme present in the hybrid 
hnes consists of bath Chinese hamster and specific human hex A moieties. The 
expression of human hex A was found to be dependent on the presence of hex B, and it 
was shown that a gene, coding for a specific hex A subunit is syntenic with the 
mannosephosphate isomerase (MP!) and pyruvate kinase (PK-3) loci, assigned to 
chromosome 15. 
MATBRTALS AND METHODS 
Purification of Chinese Hamster Hexosaminidase 
Chinese hamster hexosaminidase was purified 290 times from paoled homogenates ofliver and 
kidney. The 20,000 g supernatant was applied on a ConA sepharose column, equilibrated with 10 
mM sodium-phosphate buffer, pH 7.0, containing 0.1 mM CaC1 2 , 0.1 mM MnS04, and 0.5 M 
Na CL Hexosaminidase was eluted with 1 M a-methylglucoside in the samebuffer salution; paoled 
fractions were dialyzed and applied toa second affinity column. N-acetylglucosamine, bound to 
CN-Br activated sepharose as described by Lotan et al. [22] was used as affinity ligand. 
Hexosaminidase was eluted with 10 mMN-acetylglucosamine and 0.2 M Na Cl in 10 mM sodium-
phosphate buffer, pH 6.0. Paoled fractions, containing hexosaminidase were Iyophilized and used 
to raise antisera. 
Antisera 
Antisera against purified human hex A, hex B, and Chinese hamster hexosaminidase wcre 
raised in New Zealand white rabbits by a slight modification of the methad described by Carroll 
and Robinson (23]. Specific human hex A antiserum was prepared by absorption of anti-hex A 
serum with human liver hex B, according to Bartholomew and Rattazzi [24). 
Cel! Lines 
Normal fibroblasts, hypoxanthine-guanine phosphoribosyltransferase (HPRT) deikient fibro-
blasts, or normalleukocytes were used as human parental cell Iines in the fusion procedure. The 
Chinese hamster parental cell lines used were thymidine kinase (TK) or HPRT deficient 
fibroblasts. Details of the fusion procedure and the isolation and propagation of the hybrid cell 
lines have been described previously (25]. Preparation of celllysates was carried out as described 
by Meera Khan [26]. The human controls used were a tetraplaid epithelial kidney cellline (T-eel!) 
[27] and a normal fibroblast cell strain. 
Electrophoresis 
Electrophoresis of hexosaminidase, MPI, and PK-3 was carried out on cellulose acetate gel 
(Cellogel, Chemetron, Milan, Italy). Hexosaminidase electrophoresis was performed in 0.05 M 
potassium-phosphate buffer, pH 6.6, for 1 hr at 4°C. The staining procedure for hexosaminidase 
was carried out according to Okada and O'Brien (I 1]. The electrophoresis and staining procedures 
of MPI and PK-3 have been publisbed by van Someren et al. [28]. 
lmmunoprecipitation 
Lysates were incubated with antiserum overnight at 0°C. After incubation, the treated lysates 
were centrifugedat 35,000 g for 20 min. The supernatant was used for electrophoresis. 
82 
RESULTS 
Electrophoresis of lysates of normal human fibroblasts reveals three bands of activity: 
hex B, he x A and hex C (fig. la, lane 1 ). In lysates of Chinese hamster fibroblasts, two 
bands of activity, described as hex 1 and hex 2 (fig. lb, lane 1), were found. 
The specificity ofthe antisera against Chinese hamster hexosaminidase and against 
human hex A and hex B was tested with lysates of human and Chinese hamster 
fibroblasts. The resulting electrophoretic patterns are illustrated in figure la and lb, 
lanes 2, 3, and 4. With the concentrations used, the antiserum against Chinese hamster 
hex I does notcross-react with human hex A, he x B, and hex C (fig. la, lane 2) nor with 
FIG. I. -Electrophoretic patterns of human (a) and Chinese hamster (b) fibroblast lysates. Ume 1, A, B, C 
refer to hex A, hex B, and hex C; 1 and 2 to Chinese hamster hex 1 and hex 2: lane 2, after treatment with 
anti-Chinesehamster hexosaminidase serum; lane 3, after treatment with specific anti-human hex A serum; 
lane 4, after treatment with anti-human hex B serum. The amount oflysate used in the various lanes depended 
on the antibody concentrations of the antisera, explaining differences in staining intensity. 
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the fastmoving Chinese hamster hex 2 band. The specific anti-human hex A serum does 
not remove hex B and hex C, whereas hex A disappeared (fig. la, lane 3). The 
anti-human hex B serum reacts with both hex A and hex B but not with hex C (fig. !a, 
lane 4). No reaction of specific anti-human hex A and anti-human hex B sera with the 
Chinese hamster hexosaminidases was observed (fig. !b, lane 3 and 4). These results 
were confirmed with double immunodiffusion in agarose gels [29] and by antigen-
antibody titrations in various combinations of antigens and antisera. 
Four types of hybrid lines could be distinguished by electrophoresis of different 
man-Chinesehamster cell hybrids (fig. 2). They are indicated as hex A' +/hex B+, hex 
A' +/hex B-, hex A' -/hex B+, hex A' -/hex B-. The band of activity with a 
mobility camparabie to hex A is called hex A'. 
Lysates prepared from these four different types ofhybrid clones were treated with the 
various antisera, and the resulting isoenzyme pattems of hexosaminidase were studied 
by electrophoresis. The results obtained with a hex A' +/hex B- hybrid are shown in 
tigure 3. After treatment with anti-Chinese hamster hex I serum, both the Chinese 
hamster hex I and the hex A' band disappear. The specific anti-human hex A serum 
removes the he x A' activity, whereas no reaction with Chinese hamster hexosaminidase 
was observed. Anti-human hex B serurn does not change the electrophoretic pattern. 
Nine hex A' +/hex B- hybrid clones from five independent fusion experiments were 
tested in this way; they invariably showed the same immunological characteristics. 
Eight hex A' +/hex B+ hybrid celllines from independent fusion experiments were 
also studied with antisera (fig. 4). After treatment of the lysates with anti-Chinese 
hamster hex I serum, the hex I band di sappears along with part of the activity of the hex 
A' band (fig. 4, lane 3). Various concentrations ofthe anti-Chinesehamster he x 1 serum 
were used, but a complete removal of the activity on the hex A' position could not be 
attained. The activity of hex B doesnotseem to be affected. With specific anti-human 
hex A serum, all the activity is removed at the hex A' position, whereas hex Band 
FIG. 2. -Hexosaminidase electrophoretic pattems. From right to left: H = human T·cell (Electrophoretic 
mobility of he x isoenzymes of T-eel! and human fibroblast are comparable; the only difference is the intensity 
ofthe fastest moving band.) A' +/B+ = hybrid clone with acüvities at hex A' and hex B position; A' +/B- = 
hybrid clone with activity at he x A' position; A' -IB + = hybrid clone with activity at hex B position; A' -/B-
= hybrid clone having lost the activities at hex A' and hex B position. 
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FIG. 3.- Electrophare tic pattemsof a hex A' +/hex B- hybrid, following treatment with different antisera. 
Lane 1, human T -cel\; lane 2. hybrid without antiserum treatment; lane 3, hybrid following treatment with the 
anti-Chinese hamster hexosaminidase serum; lane 4, hybrid following treatment with the specific anti-human 
hex A serum; lane 5, hybrid following treatment with the anti-human hex B serum. 
FIG. 4.-Electrophoretic patterns of a hex A'+/hex B+ hybrid, following treatment with different 
antiserá. Lane 1, human T-eel!; lane 2, hybrid without antiserum treatment; lane 3, hybrid following treatment 
with the anti-Chinesehamster hexosaminidase serum; lane 4, hybrid following treatment with the specific 
anti-hex A serum; lane 5, hybrid following treatment with the anti-hex B serum. 
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Chinese hamster hex 1 activitîes remain unchanged. When treated with anti-human hex 
B serum, part of the activity at the hex A' position remains, and a normal Chinese 
hamster activity was detected. Also in this case, various dilutions of the antiserum were 
tested, and always residual activity at the hex A' position remained present. Figure 5 
illustrates the typical electrophoretic patterns of a hex A' -/hex B+ hybrid after 
incubation with the three antisera. Seven clones were tested. Hex B could be removed 
only by the anti-human hex B serum. The Chinese hamster hex I band cross-reacts with 
the anti-Chinesehamster hex I serum. In hex A' -/hex B- hybrids, changes in the 
electrophoretic pattem were observed only after treatment with the anti-Chinesehamster 
hex 1 serum, which removes the Chinese hamster hex 1 band. 
A relationship between the absence and the presence of the hex A' band, MP! and 
PK-3 was established, as shown by the data from several fusion experiments (table 1). 
No syntenic relationship was found with 24 other enzyme markers tested. 
DISCUSSION 
The discrepancies in the literature between data obtained in various experiments with 
man-radent somatic cel! hybrids [14, 15, 21] may be due to different interpretations of 
the hexosaminidase electrophoretic patterns from hybrid celllines with partic ui ar re gard 
to the activity at the hurnan hex A position. The characterization ofthe isoenzymes in the 
hybrid cel! lines can be greatly improved by the use of anti-Chinese hamster and 
anti-human hexosaminidase sera, as seen in the present study. 
In hex A' +/hex B- hybrid clones, the hex A' band was shown to interact with both 
FIG. 5. -Electrophoretic patterns of a hex A' ~/hex B + hybrid, following treatment with different 
antisera. Lane 1, human T -cell. In fresh homogenates an additional band of activity can be found between hex 
A and hex B. This band corresponds to the intermediate fonns 11, 12 , as seen by DEAE cellulose 
chromatography [34]. Lane 2, hybrid without antiserum treatment; lane 3, hybrid following treatment with the 
anti-Chinesehamster hexosamînidase serum; lane 4, hybrîd following treatment with the specific anti-hex A 
serum; lane 5, hybrid following treatment with the anti-hex B serum. 
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TABLE I 
ABSENCE AND PRESENCE OF HEX A', MPI, AND PK-3 IN PRIMARY AND SECONDARY HYBRID LINES 
Hex A': 
+ 
PK-3: 
+ 
30 
0 
33 
0 
MP! 
3 
28 
0 
29 
27 
0 
PK-3 
3 
35 
the anti-Chinese hamster hex 1 and the specific anti-human hex A sera, whereas no 
cross-reaction with the anti-human hex B serum was found. This finding indicates, that 
in these hybrids the isoenzyO)e at the hex A 1 position is nota normal human hex A, but a 
heteropolymerie molecule, containing both specific human hex A and Chinese hamster 
hexosaminidase moieties. The formation of heteropolymerie hexosaminidase molecules 
in man-Chinese hamster hybrids bas been suggested befare by Ropers and Schwantes 
[17], who supposed a heteropolymerie molecule at the hex A position to consist of 
Chinese hamster and human hex C subunits. In their theory, hex B and hex C are 
homopolymers, ({3{3). and (,m)., respectively, whereas hex A consists of B- and C 
subunits (af3) •. Van Cong et al. [30] described a band of activity camparabie with hex 
A', which they called "hex A fast." A relationship was demonstraled between the 
presence and absence of "hex A fast," MP!, and hex C. Fol!owing the subunit model of 
Ropers [16], ''he x A fast'' was explained as a heteropolymerie molecule with a subunits 
from hu man he x C and {3-like subunits from Chinese hamster hexosaminidase. Recently 
it bas been shown that at the hex C position two isoenzymes (hex C and hex S) can be 
detected [3, 20]. In view of these studies, it is likely that the fastest rnaving hex band 
described by VanCongis identical with hex S. Our electrophoresis system does not 
discriminate between hex S and hex C. 
The residual activity in hex A' +/hex B + hybrid cianes that could be detected at the 
hex A' position after treatment with the anti-Chinesehamster hex 1 oranti-human hex B 
serum indicates the presence of two different isoenzymes at the hex A' position. Since no 
activity is left after treatment with the specific anti-human hex A serum, a 
heteropolymerie molecule is thought to be present, similar to the heteropolymerie 
molecule found in he x A' +/hex B- hybrid clones at the he x A' position, which consists 
of human he x A and Chinese hamster he x 1 moieties. The other isoenzyme at the he x A' 
position cross-reacts with specifïc anti-human hex A and anti-human B sera and appears 
to represent a normal human hex A molecule. 
From these studies, we conclude that normal human hex A is present only in the 
presence of hex B, which is in agreement with the results of Lalley et al. (21]. A 
heteropolymerie isoenzyme cao be present independently of human he x B. The results of 
our present study fits into the two locus subunit model. According to this theory, the 
heteropolymerie isoenzyme at the he x A' position has been shown topos se ss a subunits 
from human hex A and {3-like subunits from Chinese hamster hex 1. The formation of 
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other heteropolymerie molecules, in particular between the human {3 subunit and an 
a-like subunit from the Chinese hamster cannot be excluded. The resolution of our 
electrophoresis system in the hex I and the hex B region is, ho wever, insufficient to 
distinguish possible heteropolymerie molecules. 
Evidence for the syntenic relationship betweenhex A, MP!, andPK-3 [14, 27, 31, 32] 
and the assignment of MP! to chromosome 15 [33] puts this synteny group on 
chromosorne 15. Our results show a relationship between the absence or presence of the 
isoenzymes on the he x A' position, and that of MP! and PK-3. With respect to the two 
locus subunit model, the gene coding for the a subunit of hex A is localized on 
chromosome 15. Previously, hex B has been assigned to chromosome 5 by Gilbert et al. 
[14]. According to this model, it should be the gene, coding for the {3 chain which was 
localized on cbromesome 5. 
Studies of the expression of hexosaminidases in man-Chinese hamster hybrid cell 
lines can be a tooi for onderstanding the molecular structure of hexosaminidase, 
provided that the characterization of human, Chinese hamster, and possible 
heteropolymerie components does not rely solely on electrophoretic mobilities. 
SUMMARY 
A series of man-Chinese hamster hybrids were investigated with the use of an 
anti-Chinesehamster hexosaminidase serum, a specific anti-human hex A serum and an 
anti-human he x B serum. The expression of human hex A was found to bedependenton 
the presence of he x B. A heteropolymerie molecule is formed independently of hex B, 
which consistsof Chinese hamster and specific hex A moieties. It has an electrophoretic 
mobility nearly identical to hex A. A relationship between the absence and presence of 
the heteropolymerie molecule, mannosephosphate isomerase (MP!), and pyruvate 
kinase (PK-3), assigned to chromosome 15, was established. With respect to the two 
locus subunit model, the gene coding for the "subunit, specific for hex A, bas been 
localized on cbramosome 15. 
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PAPER II 
Characterization of Residual Hexosaminidase Activity 
in Sandhofrs Disease 
Using Man-Chinese Hamster Cell Hybrids 
H.L. Hoeksema, A. J. J. Reuser, A. T. Hoogeveen, A. Westerveld, and H. Galjaard 
Department of Cell Biology and Genetics, Brasmus University, Postbus 1738, Rotterdam, 
The Netherlands 
Summary. To obtain information about the nature ofthe residual hexosami-
nidase activity in Sandhoffs disease, hybrid cel! lines between fibroblasts 
from a patient with Sandhoffs disease and Chinese hamster cells were 
isolated. 
In these hybrid celllines, a heteropolymerie isoenzyme was detected that is 
composed of human a- and Chinese hamster hexosaminidase subunits. Due to 
the electrophoretic and immunological behavior of the heteropolymerie 
molecules in interspecies hybrids with normal fibroblasts and with cells from 
a patient with Sandhoffs disease, we conclude that Sandhoff cells contain an 
a-subunit of hexosaminidase with normal characteristics. 
Introduetion 
Multiple farms of ,8-D-N-acetylhexosaminidase (E.C. 3. 2. I. 30) (he x) have been 
characterized in normal human tissues, the most common forms designated as 
hex-A, hex-B, hex-C and hex-S (Robinson and Stirling, 1968; Hooghwinkel et al., 
1972; Ikonneet al., 1975; Beutier et al., 1975). In man, two lysosomal starage 
diseases are associated with a deficient activity of acid farms of hexosaminidase. 
GM2 gangliosidosis type l (Tay-Sachs disease) is characterized by a deficiency of 
hex-A (Okada and O'Brien, 1969) and hex-S (Reuser and Galjaard, 1976). In GM2 
gangliosidosis type 2 (Sandhoffs disease), bath hex-A and hex-B are absent, 
whereas hex-S is present (Desnick et al., 1972). Complementation studies in 
heterokaryons obtained after fusion of Tay-Sachs and Sandhoff fibroblasts show 
that these two enzyme defects are based on different gene mutations (Thomas et 
al., 1974; Galjaard et al., 1974). 
Biochemica! and immunological data presented by Robinson and Stirling 
(1968) and by Srivastava and Beutier (1973) suggest a structural relationship be-
tween hex-A and hex-B. A two-locus subunit model bas been postuialed (Desnick 
et al., 1972; Ropers and Schwantes, 1973) in which hex-A = (a,B)o; hex-B = (,B,ll)o. 
This model was firmly established by the reassociation experiments of Beutierand 
93 
Kuhl (1975). Tay-Sachs disease might be explained by a defective a-subunit, 
whereas Sandhoffs disease would be caused by a mutation in the /3-subunit. 
Studies with rnan-rodent somatic cell hybrids also support the two-locus 
subunit model, sirree the expression of human hex-A depends on the preserree of 
hex-B (Lalley et al., 1974; Van Cong et al., 1975; Hoeksema et al., 1977). Insome 
hybrid clones, a heteropolymerie isoenzyme consisring of both Chinese hamster 
and specific human hex-A subunits was produced independently of hex-B 
(Hoeksema et al., 1977). The genetic information for hex-B: in this model the 
gene coding for the specific ,8-subunit could be assigned to cbramosome 5 
(Gilbert et al., 1975), whereas the gene coding for the specifica-subunit ofhex-A 
was assigned to chromosome 15 (van Heyningen et al., 1975; Hoeksema et al., 
1977). 
The residual hexosaminidase activity in Sandhoffs disease, which is a bout 1% 
of normal controls, consists mainly of hex-S (Beutler et al., 1975). This 
îsoenzyme, with an electrophoretic mobility nearly identical to the neutral form 
hex-C, is immunologica!ly related to hex-A (Beutler et al., 1975), and reassocia-
tions experiments by Beutier and Kuhl (1975) suggest that hex-S is an a-chain 
homopolymer. 
The purpose of the present study was to investigate the nature of the residual 
hexosaminidase activity in fibroblasts from a patient with Sandhoff's disease. 
Hybrids between Chinese hamster ceHs and fîbroblasts from a patient were used 
and the nature of the hexosaminidase isoenzyme pattern was analyzed with 
electrophoretic and immunological methods. 
Malerials and Methods 
The hybrids were îsolated following fusion of fibroblasts from a pa ti ent with Sandhoff's disease 
with thymidine-kinase-deficient Chinese hamster fibroblasts. The fusion procedure, isolation, 
and propagation of the hybrid cianes were described by Westerveld et al. (1971). Lysates were 
prepared by sonication in 5 mM phosphate buffer pH 6.4 containing 1 mM Na:.EDTA and 1 
mM P-mercaptoethanol. The sonicate is centrîfuged at 27,000 g for 20 min at 4c C. Chromosame 
preparatîons were made on the samebatches of cells as the lysates for the enzyme studies. The 
chromosarnes were identified with the trypsin-Giemsa technique described by Seabright (1971). 
The methods for enzyme purification and for the preparatîon of antisera against human 
Jiver hex-A and hex-B and Chinese hamster hexosaminidase were publisbed earlier (Hoeksema 
et al., 1977). Cell homogenates (5 MJ) were incubated with 5 tli antiserum overnight at occ. After 
centrifugation at 35,000 g the supernatant was used for hexosaminidase electrophoresis, which 
was done on Cellulose acetate gel (Cellogel, Chemetron, Milan, Italy) in 50 mM potassium-
phosphate buffer pH 6.6 for one hourat 4°C. Staining for hexosaminidase was performed with 
methylumbelliferyl substrate according to Okadil and O'Brien (1969). 
The specificity of the antisera was tested with lysates of h uman and Chinese hamster flbro-
blasts. Bath antihumall he x- (ap) and antihuman hex- (/J) antisera removed human he x-A as well 
as hex-B, whereas no reaction with Chinese hamster hexosaminîdase was observed. Anti-
Chinese hamster hexosaminidase antiserum did remave Chinese hamster hexosaminidase (hex-
1), but not the most anodal band (hex-2). No reaction with human hex-A and hex-B was 
observed. These results were already publisbed in more detail by Hoeksema et aL (1977). 
Results 
After fusion of Sandhoff fibroblasts and Chinese hamster cells, two hybrid cel! 
lines that contained the human chromosarnes 5 and 15 were isolated. The 
94 
C H +anti 
~ 
+anti 
Q~ 
+anti SxCH 
CH 
H s 
Fig. 1. Hexosaminîdase isoenzyme pattem of Chinese hamster cells ( CH}, fibroblasts from 
normal human (H) and from a patient with Sandhoffs disease (S). The pattem of a Sandhoff-
Chinese hamster hybrid (Sx CH) is shown befare and after treatment wîth antihuman hex-(ft), 
antihuman hex-(ajJ) and anti-Chinese hamster hexosaminida~e antisera 
hexosaminidase isoenzyme pattern of such a hybrid line, those of both parental 
cell strains, and the effect of the various antihexosaminidase antisera are shown in 
Figure I. 
Electrophoresis of control human fibroblasts reveals three bands of activity: 
starting at the origin hex-B, hex-A, and the most arrodal band, which consists of 
both hex-C and hex-S. The Sandhoff cells express most clearly the hex-C/hex-S 
activities and weak activities for hex-A and hex-B are present after administration 
of large amounts of cell homogenate. The isoenzyme pattem of Chinese hamster 
cells shows two bands: a major band (hex-1) with a mobility intermediale between 
the human hex-A and hex-B band, and a more arrodal band (hex-2) with a 
mobility comparollle to human hex-C/hex-S. 
The electrophmctic pattem of a Sandhoff-Chinese hamster hybrid cell line 
reveals three Qands of activity. An isoenzyme is present at the Chinese hamster 
hex-1 and human hex-B position. The second band of activity has an electro-
phoretic mobility comparable to hex-A, designated the hex-A' position. The most 
arrodal band is present at the Chinese hamster hex-2 and human hex-C/hex-S 
position. 
Following treatment of the Sandhoff-Chinese hamster hybrids with the anti-
Chinese hamster hexosaminidase antiserum, bath the Chinese hamster hex-1 
band and the band at the hex-A' position disappear. A faint activity remains 
at the human hex-B position. This activity was removed by subsequent in-
cubation of the treated homogenale with antihuman hex- (/J) antiserum. The 
most arrodal hex-C/hex-S/hex-2 band is not influenced by the anti-Chinese 
hamster hexosaminidase antiserum. Treatment of the Sandhoff-Chinese hamster 
hybrid cel! lysates with antihuman hex- (a/3) antiserum removes the band at the 
hex-A' position, while the antihuman hex- (/J) antiserum does not change the 
electrophoretic pattern. 
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Discussion 
According to the !wo-locus subunit model (hex-A=(ajl)" hex-B=(jJJl)o), human 
chromosome 5 bears the genetic information for the hex ,8-subunit, whereas the 
gene coding for the hex a-subunit is on chromosome 15 (Gilbert et al., 1975; van 
Heyningen et al., 1975; Hoeksema et aL, 1977). Some of the hybrid cell lines, 
isolated after fusion of normal human fibroblasts and Chinese hamster cells 
express a band of activity on a position camparabie to hex-A (hex-A' position). 
This band represents a heteropolymerie molecule containing human a- and 
Chinese hamster hexosaminidase subunits. 
The proliferating Sandhoff-Chinese hamster hybrid cell lines described in the 
present paper did contain both the human chromosarnes 5 and 15, and thus the 
necessary genetic information for the human a- and /3- hexosaminidase subunits. 
The band at the hex-A' position was also present in these hybrids. The activity, 
remairring at the hex-B position in the Sandhoff-Chinese hamster hybrids after 
treatment with the anti-Chinese hamster hexosaminidase antiserum, was the 
residual activity of Sandhoff hex-B, due to the preserree of chromosome 5 in the 
hybrid lines. This suggests a structural mutation of the /3-subunit of hexosamini-
dase in Sandhoffs disease. 
Van Cong et aL (1975) also found an isoenzyme at the hex-A' position in 
Sandhoff-Chinese hamster and Sandhoff-mouse hybrids. However, the inter-
pretalion of their data was complicated by the fact that they could not 
characterize the expressed isoenzyme. In our present studies of Sandhoff-Chinese 
hamster hybrids, the activity at the hex-A' position interaelect both with anti-
Chinese hamster hexosaminidase antiserum and antihuman hex- (a,B) antiserum, 
but the antihuman hex- (Jl) antiserum did not react. We therefore conclude that 
the isoenzyme at the hex-A' position is a heteropolymer consisting of human a-
and Chinese hamster hexosaminidase subunits. Sirree the electrophoretic and 
immunological behavior of this heteropolymerie molecule is similar to that in 
normal man-Chinesehamster hybrids (Hoeksema et aL, 1977), we also conclude 
that Sandhoff fibroblasts contain an a-subunit with normal characteristics. 
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Summary 
Acid f3-galactosidase from human !i ver consists, after gel filtratien at pH 7 .0, 
of a monomeric isoenzyme, iJ-galactosidase A and small amounts of a multimer, 
/3-galactosidase B (Narden, A.G.W., Tennant, L. and O'Brien, J.S. (1974) J. 
Biol. Chem. 249, 7969-7976). 
Our studies showed identical gel fiJtration patterns for !3-galactosidase from 
human liver and cultured skin fibroblasts. Gel fiJtration in the buffer used for 
enzyme assays (pH 4.5) however, revealed primarily dimeric J3-galactosidase, 
minor amounts of j3-galactosidase A but no multimers. As the transitions 
between monomeric and dimeric !3-galactosidase were reversible, dimeric 
/3-galactosidase is apparently the enzymatically active isoenzyme. 
The isoenzymes from patients with four different clinical variants of J3-galac-
tosidase deficiency showed altered aggregation patterns, although their molec-
ular weights corresponded to the normal molecular weights. 
It could be demonstrated that the restoration of !3-galactosidase activity, 
which occurred after cel! fusion of certain combinations of different !3-galacto-
sidase deficient fibroblasts, is not the result of intragenie complementation. 
Mixing experiments with cell-free extracts ruled out that the formation of 
dimeric !3-galactosidase is required for complementation. 
To explain the complementation a model is suggested in volving two different 
gen es: a structural gene responsible for the synthesis of the polypeptide chain 
and a second gene which is involved in a modification process. 
Introduetion 
A deficiency of the acid farms of /3-galactosidase· (/3-D-galactoside galacto-
hydroiase, EC 3.2.1.23) is responsible for the autosomal recessive disease GM1 -
gangliosidosis, where gangliosides and glycosaminoglycans are accumulated in 
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various tissues [2]. Several clinical forms of ;3-galactosidase deficiency have 
been described which differ in time of onset of the symptoms, the in volverneut 
of visceral organs and the presence of mental retardation [ 3-5]. 
Galjaard et al. [6] and Reuser et al. [7] showed that the gene rnutation in 
the classica!, infantile GM 1 -gangliosidosis (type 1) and its juvenile form (type 2) 
differed frorn the mutations in three other clinical variauts of f)-galactosidase 
deficiency (type 3 [8] and adult type 4[9] and the patient described by Andria 
et al. [ 10] ). This was shown by genetic complernentation analysis in which 
cultured skin fibroblasts from different patients were fused yielding hetero-
karyons. The presence of the genetic information of both parental cells strains 
in these heterokaryons can give rise to restoration of ;3-galactosidase activity. So 
far, two complementation groups have been demonstrated. 
An understanding of the mechanism of complementation requires knowledge 
about the molecular structure of fl-galactosidase in control and patient 's cell 
strains. In !i ver, two ;3-galactosidase isoenzymes have been demonstrated: a 
monomer, fl-galactosidase A, and its multimeric aggregate fl-galactosidase B 
[1,11]. 
In the present study we have used gel filtratien techniques to analyse normal 
fl-galactosidase, the residual activity in cultured skin fibroblasts of patients and 
the restored activity after genetic complementation. To explain this genetic 
complementation an intergenie model is proposed. 
Materials and Methods 
Cell and tissue materials. Skin fibroblasts were cultured in Harn's F10 
medium, supplemented with 15% feta! calf serum and antibictics as described 
earlier [12]. The cel!s were free of mycoplasma contamination judged by the 
methad of Chen [13]. The j)-galactosidase-deficient cell strains used were frorn 
patients with the infantile type 1 [6], the juvenile type 2 [14] or the adult 
type 4 [9] and from a patient recently described by Andria et al. [10]. Subcul-
tures from early passages were harvested by trypsinization and cell homogenates 
were prepared by repeated freezing and thawing in the same buffer used for the 
gelfiltration. After centrifugation for 20 min at 1500 Xg, the supernatant frac-
tions were used for biochemica! analysis. 
Cell fusion using 106 cells from each ;3-galactosidase-deficient strain was 
carried out as described [6]. 
Liver autopsy tissue was frozen 5-15 h after death and kept at -20'C until 
use. It was homogenized with a Waring Bleudor in ice-cold buffer and centri-
fuged for 20 min at 1500 X g. The supernatant fractions were separated by 
column chromatography. 
Gelfiltration. Packing and elution of Sephacryl 8200 superfine and 
Sepharose 6B (Pharmacia) columns (0.5 X 35 cm) were performed under grav-
ity at 4'C. 
Two different buffers were used: buffer I (10 mMsodium phosphate/10 mM 
NaCI, pH 7.0) and buffer II (0.1 M sodium acetate/0.1 M NaCl, pH 4.5), using 
the same buffer tbraughout the whole experimental procedure. Routinely 100 
fl] lysate, representing 106 cells, were applied to the columns and 100-fll 
fractions (Sephacryl 8200) and 150-fl] fractions (Sepharose 6B) were collected. 
The recovery of {l-galactosidase activity after gelfiltratien was about 50%. The 
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columns were calibrated by the metbod of Andrews [15] by using the 
Cambithek calibration protein set from Boehringer (Mannheim). As markers 
were included: cytochrome c (M, = 12 500), chymotrypsinogen a (25 000), 
albumin from hen egg ( 45 000), albumin from bovine serum (67 000), aldolase 
(158 000), catalase (240 000), ferritin (450 000). Dextran blue was used to 
estimate the void volume. 
Interconversion of monomeric, dimeric and multimeric {3-galactosidase. After 
gelfiltratien on Sephacryl 8200, the fractions containing the various iso-
enzymes we re collected and concentrated. The buffer system was changed and 
the enzyme was incubated for 30 min at 37'C, foliowed by 60 min at 4 'C. The 
enzyme activity was then measured and the remaining volume was applied to a 
Sephacryl 8200 column, equilibrated with the other buffer system. 
Enzyme assay. {3-Galactosidase activity was assayed with 1 mM 4-methyl-
umbelliferyl-{3-D-galactopyranoside in buffer !I by the metbod of Galjaard et al. 
[16]. 
Results 
The most widely used buffer for gel filtration studies of acid {3-galactosidase 
1s a low ionic strength buffer at pH 7.0 (buffer I) [11,17]. However, enzyme 
activity is always measured at low pH, which might influence the aggregation 
forms of the enzyme present at pH 7 .0. 
The elution patterns of {3-galactosidase in homogenates of normal human 
skin fibroblasts and normal human !i ver in buffer I are shown in Fig. lA. Bath 
patterns are similar and camprise a major peak, {3-galactosidase A (M, 65 000-
75 000), and a minor peak, {3-galactosidase B (M, 600 000-800 000 on a 
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Fig. 1. Gelfiltration Pattern of human liver and fibroblasts !3-galactosidase, Sephacryl 8200 elution 
Patterns of homogenates from normal human liver (0--0) and cultured human skin fibroblasts 
(•~-----e). A, eluted in buffer I; B, eluted in buffer 11. 
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Sepharose 6B column). In buffer I!, {l-galactosidase B bas disappeared, and a 
peak with a molecular weight of 130 000-150 000 becomes prominent (Fig. 
1B). The presence of minor quantities of {l-galactosidase A is seen by the 
shoulder in the elution pattem. 
To investigate whether the observed differences in the two buffer systems 
are based on reversible aggregation and dissociation phenomena, fractions 
isolated in one of the buffer systems were subjected to a second gel filtration in 
the other buffer (for details see Materials and Methods). The data showed that 
all of the changes in molecular weight are reversible except the multimeric iso-
enzyme cannot be generated from the M, ~ 140 000 fractions. These findings 
indicate that we are dealing with the multimeric and dimeric aggregation forms 
of the monomeric {l-galactosidase polypeptide. As transitions between monomer 
and dimer are reversible, most of the {l-galactosidase is in the dimeric from 
during the enzyme assay at pH 4.5 in buffer !I. 
The isoenzymes in fibroblasts from patients with the infantile (type 1), 
juvenile (type 2) or adult (type 4) form of {l-galactosidase deficiency had 
molecular weights indistinguishable from those of the normal isoenzymes. The 
aggregation pattemsin buffer I differed from the normal enzyme (Table I). The 
aggregation farms in buffer II are simHar, except for the infantile type 1. 
The restored {l-galactosidase activity after complementation between fibro-
blasts of the infantile or juvenile types and fibroblasts from either a patient 
with the adult type or the patient described by Andria et al. [10] was analysed 
by gel filtration. Fig. 2 shows the datafora fusion of infantile type 1 and adult 
type 4 cells. The heterokaryon homogenate shows after gel filtration in buffer I 
increased activity in bath the fractions corresponding to the monomeric and 
multimetic Jl-galactosidase (Fig. 2). In buffer !I, the dimeric and monomeric 
{l-galactosidase were increased. Similar results were obtained in fusions between 
fibroblasts of the patient described by Andria et al. [10] and those of infantile 
type 1 or juvenile type 2 patients. 
To investigate the possibility whether the increase in {l-galactosidase activity 
after cel! fusion is due to the formation of dimeric enzyme, studies with mix-
tures of cel! free extracts were performed. The data presented in Table II show 
TABLE 1 
AGGREGATION FORMS OF RESIDUAL /3-GALACTOSIDASE ACT!VITY IN FlBROBLASTS FROM 
PATIENTS WITH GM1-GANGLlOSIDOSIS 
Monomer: j3-galactosidase wîth molecular weight (Mr) 65 000-75 000; dimer: j)-galactosidase with Mr = 
130 000-150 000; multimer; j)-galactosidase with Mr = 600 000-800 000. 
Control 
Infantile Type 1 
Juvenile Type 2 
Type 'Andria' 
Adult Type 4 
10 mM phosphate/10 mM NaCl buffer 
(pH 7.0) 
Monomet Dim er Multimer 
++ + 
+ 
+ 
+ 
+ 
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Fig. 2. Gelfiltratien pattern of ~-galactosidase dter genetic complementatîon. Sephacryl 8200 elution 
Patterns of homogenates after fusion of: infanttie {type 1) and adult (type 4) fibroblasts (®---•); 
type 1 and type 1 fibroblasts (6---ó); and type 4 and type 4 fibroblasts (0----:J). A, eluted in 
buffer I, pH 7 .0; E, f'luted in buffer H, pH 4.5. 
that mixing of cell-free extracts of type 1 and type 4 fibroblasts, under condi-
tions where monomeric (3-galactosidase is prevailing (buffer I) and subsequently 
allowing dimers to be formed (buffer II) does not lead to increased {3-galacto-
sidase activity. Gel fiJtration of the mixture in buffer II showed that the 
{3-galactosidase indeed exists predominantly in the dimeric form. Similar results 
were obtained when homogenates of type 2 were mixed with homogenates of 
type 4 fibroblasts or fibroblasts of the patient described by Andria et al. [ 10 ]. 
TABLEli 
ATTEMPTED COMPLEMENTATION IN MIXED CE:LL HOMOGENATES OF TYPE 1 AND TYPE 4 
CELLS 
Equal amounts of homogenates of cells from the înfantile and adult type were mixed in buffer I. The pH 
was adiusted to 4.5 with buffer IL After 30 min incubation at 37°C, followed by 60 min at 4°C the mix-
ture was assayed for ;3-galactosidase actîvity. The protein content was determined ac-cording to I.owry et 
al. [27]. The aggregation state of thc P'-galactosidase was determined with a Sephacryl 5200 column. 
1 X 4: P'-galactosidase a.ctivity after fusion of infanttie (type 1) and adult (type 4) fibroblasts. The hetero-
karyens and cells used for the mixing experiments have been cultivated for the same period of time at the 
same cell density. This is esscntial fora meaningful comparison of the specific actlvities [28]. 
Cell strains 
lnfantile Type 1 
Adult Typ(' 4 
Type 1 X Type 4 
Typt• l +Type 4 
Control 
P'-Galactosîdase activity 
(nmol4-methylumbellifemne/mg protdn per h) 
3 
44 
190 
2:~ 
-Hl3 
Discussion 
Subunit structure of {3-galactosidase 
Human acid (3-galactosidase in liver consists of a monomeric polypeptide, 
(3-galactosidase A (M, = 70 000) and a multimeric aggregate of the monomeric 
form, (3-galactosidase B (M, = 600 000-800 000) [1], under conditions of low 
ionic strengthand neutral pH. Wh ether this multimeric formalso contains addi-
tional subunits remaines uncertain. 
The enzyme from human fribroblasts shows identical gel filtrabon patterns 
compared to that of human liver, indicating that the isoenzymes have the same 
subunit composition. At high ionic strength and acid pH (buffer !I) dimeric 
(3-galactosidase was the predominant form, whereas the multimeric form was 
absent. 
Repeated gel filtration of isolated fractions in both buffers used indicated 
that dimeric (3-galactosidase is the enzymatically active form, irrespective of 
whether monomers or multimers are isolated initially. In this light, character-
ization of separated (3-galactosidase A and B [3,18] is meaningless. 
A dimeric form of (3-galactosidase has already been demonstrated in human 
!i ver in varying amounts depending on the ex perimental conditions [17 ,19] and 
in human smal! intestine [20]. 
The (3-galactosidase isoenzymes from all four patients tested have molecular 
weights which are indistinguishable from those found in normal fibroblasts, 
suggesting that complete or nearly complete polypeptide ebains are syn-
thesized. However, {3-galactosidase present in these patients shows aggregation 
pattems different from normal, indic~ting that we are dealing with structurally 
altered (3-galactosidase. Th is is in agreement with immunological studies 
showing an increased amount of antigen per unit enzyme activity in adult type 
[21] and in infantile type (3-galactosidase deficiency [22]. No difference in heat 
stability, Km and pH optimum of (3-galactosidase in norm al, type 4 and type 
1 X type 4 heterokaryons could be demonstrated [ 4]. 
Mechanism of camp lementalion 
For dimeric enzymes, Crick and Orgel [ 23] have postulated a model for 
intragenie complementation, based on interaction of defective subunits. The 
reversibility in the formation and dissociation of dimeric (3-galactosidase in cell-
free extracts made an experimental test of this model possible. As no com-
plementation could be demonstrated, the Crick and Orgel model for intragenie 
complementation is not applicable. 
An intragenie mechanism similar to a-complementation described for 
(3-galactosidase deficient strains of Escherichia coli [24] is unlikely because of 
the presence of nearly normal amounts of immunological cross-reacting 
material in type 1 as well as in type 4 cells [21,22,25] and the identical heat 
sensitivity oÏ restored (3-galactosidase activity in heterokaryons and normal 
(3-galactosidase [ 4,26]. 
The intergenie complementation model, propos.ed by O'Brien and Norden 
[21] in which they postulated that (3-galactosidase B, the multimeric iso-
enzyme, contains a subunit not shared with {3-galactosidase A can be ruled out. 
This model would predict that the increased (3-galactosidase activit.y represer.ts 
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exclusively mu!timeric enzyme; this is not observed. 
We propose the following intergenie complementation model which is com-· 
patible with the experimental results. In one of the complementation groups, 
(e.g. in type 4 cells), a normal structural ~-galactosidase gene is present, how-
ever, the lack of a second gene product results in defective ~-galactosidase with 
abnormal aggregation properties. The ~-galactosidase deficiency in the other 
complementation group, type 1 and type 2 GM 1 -gangliosidosis, is thought to 
result from allelic mutations in the structural ~-galactosidase gene. After fusion 
of cells from different complementation groups the modification factor or 
process can act on the defective ~-galactosidase, resulting in a structurally 
normal !3-galactosidase. 
Enucleation studies, recently carried out in our Iabaratory, showed that the 
presence of the type 4 nucleus is required for complementation, whereas the 
cytoplasm of type 1 cells is sufficient [26]. These results are compatible with 
the proposed model for complementation. 
Biochemica! and gene localization studies are currently underway in our 
Iabaratory to establish this model. 
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Abstract-Human white blood cells with an X/22 translocation [46, XX, 
t(X; 22)(q23; q 13 )] we re fused with Chinese hamster cells. The isolated hy-
brids we re analyzedfor human chromosarnes and 21 enzyme markers. An 
electrophoretic technique for studying the {3-galactosidase isoenzymes in 
man-Chinese hamster hybrid cells was developed. Immunological 
studies showed that the {3-galactosidase marker studiedinthese hybrids 
did cant a in immunological determinants of human origin. Furthermore 
the results provided evidence that a locus for {3-galactosidase is situated 
on chromosome 22 distal to the breakpoint in q/3. 
INTRODUCTION 
In human tissues two different acid {3-galactosidase ({3GAL) 
isoenzymes can be detected with GMI-ganglioside as well as with 
4-methylumbelliferyl-{3-D-galactopyranoside as a substrate. These 
isoenzymes are designated as the A and B form. The {3GAL-A isoenzyme. 
the main form in human liver, is thought to be a monomer, whereas 
{3GAL-B is a polymer with a molecular weight about 10 times higher than 
that of {3GAL-A (1-3). Antisera prepared against {3GAL-A react also with 
{3GAL-B indicating that the two isoenzymes have at least one polypeptide 
in common (3). 
Deficiency of {3GAL is found in patients with GMI-gangliosidosis. 
Several clinical variauts have been described (4-9), basedon time of onset 
of symptoms, degree of visceral organ and skeletal involvement, occur-
rence of mental retardation and other clinical features. To study whether 
different gene mutations are involved, Galjaard et al. (I 0) assayed the 
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j3GAL activity in heterokaryons after fusion of cultured fibroblastsof dif-
ferent clinical variants of GMl-gangliosidosis. Restoration of j3GAL 
activity insome ofthe combinations revea!ed the preserree oftwo compie-
menlation groups. Because of the biochemica! and immunological rela-
tionships between the j3GAL isoenzymes. these complementation results 
might be explained in terms of intragenie as wel! as intergenie comple-
mentation. 
lnformation about the number and localization of genes involved in 
the expres si on of j3GAL in human cells can be obtained in studies of in-
terspecific somatic cel! hybrids. Purthermare the formation of 
heteropolymerie j3GAL molecules in these hybrids could give information 
about the structure ofthe j3GAL isoenzymes. The man-Chinesehamster 
hybrids preferentially lose human chromosarnes which might result in 
segregation of genes involved in the expression of the enzyme at least 
when these genes are located on different chromosomes. 
In this paper the j3GAL isoenzym es in man-Chinesehamster hybrids 
we re characterized by immunological and electrophoretical methods. and 
it was shown that a locus for j3GAL is located on chromosome 22ql3-qter. 
MATERIALS AND METHODS 
Man-Chinese hamster hybrid cells were isolated following fusion of 
hypoxanthine phosphoribosyltransferase (HPRT) delkient Chinese 
hamster cells with human leukocytes. The human leukocytes were ob-
tained from a female carrier of a balanced X/22 translation (X/22 Breda; 
46. XX. t(X; 22)(q23; ql3)). The intact X-chromosome was the late repli-
caring one (11). The Chinese-hamster HPRT-deficient cellline. E36. is a 
derivative from the V79 cel! line (12). The Chinese hamster ceillines a3 
and wg3-h. derived from the DON line. were also used as controls. The 
Chinese hamster cel! lines and the hybrids were isolated and propagated 
as described elsewhere ( 13). 
In the hybrid and parental cel! populations the following enzymes 
were characterized by means of Cellogel electrophoresis (Cellogel. Che-
metron, Milan. ltaly): phosphoglucomutases (PGM 1 • PGM3 • EC 2.7.5.1; 
PGM2 , EC 2.7.5.6), rnalate dehydrogenase (soluble) (MDH5 , EC 
1.1.1.37), galactose-1-phosphate uridyltransferase (GALT. EC 2. 7. 7.1 0). 
superoxide dismutases (SOD8 • SODM. EC 1.15.1.1). j3-glucuronidase 
(j3GUS. EC 3.2.1.31). glutathion reductase (GSR. EC 1.6.4.2). adenylate 
kinase-I (AK 1 • EC 2.7.4.3). giutamate oxaloacetate transaminase (solu-
ble) (GOT8 • EC 2.6.1.1). lactate dehydrogenases (LDHA. LDH8 • EC 
1.1.1.27). nucleoside phosphorylase (NP. EC 2.4.2.1). mannose phos-
phate isomerase (MP!. EC 5.3.1.8). peptidase-A (PEPA. EC 3.4), glu-
cose phosphate isomerase (GPJ, EC 5.3.1.9). adenosine deaminase 
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(ADA, EC 3.5.4.4), glucose-6-phosphate dehydrogenase (Gd, EC 
!.1.!.49), phosphoglycerate kinase (PGK, EC 2. 7. 2.3). 
For the characterization of most of the enzymes we foliowed the 
methods already publisbed (14-16). The technique reported by Grzeschik 
(17) was used for ,BGUS and for PGM,, the electrophoretic procedure 
described by Quick et al. (18) was adapted to the Cellogel system by 
Meera Khan (personal communication). The 1ysates were prepared as 
described by Meera Khan (14) by either sonicating or repeated freezing 
and thawing of the cells in lysis buffer. For the ana1ysis of the hybrids 
studied here, the freezing and thawing metbod was preferred. 
In order to study ,BGAL (E.C. 3 .2.1.23) in man-Chinese hamster hy-
brids an electrophoretic technique was developed using the Cellogel 
system. Electrophoresis buffer: 0.05 M Na2-,B-glycerophosphate, pH 6.2; 
running time is 3 hr at 4'C, keeping the amperage constant at an initia! 
voltage of 200 V. The gel was incubated with 0.5 mM 4-methyl-
umbelliferyl-,B-n-galactopyranoside in 50 mM acelate buffer, pH 4.8, 
containing 10 mM NaCl. Following incubation for 30 min at 37'C, the 
reaction was stopped with 1 M carbonate-bicarbonate buffer pH 10. 
Fluorescent bands indicating the zones of ,BGAL activities were vi-
sualized under long-wave UV light (350 nM). 
For the immunological characterization oftbe ,BGAL isoenzymes an 
antiserum against human ,BGAL was prepared. Human ,B-galactosidase 
was purified 165 times from liver. The liver was homogenized in 10 mM 
potassium phosphate buffer pH 6.9. The 25,000g supernatant was applied 
on a Con A Sepharose column, equilibrated with 10 mM potassium phos-
phate buffer, pH 5.6, containingO.l mM CaCl2 , 0.1 mM MnS04 , 0.1 mM 
MgS04 , and 0.5 M NaCl. A 1: I dilution of this buffer containing 1 M 
a-methylmannoside was used for the elution of ,B-galactosidase. Poeled 
fractions were dialyzed against 25 mM acelate buffer, pH 5.6, containing 
25 mM NaCl, and applied on a CH-Sepharose column with galac-
tosylamine as an affinity ligand, equilibrated with the same buffer. 
,B-Galactosidase was eluted with the same buffer salution containing 200 
mM NaCl and 20 mM galactose. Polyacrylamide gel electrop haresis ofthe 
immunogen revealed that next to the major band containing ,BGAL other 
lysosomal enzymes were found to be present also. The major contaminat-
ing component was ,8-n-N-acetyl hexosaminidase. Antiserum against this 
human ,B-galactosidase preparation was raised in New Zealand white rab-
bits using a slight modification of the methad described by Carrol (19). 
For the immunoprecipitation tests, lysates were incubated with antiserum 
ovenlight at O'C. After the incubation the mixtures were centrifugedat 
35,000g for 20 min, the supernatant was used for electrophoresis. Double 
immunodiffusion was carried out in 1% agarose gels in 10 mM potassium 
phosphate buffer, pH 6.6, allowing diffusion of the antiserum and the 
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lysates to take place at room temperature for 16 hr in a humidified 
chamber. The gels were wasbed for at least 12 hr in 10 mM potassium 
phosphate buffer, pH 6.6, at 4'C. Precipitation arcs were stained with the 
5-bromo-4-chloro-3-indolyl-fl-n-galactoside substrate, according to Lake 
(20). 
Chromosame preparations were made on the samebatches of cells as 
the lysates for the enzyme studies. ldentification of the chromosarnes was 
achieved using Q-banding (21), trypsin-Giemsa staining (22), and R-band-
ing (23). At least 20 metaphases of each clone were analyzed. 
RESULTS 
The electrophoretic patterns of flGAL abtairred from human liver, 
cultured human and Chinese hamster fibroblasts are presenled in Fig. I. 
The human fibroblasts and liver showed a two-banded pattern, channels I 
and 2, respectively. The isozymes of bath tissues did have the same elec-
trophoretic mobility. The fast-moving band is designed as flGAL-A, and 
the more cathodal band is called flGAL-B according to earlier publisbed 
electrophoretic patterns (24-26). At our electrophoretic conditions the 
flGAL activity in leukocytes (about 25% of the activity present in fibro-
blasts) is toa low to obtain a clear banded pattern. The Chinese hamster 
cell line E36 (channel 3) showed a different electrophoretic pattem as 
compared to wg3-h and a3 cells (channels 4 and 5). A good separation 
from the hu man isoenzym es couid only be es tablisbed with the E36 cells 
and the human fibroblast or human !i ver lysates. Therefore E36 cells were 
used as the radent fusion partner. 
Fig. 1. Electrophoresis of j3GAL on Cellogel showing patterns obtained from: human 
primary fibroblasts (1), human liver (2), Chinese hamster E36 (3), Chinese hamster wg3-h 
(4), Chinese hamster a3 (5). The lysates of channels 3, 4, and 5 are prepared by sonication. 
The lysates of channels I and 2 are prepared by freezing and thawing. 
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Fig. 2. The effect of different lysis procedures on the electrophoretic mobility of ,BGAL. 
Human prîmary fibroblasts (1 and 2). Chinese hamster E36 (3 and 4). The lysates of channels 
2 and 3 are prepared by treezing and thawing, those presented in I and 4 by sonication. 
It was found that different techniques for preparation oflysates, i.e., 
sonication or freezing and thawing, yielded different electrophoretic pat-
terus of the f3GAL isoenzymes (Fig. 2). Following sonication human 
fibroblasts showed a diffuse band at the A and B position (channel 1). 
Most of the activity was found at the A position. Wh en the lysate was pre-
pared by freezing and thawing (channel 2), the main activity was found at 
the B position. The lysate of Chinese hamster E36 cells showed one band 
after sonication (channel 4), whereas the presence of two bands is indi-
cated when the lysates were prepared by freezing and thawing (channel 
3). In another electrophoretic buffer system (0.05 M Tris-citrate, pH 5.0) 
the separation between these two Chinese hamster isoenzymes was 
improved. Unfortunately this buffer system could nat be used because it 
did nat allow the electrophoretic separation of the human and Chinese 
hamster isoenzymes. 
With regard to the f3GAL isoenzymes, two types of man-Chinese 
hamster hybrid cell lines were found (Fig. 3): hybrid cell lines which 
expressed only E36 f3GAL activity (channel 2) and hybrid lines showing 
an additional band of activity with a mobility intermediale to the Chinese 
hamster and the hu man B-band (channel 3). This band will be referred to 
as the test marker. The isoenzyme pattem of 4 hybrid cell lines was 
characterized with antibodies specific for human /3-galactosidase. The 
resulting electrophoretic pattem of one of these lines is presenled in Fig. 
4. The antiserum did react with human /3-galactosidase, removing all 
enzyme activity (channel I). In channel 4 a hybrid with the additional 
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Fig. 3. Electrophoretic pattem of ,BGAL isoenzymes from man-Chinese hamster cell hy-
brîds: Chinese hamster E36 (1); man-Chinesehamster hybrid without test marker (2); man-
Chinesehamster hybrid with test marker (3); human primary fibroblast (4). All the !ysates 
were prepare ct by freezing and thawîng. 
band of activity is shown. Following treatment with anti-human ,BGAL 
serum, the marker band disappeared whereas the E36 band of activity 
was not affected (channel 3). No reaction of anti-human ,BGAL serum 
with E36 ,BGAL was observed (channel 5). These results were confirmed 
with double immunodiffusion in agarose gels using various progressive di-
lutions ofthe antiserum (Fig. 5). In all the antiserum concentrations tested 
Fig. 4. The effect of anti-human ,BGAL serum on the electrophoretic pattem of ,8GAL from 
primary fibroblasts (1 and 2), man-Chinese hamster hybrid with test marker {3 and 4), and 
Chinese hamster E36 (5 and 6). The lysates of channel l. 3, and 5 we re treated with 
antihuman ,BGA L serum. All the lysates we re prepare ct by freezing and thawing. 
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Fig. S. Double immunodiffusion of anti-human ,BGAL and lysates of various een lines on 
agarose gel. The following dilutions of the antiserum we re used I : 0 { 1); 1 : 2 (2); I : 4 (3); 1 : 8 
(4); I: 16 (5); I: 32 (6). The cell !i nes tested were hu man fibroblasts (A); hybrid with test 
marker (B); hybrid without test marker (C); E36 (D). 
a precipitation line was observed in the gel containing the human fibro-
blasts and the man-Chinese hamster hybrids with the test marker band. 
The E36 and hybrid with the marker band did notshow a precipitation line 
in the gels. Furthermore, antigen-antibody titrations in various combina-
tions of antigen and antiserum showed no reaction of anti-human f3GAL 
serum with Chinese hamster f3GAL. At normal ex perimental conditions, 
no enzyme activity was found at the human f3GAL-A and B position in 
any of25 independent primary hybrid cianes obtained from two fusion ex-
periments. When overloading the gel with lysate of a hybrid showing !he 
additional f3GAL band, somelimes a slight f3GAL activity was observed 
at the f3GAL-B position. 
The translocation chromosomes, a diagram of the translocation, and 
the position of the X-chramosomal markers on these chromosarnes are 
represented in Fig. 6. The PGK marker is located on the X/22 and the 
f3GAL-A, HPRT, and Gd marker on the 22/X translocation product (see 
ref. 27). In this reference the X/22 Breda line is reported as X/22 Leiden. 
The presence of the 22/X derivative could not be established in hybrid 
cells with certainty because this cbramosome does not show a very 
characteristic banding pattem and moreover it could not be distinguished 
from Chinese hamster chromosom es of the same size. The data from Ta-
bie I show that the f3GAL marker is present logether with cbramosome 22 
and/or !he X/22 chromosome. Two cianes expressed !he test marker and 
PGK logether with cbramosome 22 and the X/22 translocation product. 
Six cianes did contain the X/22 chromosome, PGK, and the f3GAL 
marker, but no intact chromosome 22. In two clones the f3GAL marker 
was found logether with cbramosome 22, while PGK and the X/22 
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Fig. 6. The X chromosome, cbramosome 22. and their translocatîon products (Q-banding) 
tagether with a diagram of this X/22 Breda translocatîon showing the breakpoints in cbra-
mosome X and 22 and the positîon of the X-chromosomal markers on the translocation 
products. 
translocation chromosome could not be detected. Thirteen clones were 
negative for the two enzyme markers, the X/22 piece, and chromosome 
22. In one clone PGK and the (3GAL marker were present in apparent 
absence of chromosome 22 and the X/22 translocation product. The chro-
mosome data of the 13 clones being negative forthetest marker revealed 
that all human autosomes, except cbramosome 22 and the X/22 transloca-
ti on product, could be recognized (Table 2). To extend the assignment 
Table 1. Dis tribution of POK and ,8GAL and the pre se nee or absence of human 
cbramosome 22 and the X/22 translocation cbramosome 
Number of clones PGK flGAL X/22 22 
2 + + + + 
6 + + + 
2 + + 
13 
J + + 
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Table 2. Human chromosome constitution ofthe hybrid cl on es negative for hu man PGK and (3GAL 
~--~~-~~-~···-~ 
Hu man chromosomes~> 
-~ .. --~·--~-----··-----~ 
Cellline" I 2 3 4 5 6 7 8 9 10 IJ 12 13 14 15 16 17 18 19 20 21 22 x X/22 
--·------·--~.·--~·--~··---·--···--·---··--- ---·---·-----~··--~---·-----~ 
El6.4a + 
El6.13a + + +' + + + + 
Ei6.14a + + + + + + + + + +" + + + + + + + 
E16.2la + + 
~ 33.9 + + + + ~ 
'"' 
33.14 + + + + + + + + + 
33.15 + + + 
33.1.10 + + + + + + + + + + 
33.11.20 + + + + + + + + + + + + + 
33 m.p. + + + + + + + + 
---·--~·------··---·---·---··--·---·---·-----~···------·------·--·---·---. 
"Analysis of ten hybrid clones are given: in the other three lines no intact human chromosomes could be recognized. The primary cianes are 
derived from two fusion experiments (the "'E 16" and "33" series). 
11The retained chromosarnes werc found in a frequency of JO% or more. 
cFrequency of cbramosome retention is about 5%. 
Table 3. Synteny relationships between ,BGAL and 19 human enzyme markers 
Chromosome to 
,BGal!marker, number of clonesb 
whîch marker is 
Marker assignecta ++ +- -+ 
PGM1 I 5 6 3 5 
MDH, 2 3 8 4 10 
GALT 3 5 2 8 I 
PGM2 4 2 3 5 2 
PGM3 6 0 10 0 9 
SODM 6 I 5 0 9 
jlGUS 7 4 2 2 2 
GSR 8 6 5 3 10 
AK, 9 4 7 3 10 
GOT5 JO 7 4 3 10 
LDHA 11 8 3 5 5 
LDHB 12 5 6 6 4 
NP 14 7 4 6 7 
MP! 15 3 3 I 3 
PEPA 18 6 5 7 5 
GPI 19 6 5 4 9 
ADA 20 9 2 7 6 
SOD, 21 2 3 3 6 
Gd 22/X' 11 0 11 2 
"Confirmed or tentative assignment, see Baltirnare Conference on Human Gene Mapping 
(28). 
b + + means both markers are present; +- means ,BGAL present, but the other absent; - + 
means ,BGAL absent, whereas the other marker is present; --bath markers are absent. 
crn these particular experiments (27). 
data we studied the segregation pattem of the (3GAL marker logether wi th 
19 other enzyme markers, firmly or tentatively assigned to partienlar 
chromosarnes (see Baltirnare Conference on Human Gene Mapping, 
1975, 28) (Table 3). No concordant segregation between the test marker 
and the other enzyme markers was found. 
DISCUSSION 
Evidence has been presenled for a molecular relationship between 
(3GAL-A and (3GAL-B, A is thought to be a morromerand B adecamer of 
A subunits (3, 29). Our data obtained with lysates either prepared by soui-
cation (main!y (3GAL activity at the A position) or freeze-thawing, may 
indicate that (3GAL-B can be converled into (3GAL-A; they support the 
hypothesis of a relationship between the two types of (3GAL. 
In our experimental conditions the electrop haretic bands of human 
(3GAL-A and -B are absent in man-Chinese hamster hybrid cells. The 
results obtained with a specific anti-human (3-galactosidase serurn 
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revealed that a human ,BGAL component in these hybrids is represented 
by an intermediale band. It is attractive to postulale that the intermediale 
band in hybrid cells is a heteropolymer between human and Chinese 
hamster subunits. In these hybrids the Chinese hamster karyotype is 
pseudotetraploid, and this could result in an excess of Chinese hamster 
,BGAL subunits. lf this is the case, formation of heteropolymers would 
u se up all the human subunits available and explain the absence ofhuman 
,BGAL-A and -B in the hybrid cells. A definite proof ofthis hypothesis can 
be obtained by further identification of the marker band using specific 
antisera against Chinese hamster ,BGAL. The ,BGAL marker was found to 
be presentor absent logether with hu man chromosome 22 and/or the X/22 
translocation chromosome (Table l). The exceptional clone expressing 
the enzyme but not the chromosome 22 and 22/X was interpreled as the 
result of secondary cbramosome breakage and rearrangement occurring 
in these hybrid cells. ldeally to assign a gene to a chromosome all the 
other human chromosarnes should be definitely excluded as candidates 
for carrying that specific gene. Table 2 demonstraled that all human au-
tosomes except cbramosome 22 and the translocation product X/22 are 
present in at least 10% of the metaphases studied in the hybrids having 
lost the ,BGAL marker (The normal X chromosome, being inactive, is nol 
considered here). These exclusions were confirmed by the segregation 
patterns of isoenzyme markers presenled in Table 3 since these marker 
enzymes have been assigned to the following chromosomes: 22/X. L 2, 3, 
4,6, 7,8,9, 10, ll, 12, 14, 15, 18, 19,20,and21(28). 
In these experiments a human line carryinga balanced translocation 
[ t(X;22) (q23;ql3) J was used. Regional mapping of the ,BGAL locus was 
therefore possible. In the six cianes where the X/22 translocation is 
present and the cbramosome 22 absent (Table 1), ,BGAL is present 
logether with PGK. In this particular translocation PGK was assigned to 
the X/22 derivative and the other X markers (Gd, HPRT, and aGAL-A) to 
the recipracal 22/X derivate (27). The 22/X translocation chromosome 
could not be recognized cytologically. But in Table 3 we see that 11 clones 
are positive for Gd (and therefore presumably contain the 22/X derivative) 
and negative for the ,BGAL marker band. 
Combination of all these data demonstrate that a locus for ,BGAL is 
located on cbramosome 22 and more precisely in the region 22q 13-qter. 
ACKNOWLEDGMENTS 
We wish to thank Mrs. M. Nijman for her technica! assistance, Dr. 
A. J. J. Reuser and Mr. A. Hoogeveen for stimulating discussions, Dr. 
P.O. Gerald (Boston) for the E36 cellline, and Dr. P. L. Pearson for cel! 
121 
material from the patient with the X/22 translocation. The purification of 
,8-galactosidase was carried out in collaboration with Mr. I. Brown. Drs. 
M. W. Ho and D. Robinson (Dept. of Biochemistry. Queen Elizabeth 
College. London). This work was supported in part by The Netherlands 
Foundation for Medica! Research FUNGO. and EURATOM, Contract 
no. 196-76 BION. 
LITERA TURE CITED 
I. Ho, M. W., Cheetham. P .. and Robinson, D. (1973). Biochem. J. 136:351-359. 
2. Narden, A.G. W., and O'Brien, J. S. (1973). Arch. Biochem. 159:383-392. 
3. Narden, A.G. W., Tennant, L. and O'Brien, J. S. (1974). J. Biol. Chem. 249:7969-
7976. 
4. Loonen, N. C. B .. Lugt, van der L.. and Franke, C.L. (1974). Lancet 2:785. 
5. Wolfe. L.S., Cal\ahan, J., Fawcett. J. S .. Anderma. F .. and Scriver, C. R. (1970). 
Neurology 20:23-44. 
6. O'Brien, J. S .. ( 1972). In Advances in Hu man Generics, Vol. 3, (ed.) Harris, H., and 
Hirschhorn, K. (Plenum, New York) pp. 39-98. 
7. Lowden. J. A., Callahan, J. W .. Norman. M.G., Than. M .. and Pritchard. J. S. ( 1974). 
Arch. Neurol. 31:200-203. 
8. Pinsky, L. MiJler, J., Stanfield, B ., Watters. G .. and Wolfe. L.S. ( 1974). Am. J. Hum. 
Genet. 26:563-577. 
9. Okada, S., and O'Brien. J. S. (1968). Science 160:1002-1004. 
JO. Galjaard, H .. Hoogeveen, A., Keijzer, W., Wit+ Verbeek de H.A .. Reuser, A. J. J., 
Ho, M. W., and Robinson, D. (1975). Nature 257:60-62. 
IJ. Pearson, P. L .. Sanger, R .. and Brown, J. A. (1974). Report of the committee on the 
genetic constitution of the X-chromosome. In Rotterdam Conference ( 1974). Second 
International Workshop on Human Gene Mapping. pp. 20-25. Birth Defects: Origina1 
Artiele Series. Vol. 11, No. 3, The National Foundation, New York, 1975. 
12. Gillin, F. D., Roufa. D. ]., Beaudet, A. L., and Caskey, C. T. (1972). Genetics 72:239-
252. 
13. Westerveld, A., Meera Khan. P., Visser, R.P. L.S., and Bootsma. D. (1971). Nature 
(London), New Biol. 234:20-24. 
14. Meera Khan. P. (1971). Arch. Biochem. Biophys. 145:470-483. 
15. Someren, H. van, Beyersbergen van Henegouwen. H .. Los, W., Würzer-Figurelli, E., 
Doppert, B., Vervloet, M., and Meera Khan, P. (1974). Humangenetik 25:189-201. 
16. Westerveld, A., Beyersbergen van Henegouwen, H.M. A., and Someren. H. van. 
(1974). In Rotterdam Conference (1974). Second International Workshop on Human 
Gene Mapping, pp. 283-284. Birth Defects: Original Artiele Series, Vol. 11, No. 3, The 
National Foundation, New York, 1975. 
17. Grzeschik, K. H. (1975). In Baltirnare Conference (1975): Third International Work-
shop on Human Gene Mapping, pp. 142-148. Birth Defects: Original Artiele Series. 
Vol. 12, No. 7, The Natîonal Foundation, New York, 1976. 
18. Quick, C. B., Fisher, R. A., and Harris, H. (1972). Ann. Hum. Genet. 35:445-454. 
19. Carroll, M., and Robinson, D. (1974). Biochem. J. 137:217-221. 
20. Lake, B.D. (1974). Histochem. J. 6:211-218. 
21. Jongsma, A.P. M., Someren, H. van, Westerveld, A., Hagemeijer, A .. and Pearson, 
P. L. (1973). Humangenetik 20:195-202. 
22. Seabright, M. (1971). Lancet 2:971-972. 
23. Verma. R. S., and Lubs, H.A. (1975). Am. J. Hum. Genet. 27:110-117. 
24. Ho, M. W ., and O'Brien, J. S. (1969). Science 165:611-613. 
25. Suzuki, Y., Crocker, A., and Suzuki, K. (1971). Arch. Neurol. 24:58-64. 
122 
26. Fluhartty, A. L., Lassila, E. L., Porter, M. T .. and Kihara, H. (1971).Biochem. Med. 
5,158-164. 
27. Pearson. P. L .. Linden. A. G. J. M., van der and Hagemeijer, A. { 1973). In New Haven 
Conference (1973). First International Workshop on Human Gene Mapping, pp. 136-
142. Birth Defects: Original Artiele Series, Vol. 10. No. 3, The National Foundation, 
New York 1974. 
28. Baltirnare Conference (1975): Third International Workshop on Human Gene Map-
ping. Birth Defects: Original Artiele Series; VoL 12, No. 7, The National Foundation, 
New York, 1976. 
29. O'Brien. J. S. ( 1975). Clin. Genet. 8:303-313. 
123 

1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
. Je; 11 
1 
1 
1 
1 
1 

PAPER V 
ASSIGNMENT OF STRUCTURAL p-GALACTOSIDASE LOCI 
TO HUMAN CHROMOSOMES 3 AND 22 
J. DE WIT, H.L.HOEKSEMA, D.BOOTSMA and A.WESTERVELD 
Department of Cell Biology & Genetics, Erasmus 
University, P.O.Box 1738, Rotterdam, The Netherlands 
SUMMARY 
Hybrid cell lines isolated after fusion between Chinese 
hamster E36 cells and normal human white blood cells were 
analyzed for human }3-galactosidase isoenz:ymes and for human 
chromosomes, especially 3, 12, and 22, the candidates for 
bearing a {3-galactosidase locus. Results of neuraminidase 
treatment of the cell lysates and inmmnological studies 
showed that in man two structural .8-galactosidase loci are 
present and can be assigned to chromosarnes 3 and 22. No cor-
relation was found between the expression of human 
}3-galactosidase and the presence of human chromosome 12. 
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INTRODUCTION 
Independent studies on the localization of genes 
involved in the expression of the lysosomal enzyme 
jl-galactosidase (JlGAL; E.C. 3.2.23) have revealed 
conflicting data. Our own group located a structural 
PGAL locus on chromosome 22 and excluded the other 
chromosarnes (de Wit et al., 1977). Bruns et al. 
(1977) and Shows et al. (1977) assigned a JlGAL locus 
on chromosome 3 and excluded the other chromosarnes 
as well. Recently Rushton and Dawson (1977) assigned 
a pGAL locus on chromosome 12. Different techniques 
for the detection of ~GAL activities have been used 
in these studies, and it cannot be excluded that 
these techniques may have different specificity to-
ward different gene products involved in the expres-
sion of PGAL. The discrepancies in the literature 
could therefore indicate the existence of more than 
one structural PGAL locus. Moreover the use of human 
cells from only one individual, carrying an X/22 
translocation, in the production of the hybrids in 
our previous study (de Wit et al., 1977) could have 
affected our data. 
In the present study we reinvestigated our pre-
vious man-Chinese hamster hybrids with the X/22 
translocation by using different electrophoretic 
techniques, and a new man-Chinese hamster hybrid cell 
panel was isolated in which PGAL was characterized 
with electrophoretic and immunological methods. 
The data revealed that cbramosome 3 and 22 both 
bear a structural PGAL locus. Assignment of ~GAL to 
chromosome 12 was excluded in the present study. 
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MATERIALS AND METHODS 
Thirty-six primary man-Chinese hamster hybrid cells were 
isolated following fusion of hypoxanthine phosphoribosyl-
transferase (HPRT) deficient Chinese hamster cells (E36) with 
normal human male leucocytes. 
The E36 cell line is a derivative from the V79 cell line 
(Gillin et al.,1972). The mutant cell line and the isolated 
hybrids were grown respectively in F10 and F10 HAT (Ham,1973, 
Littlefield,1964) medium supplemented with 5% fetal calf 
serum and antibiotics. 
The fusion procedure is essentially the same as described 
previously (Westerveld et al.,1971). The hybrid panel used 
in our previous study (de Wit et al.,1977) in which a human 
X/22 translocation (X/22 Breda; 46 XX,t(x;22) (q23;q13)) is 
involved was reinvestigated. 
The following enzymes were characterized by means of 
Cellogel electrophoresis; p-galactosidase (pGAL; E.C.3.2.23), 
lactate dehydrogenase (LDH; E.C.1.1.1.27), aconitase 
(mi toehondrial) (ACON ; E.C. 4. 2. 1. 3) and glutathione 
peroxidase (GPX; E.C.m1.11.1.9). The methods for the charac-
terization of LDH, ACON and GPX are described by Meera Kahn 
m (1971, 1977) and Wijnen et al. (1977). 
The genes coding for the following enzymes have been 
firmly or tentatively assigned to particular chromosomes: 
LDH to 12 and GPX to 3 (Bootsma and Ruddle,1977), ACON 
to~2 (Ferguson-Smith and Westerveld,1977). ----m 
Two different electrophoretic techniques were applied 
in order to characterize pGAL. One technique was performed 
by Cellogel electrophoresis in a 0. 05 M Na 2- p -glycero-phosphate buffer pH 6.2 at an initial voltage of 200 volts 
keeping the amperage constant for 3 hours at 4°C as described 
by us before (de Wit et al.,1977). The other method has 
been publisbed by Bruns et al. (1977), and involves Cellogel 
electrophoresis in a 0.1 M Tris, citric acid buffer, pH 6.5 
0 
at 200 volts for 4 hours at 4 C. _ 3 The cell sonicates were prepared_~n 5 x 10 M phosp~~te 
buffer pH 6.4, containing 1 ~ 5 10 M Na 2EDTA, 1 x 10 M ~-mercaptoethanol and 2 ~ 3 10 M NADP as described by Meera Khan (1971) or in 5 x 10 M potassium phosphate buffer 
pH 6.5 containing 1 x 10-JM Na 2EDTA as described by Bruns 
et al. (1977) Treatment of cell sonicates by neura.minidase 
(Sigma type VI) was performed according to Bruns (1977\. Anti-
serum against purified acid humanpGAL isolated from liver 
was raiseó in New Zealand Wnite Rabbits (de Wit et al., 1977). 
0 
Lysates were incubated with antiserum overnight at 0 C, the 
mixtures were then centrifuged at 35,000 g for 20 min. and 
the supernatant was used for electrophoresis. 
Chromosame preparations were made from the same batches 
of cells as where the lysates for enzyme studies. Identifi-
cation of the chromosarnes was achieved for enzyme studies. 
Identification of the chromosarnes was achieved using 
Q-banding (Jongsma et al., 1973), trypsin-Giemsa staining 
(Seabright, 1971), and R-banding (Verma and Lubs, 1975). At 
least 20 metaphases of each clone were analyzed. 
RESULTS 
The isolated hybrid cell lines were analyzed for 
the presence or absence of the human chromosarnes 3 1 
12, and 22 and for the presence of human GPX, LDHB 
and ACON . 
m 
The PGAL isoenzyme patterns were investigated 
of hybrids with chromosome 3 in the absence of 22 
(3+22-), hybrids containing chromosome 22 but not 
chromosome 3 (3-22+), hybrids with both chromosarnes 
3 and 22 (3+22+), hybrids with chromosome 12 but 
without the chromosarnes 3 and 22 (3-12+22-). Compar-
able results were obtained with the electrophoretic 
methad previously described by our own group (de 
Wit et al., 1977) and with that used by Bruns (1977) 
without the neuraminidase treatment. The best 
separation of the different isoenzymes was obtained 
by applying to the gels the lysates prepared 
according to the method of Bruns et al. (1977) 
combined with the electrophoretic system developed 
by us (de Wit et al., 1977). Fig. 1 shows the pGAL 
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Figure 1. Electrophoretic pattern of pGAL isoenzymes 
from man-Chinese hamster cell hybrids: human primary 
fibroblast (1); Chinese hamster E36 (2); man-Chinese 
hamster hybrid with cbramosome 22 present in 65% of 
the metaphase cells and without 3 (3); hybrid with 
cbramosome 3 present in 87% of the metaphase cells 
and without 22 (4); hybrid with chromosarnes 22 and 3 
in 80% and 70% of the metaphase cells, respectively 
(5); hybrid without chromosarnes 22 and 3 and with 
chromosome 12 present in 60% of the metaphase cells 
(6) • 
electrophoretic patterns of the above-mentioned 
types of hybrids obtained with this method. 
Lysates of human fibroblasts yielded two bands, 
designated (JGAL 8 and (JGALA (lane 1, see also Fig. 2 
lane 1). The Chinese hamster E36 cells show one 
band of activity (lane 2). A hybrid cell line 
containing chromosome 22 in the absence of chromo-
saroe 3 is presented in lane 3. 
In our previous paper (de Wit et al., 1977) the 
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activity anodal to, but not separated from, the 
hamster band is referred to as the marker band. 
Hybrid cell lines, containing chromosome 3 in the 
absence of chromosome 22 also show this marker band 
(lane 4). 
A very weak band of activity in these hybrids 
was observed when chromosome 3 was present in about 
20% of the cells, indicating that this frequency is 
the lower limit at which ~GAL can be detected. In 
3+22+ hybrid cell lines next to the additional 
activity seen in 3+22- and 3-22+ hybrids, a more 
anodal band is present at the human ~GALB position 
(Fig .1, lane 5, see a lso Fig. 2 and 3, lane 9). In 
3-22- hybrids in which the markers GPX and ACON 
m 
were absent but chromosome 12 and LDH 8 are present, 
activity could be detected only at a position 
comparable to that of the Chinese hamster band 
( lane 6) . The presence or absence of chromosome 12 
in hybrids having either cbramosome 3 or 22 or both 
did not influence the electrophoretic patterns, as 
shown in Fig.1. 
To investigate the presence of determinants of 
human origin in the markei band, the hybrid cell 
lines were analyzed with an antiserum directed 
against human pcAL. The results are presented in 
Fig.2. The humanpGAL activity disappeared (lane 2) 
whereas the anti-human pGAL serum only slightly 
reduced the Chinese hamster fJGAL activity (lane 4). 
Quantitative measurements showed that the human 
PGAL activity is reduced by 98%, whereas the Chinese 
hamster activity is reduced by 9%. The marker band 
of lysates from 3-22+, 3+22-, and 3+22+ hybrids 
132 
Figure 2. The effect of anti-humanPGAL serum on the electrophoretic pattern of 
human fibroblasts (1 and 2); Chinese hamster E36 (3 and 4); 22+3- hybrid (5 and 
text); 3+22- hybrid (7 and 8); 22+3+ hybrid (9 and 10). The lysates of channels 2,4,6,8 
and 10 were treated with anti-humanPGAL serum 
Figure 3. The effect of neuraminidase treatment on the electrophoretic pattern of 
from human primary fibroblasts (1 and 2); Chinese hamster E36 (3 and 4); 22+3- hybrid 
(5 and 6); 3+22- hybrid (7 and 8); 3+22+ hybrid (9 and 10). The lysates of channels 2,4, 
6,8 and 10 were treated with neuraminidase 
was removed after treatment of the lysates with 
anti-human j3GAL serum (lanes 6, 8, and 10). 
Thus the electrophoretic mobility and anti-
genicity of the marker bands in 3-22+ hybrids and 
3+22- hybrids were similar. The marker band in 
3-22+ hybrids was very labile compared with that 
in 3+22- hybrids and was found only when freshly 
prepared lysates were used. 
The effect of neuraminidase treatment on human 
cells, Chinese hamster cells, and the different 
types of hybrid cells is presented in Fig.3. 
Neurarninidase treatment of human lysate shifted the 
position of human j3GAL to a slightly more cathodal 
position (lanes 1 and 2) whereas that of the 
Chinese hamster j3GAL was not affected (lanes 3 and 
4). Neurarninidase treatment removed the marker 
band in 3-22+ hybrids (lanes 5 and 6) but not in 
3+22- hybrids (lanes 7 and 8). The more anodal 
band in 3+22+ hybrids remained after neurarninidase 
treatrnent, whereas the intermediate activity dis-
appeared. 
The results of the analysis of all 36 primary 
hybrid cell lines are summarized in Table 1. 
Fifteen clones did express the j3GAL marker band. 
In six of these clones the marker band disappeared 
after neuraminidase treatment. These six clones 
had all lost chromosome 3 and GPX but not chromo-
some 22 and ACON 
m 
In nine clones the ~GAL marker band was not 
affected. Four of these clones had retained chromo-
some 3 and GPX but lost chromosome 22 and ACON 
m 
'rhree clones had retained chromosarnes 3 and 22 as 
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Table 1. The expression of human {)GAL befare and af ter 
neuraminidase treatment and the preserree of GPX, ACON 
' m 
and human chromosarnes 3 and 22 
Number {)-Galactosidase Chromosarnes GPX ACON 
m 
of clones 3 22 -neur. +neur. 
6 + + :>1 0% + 
4 + + + >2 0% + 
3 + + + ::>30% +>25% + + 
20 
1 + + 
1 + 5% + 
1 + + +50% +5% + 
Table 2. Relationship between fJ GAL and LDH and {JGAL and 
chromosome 12 in the man-Chinese hamster h~brids. 
+ 
+ 10 
5 
pGAL 
11 
Chromosame 12 
10 
+ 
+ 6 
- 3 
pGAL 
4 
1 
Table 3. Human {3GAL, GPX, ACON , and PGK activity in the 
absence or preserree of human cNromosomes 3, 22,· and X/22 
in hybrids with an X/22 translocation. 
Number {)GAL Chromosarnes 
of clones ~3~~~~~~2~2~---X~/ö2ö2 Markers GPX ACON PGK 
m 
1 + 
3 + 
2 + 
2 
4 
1 + 
1 + 
+30-80% 
+ 5-10% 
+50% + 5 96 
+15- 50% 
+50-100% + 
+ 5% 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
well as GPX and ACON . In one clone having 
m 
chromosome 22 in 5% of the cellsl ACON could not 
m 
be detected whereas PGAL 1 cbramosome 3, and GPX were 
present. Only 
chromosarnes 3 
marker band, 
one clone, in which GPX, ACON 
m 
and 
and 22 were lost, did express the 
and this band was not affected by 
neuraminidase. Twenty-one cases had lost the marker 
band. In twenty of these clones GPX 
also lost and chromosarnes 3 and 22 
and ACON were 
m 
could not be 
detected. One clone that was negative for the PGAL 
marker band did express GPX, whereas cbramosome 3 
was present in a low frequency. 
The segregation data for pGAL and LDH or chromo-
some 12 of the primary clones (Table 2) indicate 
that there is no correlation between the presence 
or absence of LDHB or cbramosome 12 and PGAL. 
Previously we assigned a structural locus for 
PGAL to chromosome 22 by studying hybrids isolated 
after fusion of white blood cells from an individ-
ual with an X/22 translocation with Chinese hamster 
cells. Human PGK segregated with the X/22 piece, 
whereas aGALA, HPRT, and Gd were assigned to the 
22/X chromosome (de Wit et al., 1977) These hybrids 
were reinvestigated with respect toPGAL and cbramo-
some 3 and 22. The results are shown in Table 3: 
four clones did express PGAL, PGK, and ACONm and 
had retained cbramosome 22 and or X/22. Two clones 
with chromosarnes 3 and X/22 did contain human PGAL, 
GPX, ACON f and PGK, Two other clones had lost 
m 
chromosarnes 3, 22, and the X/22 piece, and no human 
information for the four markers could be detected 
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either. Four clones had retained chromosome 3 in a 
low frequency (5%-10%) and lost chromosarnes 22 and 
X/22. In these clones ~GAL,GPX, ACON , 
m 
and PGK 
were also absent. PGK and PGAL were present in two 
clones. In one of these clones the X/22 piece was 
present in 5% of the cells, whereas in the other 
clone chromosarnes 3, 22, and X/22 could not be 
detected. In these two clones GPX and ACON were 
m 
absent. 
DISCUSSION 
Three human chromosomes, namely 3, 12, and 22, 
have been proposed as candidates for bearing a 
~GAL locus. Our previous study (de Wit et al., 
1977) as well as the data described in this paper 
and the data publisbed by Bruns et al. (1977) and 
Shows et al. (1977) conflict with the assignment 
of ~GAL to cbramosome 12 (Rushton and Dawson, 
1977). The discrepancy between the data of Rushton 
and Dawson (1977) and these studies remains unex-
plained. 
Electrophoresis of the 3-22+ hybrid cell lines 
did show an additional band of activity designated 
as the ''marker band''. An anti-human acid-PGAL 
antiserum precipitates this PGAL activity, thus 
demonstrating that it contains human ~GAL deter-
minants and that a structural PGAL locus is 
located on cbramosome 22. Electrophoresis of 
lysates from 3+22- hybrid cell lines revealed a 
137 
similar marker band. The absence of this band after 
treatment with the antiserum indicates that a 
second structural ~GAL locus is located on chromo-
some 3. 
The marker bands present in these two types of 
hybrid cell lines differ in several characteristics. 
First, the marker band in 3-22+ hybrids is thermo-
labile compared with the marker band in 3+22-
hybrids. After neuraminidase treatment the marker 
band in 3-22+ hybrids is not detectable whereas the 
pattern seen in 3+22- hybrids is not affected by 
this treatment. ~GAL activity is observed in 3-22+ 
hybrids if the chromosome 22 is present in at 
least about 5% of the cells (see Table 3). 
However the frequency of the chromosome 3 in 
3+22- hybrids should be higher than 20% before the 
marker band can be seen on the gel. The discrep-
ancy between our previous results (de Wit et al. 
1977) and those presented in this paper may be 
due to the high frequency of chromosome 3 needed 
to express the marker band. In none of the hybrid 
cell lines of the panel previously used was chromo-
some 3 present in a frequency higher than 20%. 
The more anodal band in 3+22+ hybrids remains 
after neuraminidase treatment. Possibly there is 
an interaction between the gene products of the 
two loci that could result in a complete human 
PGAL, whereas the marker bands in 3+22- and 3-22+ 
hybrids may represent heteropolymerie PGAL, con-
sisting of human and Chinese hamster subunits 
(de Wit et al., 1977). 
Bruns et al. (1977) who located PGAL on chromo-
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some 3, routinely used neuraminidase-treated 
hybrid cell lysates for their electrophoresis. 
This fact tagether with the instability of the 
marker band in 3-22+ hybrids may be responsible 
for the absence of this marker band in their 
studies. Shows et al. (1977), using an anti-human 
PGAL antiserum, also assigned PGAL to chromosome 3. 
The discrepancy between their results and those 
described in this paper remains unexplained. 
The assignment of PGAL loci to chromosome 3 
and 22 indicates that at least two structural 
PGAL loci exist in the human genome. At present 
it cannot be excluded that one of the marker bands 
contains another human p-galactosidase, for in-
stance the galactosyl-cerebroside pGAL deficient 
in Krabbe • s disease (Suzuki and Suzuki, 1974). This 
possibility would be ruled out by the demonstra-
tion of a pGAL isoenzyme composed of the gene 
products of both loci in 3+22+ hybrids. This will 
be investigated with a specific anti-Chinese 
hamster antiserum. 
Complementation analysis with fibroblasts from 
different types of patients with a GM 1 -~GAL defi-
ciency has indicated the presence of two comple-
mentation groups (Galjaard et al., 1975). Analysis 
of PGAL in human liver has shown tha·t the enzyme 
consists of a 70,000 mol.wt. monomeric protein and 
a multimeric aggregate of the same protein (Narden 
et al., 1974). Analysis of the restored ~GAL activ-
ity after fusion of fibroblasts with different 
types of ~GAL deficiency (Hoeksema et al., 1979) 
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and cornplementation studies with enucleated fibro-
blasts (de Wit-Verbeek et al.,1978) provided evi-
dence for intergenie cornplementation, in which 
only one structural ~GAL gene is involved. Cells 
from patients with type 1 or type 2 GM 1 -gangliosi-
dosis1 belonging to one cornplernentation group, are 
thought to be mutated in a structural PGAL gene, 
whereas recently evidence was presented that in 
cells of patients with the adult type of pGAL 
deficiency, belonging to the other complementation 
group, a neuraminidase deficiency was present as 
well (Wenger et al.,1978) It has been suggested 
that the pGAL deficiency is due to an inhibition 
of its pGAL activity by accumulated sialo-oligo-
saccharides (0 1 Brien, 1978). 
Studies are now in progress in which we isolate 
cell hybrids after fusion of Chinese hamster cells 
with fibroblasts from different types of patients 
with a PGAL deficiency. These studies should give 
more insight into how the two loci are involved 
in the expression of PGAL and which PGAL gene is 
rnutated in the different types of GM 1 -gangliodosis. 
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PAPER VI 
THE GENETIC DEFECT IN THE VARIOUS TYPES OF 
HUMAN ~-GALACTOSIDASE DEFICIENCY 
H.L.HOEKSEMA, J. DE WIT and A.WESTERVELD 
Department of Cell Biology & Genetics, Erasmus 
University, P.O.Box 1738, Rotterdam, The Netherlands 
SUMMARY 
Gene localization studies revealed the presence of two 
structural p-galactosidase <PGAL) loci, on the human chromo-
sames 3 and 22 (de Wit et al., in press). Todetermine the 
function of these genes, proliferating hybrid cell lines were 
isolated following fusion of fibroblasts from two different 
patients with a PGAL deficiency and Chinese hamster cells. 
The hybrids were analysed electrophoretically and irnmuno-
logically. 
Fibroblasts from a patient with an adult type of ~GAL 
deficiency associated with a neuraminidase deficiency were 
used for the first fusion. No evidence for a structural PGAL 
mutation is found in these hybrids. The absence of a structural 
{JGAL mutation is in agreement with a primary defect in neura-
minidase in this adult patient. 
Fibroblasts from a patient with the infantile type 1 G 1-
gangliosidosis were used for the second fusion. It is con~ 
cluded that the human determinants present in the isolated 
hybrid lines occur in heteropolymerie man-Chinese hamster 
molecules. 
The heteropolymerie isoenzyme in 3+22- hybrids is very 
labile and sensitive to neuraminidase treatment. The~efore it 
is concluded that the infantile type 1 patient is mutated in 
the structural ~GAL gene on chromosome_ 3. Because this pa ti ent 
has a primary defect in G 1-{)GAL the /)GAL gene on chromosome 3 
is apparently a G -{JGAL ~ene.. Interaction of the two {JGAL loci 
result in an addi~lonal band of PGAL acti~ity on electro-
phoresis. This suggests that also the gene on chromosome 22 
is a structural GM 1 -~GAL gene. 
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INTRODUCTION 
The autosomal recessive disease GM 1 -gangliosidosis 
is characterized by the lysosomal starage of 
gangliosides and glycosaminoglycans, due to a defi-
ciency of acid GM 1 -~-galactosidase (~-D-galactoside 
galactohydrolase E.C.3.2.1.23) (Okada and O'Brien, 
1968). Several clinical forms of human acid ~-galac­
tosidase deficiency have been described, which dif-
fer in time of onset of the symptoms, the involve-
ment of visceral organs and the occurrence of men-
tal retardation (O'Brien, 1975; Galjaard and Reuser, 
1977; Suzuki et al., 1977) 
Somatic cell hybridization studies by Galjaard et 
al. (1975) showed that the infantile type 1 and 
juvenile type 2 GM 1 -gangliosidosis are based on a 
different gene mutation than that in a patient with 
the adult variant of ~-galactosidase deficiency (de-
signated as type 4). Complementation studies with 
enucleated fibroblasts from the different types of 
patients (de Wit-Verbeek et al. ,1978) and gel-
tiltration studies of human ~-galactosidase (Hoek-
sema et al.,1979) provided evidence for the occur-
rence of intergenie complementation. Recently, it 
has been shown that the p-galactosidase deficiency 
in patients with milder clinical features, including 
the adult type 4, is associated with a neuraminidase 
deficiency (Wenger et al.,1978; Lowden and O'Brien, 
1979; Hoogeveen et al., to be published). 
Tmmunolooical studies (Meisler and Rattazzi,1974; 
O'Brien and Norden,1977) showed the presence of 
immunologically cross reacting material for p-galac-
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tosidase in fibroblasts from patients with the in-
fantile and adult types of ~-galactosidase defi-
ciency. Gelfiltration studies (Hoeksema et al.,1979) 
indicated a disturbance of the aggregation of ~­
galactosidase monoroers to high molecular weight 
farms. These data indicate the presence of structur-
ally altered ~-galactosidase in infantile and adult 
patients. 
Gene localization studies of ~-galactosidase 
(/)GAL) have been contradictory. De Wit et al. (1977) 
located a structural pGAL locus on chromosome 22. On 
the other hand, Bruns et al. (1977} and Shows et al. 
(1978} presented evidence for a /)GAL locus on chromo-
some 3. Rushton and Dawson (1977} assigned a ~GAL 
locus on chromosome 12. Recently, analysis of a new 
series of man-Chinese hamster hybrid cell lines in 
our laboratory showed tPe presence of two structural 
~GAL loci on chromosarnes 3 and 22 (de Wit et al., in 
pre ss} . 
The purpose of the present study was to investi-
gate which structural genes coding for ~GAL are in-
volved in the infantile and adult types of {3-galac-
tosidase deficiency. Proliferating cell hyb~ids 
were isolated after fusion of fibroblasts from pa.-
tients with the infantile type 1 or adult type 4 
PGAL deficiency and Chinese hamster cells. 
Electrophoretic and immunological characterization 
of the ~GAL pattern in these hybrids confirmed the 
presence of two structural ~GAL genes, on the human 
chromosarnes 3 and 22. The data indicate that in the 
infantile type 1 the mutation is located in the 
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structural gene for ~~AL on chromosome 3. There was 
no evidence for a structural ~GAL mutation in the 
adult type p-galactosidase deficiency. 
MATERIALS AND METHODS 
Skin fibroblasts from a patient with the infantile type 
1 GM1 -gangliosidosis and from a patient with the adult type 4 ~-galactosidase deficiency (Loonen et al.,1974i Galjaard et 
al.,1975) were cultured in Harn's F10 medium supplemented with 
15% fetal calf serum and antibiotics. The Chinese hamster cell 
line used (E36) is a derivate of the V79 cell line (Gillin et 
al.,1972) and is deficient in hypoxanthine phosphoribosyltrans-
ferase. The cells were free of mycoplasma contamination as 
judged by the methad of Chen (1977). 
The fusion procedure and isolation of the hybrid cell lines 
in the HAT selection system (Littlefield, 1964) was essentially 
the same as described previously (Westerveld et al.,1971). The 
same batches of cells were used for chromosome analysis and 
preparation of cell homogenates. Trypsin-Giemsa staining 
(Seabright,1971) was used for identification of the chromo-_3 
somes. Cell homogenates were prepared by sonicati~~ in 5.10 M 
potas si urn phosphate buffer pH 6.5 containing 1.10 M Na 2EDTA. Cellogel electrophoresis for ~-galactosidase was performed 
in a 0.05 M Na 2 p-glycerophosphate buffer pH 6.2 during three hours at 4°C as described befare (de Wit et al.,1977). Treat-
ment of the cell homogenates by neuraminidase (Sigma type VI) 
was performed according to Bruns (1977). Electrophoresis of 
glutathion peroxidase (GPX; E.C. 1.11.1.9) and aconitase 
(mi tochondrial) (ACONm; E.C. 4. 2 .1. 3) was carried out as de-
scribed by Wijnen et al. (1977) who assigned GPX to chromo-
saroe 3, and Meere Khan (1977) who assigned ACONm to chromo-
some 22. 
Antiserum against partially purified ~-galactosidase and N-
acetyl-~galactosaminidase isolated from human liver was raised 
in rabbits (Schram et al., 1977). Homogenates were incubated 
with antiserum during three hours at 0 C, the mi-xtures were 
then centrifuged at 35.000g for 30 minutes and the supernatant 
was used for electrophoresis. 
~-Galactosidase was assayed quantitatively with 1mM 4-
Methylumbelliferyl-p-D-galactopyranoside in 0.05 M sodium-
acetate buffer in 0.1 M NaCl, pH 4.2 as described befare 
(Galjaard et al., 1974). 
148 
RESULTS 
I. Hybrids between human fibroblasts from the adult 
type p-galactosidase deficiency and Chinese 
hamster cells 
Twenty-eight primary and sixty-seven secondary 
hybrid clones were isolated following fusion of 
fibroblasts from a patient with the adult type 4 
p-galactosidase deficiency and Chinese hamster cells. 
The hybrid clones were analysed for the presence 
and absence of the human chromosarnes 3 and 22, and 
for the presence of hurnan P-GAL, GPX and ACONm. 
Eighteen primary clones retained all human chromo-
somes. 
The hybrid cell lines isolated could be divided 
in four categories: hybrids in which chromosome 3 
is present in the absence of chromosome 22 (3+22-) 
hybrids in which chromosome 3 is absent and chromo-
some 22 is present (3-22+), hybrids in which bath 
chromosarnes 3 and 22 are present ( 3+22+) and hybrids 
in which bath chromosarnes 3 and 22 are absent 
(3-22-). 
Figure 1 shows the ~GAL electrophoretic patterns 
of three types of hybrid clones (3+22-; 3-22+; 
3+22+) and of the parental cell lines. Fibroblasts 
from the adult type 4 patient have 10-20% residual 
pGAL activity. A concentrated cell homogenate is 
used to visualize this pGAL activity on electropho-
resis (figure 1, lane 4). Both 3+22- and 3-22+ 
hybrids show activity at the position of the hamster-
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Figure 1. Electrophoresis of ~-galactosidase (~GAL) from 
type 4 x Chinese hamster hybrids. Lane 1: 3+22- hybrid; 
lane 2: 3-22+ hybrid; lane 3: 3+22+ hybrid; lane 4: 
fibroblasts from the adult type 4 patient; a concentratea 
cell homogenate is used to visualize the PGAL activity 
(4 x the protein concentration used in the other lanes). 
Lane 5: Chinese hamster E36. Lane 6: normal human fibro-
blasts. A: jJGALA; B: {JGALB. 
band (see figure 1, lane 5) a!ld activity anodal but 
nat separated from this band. The more anodal activ-
ity is referred to as the markerband. In 3+22+ hy-
brids ( figure 1, lane 3) an addi tional, anodal band 
of activity is present at a position comparable to 
the control human pGALB position ("B"-band). Hybrids 
which lost both chromosarnes 3 and 22 (3-22-) show a 
~GAL electrophoretic pattern comparable to the 
Chinese hamster pattern. 
To investigate the presence of human determinants 
in the markerbands, the pGAL isoenzyme pattern of 
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Figure 2. The effect of anti~human antiserum on the electrophoretic pattern 
of ftGAL from type 4 x Chinese hamster hybrids. Lane 1 and 2: 3+22~ hybrid; lanes 
3 and 4: 3~22+ hybrid; lanes 5 and 6: 3+22+ hybrid; lanes 7 and 8: fibroblasts 
from the adult type 4 patient. The cell homogenates of lanes 2,4,6 and 8 were 
treated with the anti~human ~GAL antiserum. 
Figure 3. The effect of neuraminidase 
of ~GAL from type 4 x Chinese hamster 1 and 2: 3+22-
3 and 4: 3-22+ hybrid; lanes 5 and 6: 3+22+ hybrid; lanes 7 and 8: fibroblasts 
frorn the adult type 4 patient. Lanes 1,3,5 and 7 show the ~GAL patterns after in-
cubation with buffer for 1 hour at 37°C. Lanes 2,4,6 and 8 show the ~GAL patterns 
after treatment with neuraminidase for 1 hour at 37°c. 
Figure 4. Electrophoresis of ~GAL from infantile type 1 G l-gangliosidosis x 
Chinese hamster hybrids. lane 1: 3+22- hybrid; lane 2: 3-~ + hybrid; lane 3: 
3+22+ hybrid; lane 4: Chinese hamster E36. Only freshly prepared cell homo-
genates were used. 
the hybrids was characterized with an antiserum di-
rected against purified hurnan p-galactosidase from 
normal liver. The antiserum is able to precipitate 
the residual pGAL activity in fibroblasts from the 
adult type 4 patient (figure 2, lanes 7 and 8). In 
the hybrids, all the ~GAL activity other than that 
of the Chinese hamster is removed by the antiserum 
(figure 2, lanes 2,4 ,6). The antiserum does not af-
fect the ~GAL activity of the Chinese hamster (fi-
gure 6, lanes 1 and 21. 
The effect of neuraminidase treatment on type 4 
fibroblasts and on the different types of hybrid 
cell lines is illustrated in figure 3. After incu-
bation for 1 hour at 37°C in buffer, the pGAL of 
type 4 fibroblasts is present as a broad band of 
activity (figure 3, lane 7). This activity shifts 
to a more cathodal position after neuraminidase 
treatment (figure 3, lanes 7 and 8). Quantitative 
analysis showed that the type 4 ~GAL is not af-
fected by the treatment. The markerband in 3+22-
hybrids is not removed, whereas the markerband in 
3-22+ hybrids disappears after.neuraminidase treat-
ment (figure 3, lanes 1,2,3 and 4). The additional 
band of activity on the human PGALB position in 
3+22+ hybrids remains present after treatment, but 
the activity between this band and the Chinese 
hamster band disappears. 
The data of the chromosome and enzyme analysis 
of the hybrid clones are summerized in Table I. In 
one clone, in which the PGAL markerband is present 
befare and after neuraminidase treatment, no chromo-
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Figure 5. Electrophoresis of ~GAL from type 1 x Chinese hamster hybrids after 
freezing to -70°c and thawing of the homogenates. Lane 1: 3+22- hybrid; lane 2: 
3-22+ hybrid; lane 3: 3+22+ hybrid. 
Figure 6. The effect of anti-human ~GAL antiserum on the electrophoretic pattern 
of ~GAL from type 1 x Chinese hamster hybrids. Lanes 1 and 2: Chinese hamster 
E36; lanes 3 and 4: 3+22- hybrid; lanes 5 and 6: 3-22+ hybrid; lanes 7 and 8: 
3+22+ hybrid. The cell homogenates of lanes 2,4,6 and 8 were treated with the 
antiserum. 
Figure 7. The effect of neuraminidase treatment on the electrophoretic pattern 
of ~GAL from type 1 x Chinese hamster hybrids. Lanes 1 and 2: 3+22- hybrid; 
lanes 3 and 4: 3-22+ hybrid; lanes 5 and 6: 3+22+ hybrid. Lanes 1,3 and 5 show 
the ~GAL patterns after incubation of the cell homogenates with buffer for 1 
hour at 37°C. Lanes 2,4 and 6 show the ~GAL patterns after treatment with neur-
aminidase for 1 hour at 37°C. 
some 3 and GPX could be detected. This can be due to 
breakage of chromosome 3. 
II. Hybrids between fibroblasts from a patient with 
infantile type 1 GM 1 - gangliosidosis and Chinese 
hamster cells. 
Eighteen primary and eighteen secondary clones 
were isolated following fusion of fibroblasts from 
the patient with infantile type 1 GM 1 -gangliosidosis 
and Chinese hamster cells. Most of these clones re-
tained the human chromosarnes 3 and 22. Starting with 
a mixed cell population, another six hybrid clones 
were selected in the presence of 106/ml 6-thioguanine 
in the culture medium (Table II). 
Figure 4 shows that the PGAL electrophoretic pat-
terns of three different types of hybrid cell lines 
(3+22-; 3-22+; 3+22+) are very similar. Each of them 
consists of activity at the position of the hamster-
band (see figure 4, lane 4) and the activity anodal 
but not separated from this band which is called 
the markerband. The PGAL electrophoretic pattern 
shown in figure 4 was only observed in all types of 
hybrids if freshly prepared homogenates were used 
for electrophoresis. The residualPGAL activity in 
fibroblasts from the type 1 GM 1 -gangliosidosis pa-
tient is less than 1% and is not detectable in our 
electrophoretic system. 
When freshly prepared homogenates of the three 
types of hybrids were stored overnight at -70°C and 
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TABLE I ANALYSIS OF HUMAN ADULT TYPE ~-GAL- X CHINESE HAMSTER 
HYBRIDS 
Number of % chromosarnes enzymes 
clones present GPX ACON ~-GAL 
3 22 m markerband 'B' band 
-neur +neur 
71 25-100 35-90 + + + + 
19 20-60 + + 
1 + + 
1 60 + + + 
4 
TABLE II ANALYSIS OF HUMAN GM1-GANGLIOSIDOSIS TYPE 1 X CHINESE HAMSTER HYBRIDS 
Nurnber of % chromosarnes enzyrnes 
clones present GPX ACON ~-GAL markerband 
m 3 22 -neur +neur 
26 20-80 30-90 + + + 
10 10-60 + + 
after selection in 6-thioguanine: 
3 
2 
1 
n. t. 
60 
n. t. 
n.t.: not tested. 
n. t. + + + 
+ + 
n.t. + + 
thawed shortly prior to electrophoresis, the marker-
band in 3+22- hybrids was no longer detectable (fig-
ure 5, lane 1). The {JGAL isoenzyme pattern in 3-22+ 
hybrids was not affected by this treatment (figure 
5, lanes 2 and 3). 
Characterization of these {JGAL electrophoretic 
patterns with an anti-human PGAL antiserum is illus-
trated in figure 6. The antiserum does notaffect 
the pGAL activity of the Chinese hamster whereas the 
activity at the position of the makerbands was re-
moved in all types of hybrids. 
Neuraminidase treatment of type 1 x Chinese ham-
ster hybrids resulted in a disappearance of the ac-
tivities at the position of the markerband (figure 
7). Incubation for 1 hour in buffer, which served 
as a control, reduced the activity of the marker-
band in 3+22- hybrids (figure 7, lane 1). 
The results of the analysis of all 42 hybrid 
clones are summarized in Table II. 
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DISCUSSION 
Gene localization studies revealed the presence 
of two structural ~-galactosidase <PGAL) loci, on 
the human chromosarnes 3 and 22 (de Wit et al., in 
press). The function of these two gene.s and their 
relation with different autosomal reces$ive diseases 
associated with ~-galactosidase deficiency is as 
yet unknown. In the present study, hybrid cell lines 
were isolated after fusion of fibroblasts frorn two 
different types of ~-galactosidase deficiency and 
Chinese hamster cells. 
In the first fusion, fibroblasts from a patient 
with the adult type ~GAL deficiency and Chinese 
hamster cells have been used. The hybrid cell lines 
isolated show pGAL electrophoretic patterns similar 
to the patterns from hybrids between control human 
fibroblasts and Chinese hamster cells ( 11 Control ·hy-
br ids 11 ) • 
With the anti-human ~GAL antiserum it could be 
shown that the markerbands as well as the additional 
band of activity on the human ~GALB position in 
3+22+ hybrids contain human determinants: Neuramini-
dase treat~ent of type 4 x Chinese hamster hybrids 
gave similar results eeropared to neuraminidase 
treatment of control hybrids. 
In every respect type 4 x Chinese hamster hybrids 
behave as hybrids between control fibroblasts and 
Chinese hamster cells; no evidence for a structural 
~GAL mutation in the adult type 4 is obtained. 
Wenger et al. ( 1978) found a neuraminidase defi.! 
ciency in one of his adult patients with a PGAL de-
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ficiency. In our laboratory we also found a neura-
minidase deficiency in our adult type 4 pGAL defi-
ciency (Hoogeveen et al., to be published). The ab-
sence of a structural PGAL mutation in the type 4 
patient is in agreement with a primary defect of 
neuraminidase in this patient. How PGAL deficiency 
can occur due to neuraminidase deficiency is as yet 
unknown. 
Another series of hybrid cell lines has been iso-
lated following fusion of fibroblasts from a patient 
with the infantile type 1 GM 1 -gangliosidosis and 
Chinese hamster cells. PGAL electrophoresis of these 
hybrid lines showed the presence of a markerband in 
3+22-, 3-22+ and 3+22+ hybrids. Immunological stu-
dies revealed the presence of human determinants in 
the isoenzymes of these markerbands. Because of the 
low residual ~GAL activity in the type 1 fibroblast~ 
it appears that the markerbands consist of hetero-
polymerie pGAL molecules formed by human and Chinese 
hamster subunits. In general, hybrids, isolated fol-
lowing fusion of fibroblasts with an enzyme defi-
ciency and radent cells, only show heteropolymerie 
molecules for the deficient enzyme if cross reacting 
material is present (Chern, 1977; Hamers, 1978). 
The markerband in 3+22- type 1 x Chinese hamster 
hybrids is labile compared to the markerbands in 
3-22+ and 3+22+ hybrids. This is in contrast with 
control hybrids, in which the markerband in 3+22-
hybrids is stabile compared to the markerband in 
3-22+ hybrids (de Wit et al., in press). Also the 
different behaviour of 3+22- type 1 x Chinese ham-
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ster hybrids towards neuraminidase treatment demon-
strates the abnormality of the markerband in 3+22-
hybrids. The additional band at the human pGALB 
position in 3+22+ control hybrids, which is most 
distinct after neuraminidase treatment (de Wit et 
al., in press), is lacking in type 1 x Chinese ham-
ster hybrids which contain bath chromosarnes 3 and 
22. These data indicate the presence of a mutation 
in the structural ~GAL gene on chromosome 3 in the 
type 1 patient. Because GM 1 - ~GAL is deficient in 
type 1 GM 1-gangliosidosis patients (Okada and 
O'Brien, 1968) and these patients' parents show he-
terozygous pGAL values (Wolfe et al., 1970), the P·· 
GAL gene on chromosome 3 is apparently a structural 
gene for GM 1 -p-galactosidase. 
Both series of hybrid cell lines confirm the lo-
calization of two structural PGAL genes on the human 
chromosarnes 3 and 22. As the result of the interac -
tion of the gene products coded for by these pGAL 
loci an additional band of activity at the human 
~GALB position can be formed. Because the gene on 
chromosome 3 is a structural GM 1 -~GAL gene, this 
suggests that also the gene on chromosome 22 is a 
structural GM 1 -pGAL gene. 
Biochemical studies revealed the presence of two 
GM 1-p-galactosidase isoenzymes (Narden et al., 1974) 
pGALA (Molecular Weight 70 000) is thought to be a 
monomer and pGALB (M.W. 700 000) is thought to be a 
multimeric aggregate of the monomeric protein. 
Whether this multimeric form also contains addi-
tional subunits is unknown (Frost et al., 1978). The 
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relationship 
siC(ase genes 
between the structural G _g_galacto-M1 1-' 
on chromosarnes 3 and 22 and the PGALA 
and pGAL 8 isoenzymes has to be illvestigated. 
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